Pfizer Inc
PFEHealthcare|Drug Manufacturers - General|USA
$27.83
-0.49 (-1.73%)
DCF (FCF)
$43.06
Earnings Power
$22.11
Clinical Trials (945)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT06862219 A Safety Study of Enfortumab Vedotin in Indian Adults With Urothelial Cancer | Metastatic Urothelial Carcinoma | P4 | Recruiting | 100 | Open-label | Enfortumab Vedotin |
| NCT06952660 Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer | Cervical Cancer | P4 | Recruiting | 100 | Open-label | TIVDAK |
| NCT05160922 Crizotinib Continuation Clinical Study | NSCLC, ALCL | P4 | Active | 27 | Open-label | crizotinib |
| NCT05203172 The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical Trials | Solid Tumors | P4 | Recruiting | 46 | Open-label | Binimetinib only treatment, Encorafenib only Treatment, Encorafenib & Binimetinib Treatment, Treatment of Encorafenib & Binimetinib & Ribociclib, Treatment of Encorafenib & Binimetinib & Cetuximab |
| NCT06985342 Acute Migraine Treatment in the ED With Gepants | Migraine Headaches | P4 | Recruiting | 100 | Open-label | Rimegepant, Zavegepant |
| NCT06684743 Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults | RSV | P4 | Recruiting | 690,000 | RCT, Open-label | RSV prefusion F protein-based vaccine |
| NCT02513394 PALbociclib CoLlaborative Adjuvant Study | Breast Cancer | P3 | Active | 5,796 | RCT, Open-label | Palbociclib, Standard Adjuvant Endocrine Therapy |
| NCT02319837 Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) | Hormone Sensitive Prostate Cancer, Prostate Cancer | P3 | Active | 1,068 | RCT, Open-label | Enzalutamide, Placebo (No longer applicable in Open Label study period), Leuprolide Open Label |
| NCT05132582 A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer | HER2 Positive Breast Cancer | P3 | Active | 654 | RCT, Double-blind | Tucatinib, Trastuzumab, Pertuzumab, Combination product: Trastuzumab + Pertuzumab, Placebo |
| NCT05654623 A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer | Advanced Breast Cancer | P3 | Active | 624 | RCT, Open-label | ARV-471, Fulvestrant |
| NCT06012435 A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | P3 | Active | 703 | RCT, Open-label | sigvotatug vedotin, docetaxel |
| NCT06650579 REVELUTION-2: Relugolix+Abiraterone Acetate (AA) Versus Leuprolide+AA Cardiac Trial | Recurrent Prostate Carcinoma, Stage III Prostate Cancer AJCC v8 | P3 | Recruiting | 72 | RCT, Double-blind | Abiraterone Acetate, Bicalutamide, Leuprolide, Prednisone, Relugolix |
| NCT04821622 Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPC | Prostate Cancer | P3 | Active | 599 | RCT, Double-blind | talazoparib plus enzalutamide, Placebo plus enzalutamide |
| NCT05911295 Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2 | Urothelial Carcinoma | P3 | Active | 412 | RCT, Open-label | disitamab vedotin, pembrolizumab, gemcitabine, cisplatin, carboplatin |
| NCT05253651 A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer | Colorectal Neoplasms | P3 | Recruiting | 400 | RCT, Open-label | tucatinib, trastuzumab, bevacizumab, cetuximab, oxaliplatin, leucovorin, levoleucovorin, fluorouracil |
| NCT03975647 A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer | HER2-positive Breast Cancer | P3 | Active | 466 | RCT, Double-blind | tucatinib, placebo, T-DM1 |
| NCT07029828 A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. | Severe Alopecia Areata | P3 | Recruiting | 140 | RCT, Double-blind | Ritlecitinib higher dose, Ritlecitinib lower dose |
| NCT06758401 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1. | Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung | P3 | Recruiting | 714 | RCT, Single-blind | Sigvotatug Vedotin, Pembrolizumab |
| NCT05326464 Tofacitinib in Recurrent GBM Patients | Glioblastoma | P3 | Active | 17 | Open-label | Tofacitinib 10mg |
| NCT07226089 Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature. | ISS, SGA | P3 | Recruiting | 254 | RCT, Open-label | Somatrogon, Genotropin |
| NCT07300839 A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age | COVID-19, SARS-COV-2 Infection | P3 | Recruiting | 25,500 | RCT, Double-blind | BNT162b2 Vaccine, Placebo |
| NCT06463457 Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED) | Prostate Cancer, Advanced Prostate Cancer | P2 | Active | 33 | Open-label | Darolutamide, Relugolix |
| NCT05548127 TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A) | Breast Cancer | P1P2 | Active | 37 | Open-label | ARV-471, Abemaciclib |
| NCT06330805 Effects of Relugolix vs Leuprolide on Cardiac Function in Patients With Prostate Cancer | Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8 | P2 | Recruiting | 70 | RCT, Open-label | Leuprolide, Relugolix |
| NCT03297606 Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR) | Lymphoma, Non-Hodgkin, Multiple Myeloma | P2 | Recruiting | 720 | Open-label | Olaparib, Dasatinib, Nivolumab plus Ipilimumab, Axitinib, Bosutinib, Crizotinib, Palbociclib, Sunitinib, Temsirolimus, Erlotinib, Trastuzumab plus Pertuzumab, Vemurafenib plus Cobimetinib, Vismodegib, Tucatinib |
| NCT05199051 A Phase 2 Study of Gemtuzumab Ozogamicin (GO)-Gilteritinib Combination in Adults With FLT3-ITD and/or FLT3-TKD Relapse/Refractory (R/R) AML | AML, Leukaemia (Acute Myeloid) | P2 | Active | 19 | Open-label | — |
| NCT04486352 A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer | Endometrial Cancer | P1P2 | Recruiting | 148 | Open-label | Atezolizumab - 28 Day Cycle, Bevacizumab, Ipatasertib, Talazoparib, Trastuzumab emtansine, Tiragolumab, Atezolizumab - 21 Day Cycle, Inavolisib, Letrozole, Giredestrant, Abemaciclib |
| NCT03260023 Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers | HPV-Related Carcinoma, HPV-Related Cervical Carcinoma | P1P2 | Active | 143 | RCT, Open-label | TG4001, Avelumab |
| NCT03911973 Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers | TNBC - Triple-Negative Breast Cancer | P1P2 | Active | 37 | Open-label | Gedatolisib, Talazoparib |
| NCT04072952 A Phase 1/2 Trial of ARV-471 Alone and in Combination With Palbociclib (IBRANCE®) in Patients With ER+/HER2- Locally Advanced or Metastatic Breast Cancer | Breast Cancer | P1P2 | Active | 217 | Open-label | ARV-471, ARV-471 in combination with palbociclib (IBRANCE®) |
| NCT03485209 Efficacy and Safety Study of Tisotumab Vedotin for Patients With Solid Tumors | Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung | P2 | Active | 352 | Open-label | tisotumab vedotin, pembrolizumab, carboplatin, cisplatin |
| NCT04430738 Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers | Colorectal Carcinoma, Gastric Adenocarcinoma | P2 | Active | 40 | Open-label | tucatinib, trastuzumab, oxaliplatin, leucovorin, fluorouracil, capecitabine, pembrolizumab |
| NCT02693535 TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer | Lymphoma, Non-Hodgkin, Multiple Myeloma | P2 | Recruiting | 4,200 | Open-label | Palbociclib, Sunitinib, Temsirolimus, Trastuzumab and Pertuzumab, Vemurafenib and Cobimetinib, Regorafenib, Olaparib, Nivolumab and Ipilimumab, Abemaciclib, Talazoparib, Atezolizumab and Talazoparib, Tucatinib plus Trastuzumab Subcutaneous (SC), Futibatinib, Dabrafenib plus Trametinib, Fam-Trastuzumab Deruxtecan-Nxki (TDxD) |
| NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study | Prostate Cancer | P2 | Recruiting | 900 | Open-label | enzalutamide, abiraterone acetate, prednisone, Leuprolide acetate |
| NCT05170334 Binimetinib Plus Belinostat for Subjects With Metastatic Uveal Melanoma | Metastatic Uveal Melanoma | P2 | Active | 7 | Open-label | Binimetinib, Belinostat |
| NCT03786081 Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer | Cervical Cancer | P1P2 | Active | 214 | Open-label | Tisotumab Vedotin, Bevacizumab, Pembrolizumab, Carboplatin |
| NCT06157892 A Study of Disitamab Vedotin With Other Anticancer Drugs in Solid Tumors | Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma | P2 | Recruiting | 172 | RCT, Open-label | disitamab vedotin, tucatinib |
| NCT06003231 A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2 | Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms | P2 | Active | 120 | Open-label | disitamab vedotin |
| NCT02664935 National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer, Carcinoma, Squamous Cell | P2 | Active | 423 | Open-label | AZD4547, Vistusertib, Palbociclib, Crizotinib, Selumetinib, Docetaxel, AZD5363, Osimertinib, Durvalumab, Sitravatinib, AZD6738 |
| NCT02925234 The Drug Rediscovery Protocol (DRUP Trial) | Cancer, Tumors | P2 | Recruiting | 1,550 | Open-label | Panitumumab, Olaparib, Dabrafenib, Nilotinib, Trametinib, Erlotinib, Trastuzumab and Pertuzumab (combination treatment), Vemurafenib and Cobimetinib (combination treatment), Vismodegib, Regorafenib, Nivolumab, Afatinib, Dabrafenib and trametinib, Ribociclib, Lenvatinib, Pembrolizumab, Durvalumab, Rucaparib, Axitinib, Palbociclib, Crizotinib, Sunitinib, Cabozantinib, Abemaciclib, Alectinib, Atezolizumab and Bevacizumab, Ipilimumab and nivolumab, Entrectinib, Talazoparib, Dacomitinib, Lorlatinib, Erdafitinib, Alpelisib, Niraparib, Pemigatinib, Selpercatinib, Tepotinib |
| NCT04879329 A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2 | Urothelial Carcinoma | P2 | Recruiting | 372 | RCT, Open-label | disitamab vedotin, pembrolizumab |
| NCT06206837 A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer. | Breast Cancer | P1P2 | Active | 71 | Open-label | vepdegestrant, PF-07220060 |
| NCT04039230 Study to Evaluate Sacituzumab Govitecan in Combination With Talazoparib in Patients With Metastatic Breast Cancer. | Breast Cancer | P1P2 | Active | 75 | Open-label | Talazoparib, Sacituzumab Govitecan |
| NCT04557449 Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors | Liposarcoma, Prostate Cancer | P2 | Active | 362 | Open-label | PF-07220060, Midazolam |
| NCT00329043 Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy | Prostate Cancer | P2 | Active | 64 | Open-label | LHRH Agonist, Sunitinib Malate |
| NCT06712836 A Phase 2b Study to Examine the Safety and Efficacy of Once-Weekly MET097 in Adults With Obesity or Overweight | Obesity, Overweight or Obesity | P2 | Active | 225 | RCT, Double-blind | MET097, Placebo |
| NCT05995964 A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis | Atopic Dermatitis | P2 | Recruiting | 340 | RCT, Double-blind | PF-07275315, PF-07264660 |
| NCT06483100 Measurable Residual Disease-Guided Post-Transplant Elranatamab Maintenance | Multiple Myeloma | P2 | Recruiting | 65 | Open-label | Elrantamab |
| NCT05149768 Open Label Extension Study of Brentuximab Vedotin in Early dcSSc | Diffuse Cutaneous Systemic Sclerosis | P2 | Recruiting | 11 | Open-label | Brentuximab vedotin |
| NCT05357794 Effectiveness of Concurrent Ultra-Low-Dose Total-Skin Electron Beam Therapy and Brentuximab Vedotin Given Quarterly Over 12 Months for Patients With Mycosis Fungoides | Mycosis Fungoides | P2 | Recruiting | 30 | Open-label | Brentuximab vedotin |
| NCT05805826 To Understand the Safety and Effects of a C. Difficile Vaccine With New Adds-Ons That Will Be Given to Healthy Adults | Clostridoides Difficile Associated Disease | P1P2 | Active | 936 | RCT, Double-blind | C. difficile vaccine (previously studied formulation)., C. difficile vaccine formulation 1., C. difficile vaccine formulation 2., C. difficile vaccine formulation 3. |
| NCT07231991 A Study to Learn How the Body Processes the Study Medicine Called Vepdegestrant in People With Loss of Liver Function | Healthy Participants | P1 | Recruiting | 24 | Open-label | vepdegestrant |
| NCT04389632 A Study of Sigvotatug Vedotin in Advanced Solid Tumors | Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck | P1 | Recruiting | 1,006 | Open-label | sigvotatug vedotin, pembrolizumab, cisplatin, carboplatin |
| NCT06130995 Relugolix + Enzalutamide Study in High-Risk Prostate Cancer | Androgen Deprivation Therapy, Locally Advanced Prostate Cancer | P1 | Recruiting | 46 | Open-label | Relugolix and Enzalutamide |
| NCT06254495 A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers | Hodgkin Disease, Lymphoma, T-Cell, Peripheral | P1 | Active | 57 | Open-label | PF-08046044/SGN-35C |
| NCT04227847 A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies | Myelodysplastic Syndrome, Acute Myeloid Leukemia | P1 | Recruiting | 178 | Open-label | SEA-CD70, azacitidine, Venetoclax |
| NCT05208762 A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | Carcinoma, Non-Small-Cell Lung, Squamous Cell Carcinoma of the Head and Neck | P1 | Recruiting | 714 | Open-label | PF-08046054, pembrolizumab |
| NCT05266105 A Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients | Breast Cancer | P1 | Active | 60 | Open-label | Palazestrant, Palbociclib |
| NCT06466187 A Study of SGN-MesoC2 in Advanced Solid Tumors | Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms | P1 | Active | 19 | Open-label | PF-08052666 |
| NCT05508906 Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer | Metastatic Breast Cancer, ER-positive Breast Cancer | P1 | Recruiting | 190 | Open-label | Palazestrant, Ribociclib, Alpelisib, Everolimus, Atirmociclib |
| NCT06686797 A Study to Learn How Different Amounts of the Study Medicine Called PF-08049820 Are Tolerated and Act in the Body in Healthy Adults | Healthy | P1 | Active | 71 | RCT, Double-blind | PF-08049820, Placebo |
| NCT05538130 A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors | Melanoma, Glioma | P1 | Recruiting | 124 | Open-label | PF-07799544, PF-07799933 |
| NCT03460977 A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma | Metastatic Castration Resistant Prostate Cancer (mCRPC), Small Cell Lung Cancer (SCLC) | P1 | Recruiting | 453 | Open-label | Mervometostat (PF-06821497), Enzalutamide, Itraconazole |
| NCT06974734 A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies | Carcinoma, Non Small Cell Lung, Carcinoma, Pancreatic Ductal | P1 | Active | 9 | Open-label | PF-08046037, sasanlimab |
| NCT06704724 A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. | Carcinoma, Pancreatic Ductal, Colorectal Neoplasms | P1 | Active | 30 | Open-label | PF-07985045 |
| NCT07400679 A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity. | Overweight, Obesity | P1 | Recruiting | 54 | RCT, Open-label | PF-08653944 |
| NCT06995729 A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine | Acute Treatment of Migraine | P1 | Recruiting | 16 | Open-label | Zavegepant |
| NCT05198245 Study of Pregnancy Outcomes in Women Exposed to Rimegepant During Pregnancy | Migraine | Active | 1 | — | Rimegepant, Various | |
| NCT01848028 PsoBest - The German Psoriasis Registry | Psoriasis, Psoriatic-arthritis | Recruiting | 3,500 | — | — | |
| NCT01731353 FungiScope - A Global Emerging Fungal Infection Registry | Invasive Fungal Disease | Recruiting | 1,000 | — | — | |
| NCT01277419 German Spondyloarthritis Inception Cohort | Ankylosing Spondylitis (AS) / Radiographic Axial SpA (r-axSpA), Non-radiographic Axial Spondyloarthritis (Nr-axSpA) | Recruiting | 1,000 | — | — | |
| NCT02009345 Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada | Familial Hypercholesterolemia, Lipid Disorder | Recruiting | 6,000 | — | — | |
| NCT05879913 ASCVD Management Using CCTA in Prostate Cancer Patients on ADT | Prostate Cancer | N/A | Recruiting | 100 | RCT, Open-label | — |
| NCT03275311 Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | Metastatic Breast Cancer | Recruiting | 40,000 | — | — | |
| NCT03577197 Southeast Netherlands Advanced Metastatic Breast Cancer Registry | Advanced Breast Cancer, Metastatic Breast Cancer | Recruiting | 7,000 | — | — | |
| NCT04398628 ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders | Hematologic Disorder, Bleeding Disorder | Recruiting | 3,000 | — | — | |
| NCT00901602 Lebanese Interhospital Pneumococcal Surveillance Program | Pneumonia, Meningitis | Recruiting | 700 | — | — | |
| NCT03292094 The African-PREDICT Study | Cardiovascular Diseases, Hypertension | Active | 1,202 | — | — | |
| NCT01104220 Role of Immune System in Obesity-related Inflammation and Cardiometabolic Risk | Non-alcoholic Fatty Liver Disease, Metabolic Syndrome | N/A | Active | 144 | Open-label | — |
| NCT06813872 Effectiveness of ABRYSVO® Maternal Respiratory Syncytial Virus (RSV) Vaccine Against RSV in Infants in Western Pennsylvania | Respiratory Syncytial Viruses | Active | 1 | — | ABRYSVO Vaccination | |
| NCT06678555 A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out. | Carcinoma, Non-Small-Cell Lung | Active | 35 | — | Lorlatinib | |
| NCT00304772 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients | Candidiasis, Sepsis | P4 | Withdrawn | — | RCT, Single-blind | Fluconazole, Micafungin |
| NCT03711708 Relative Bioavailability Study of Zoloft Oral Solution to Zoloft Tablets | Healthy | P4 | Completed | 36 | RCT, Open-label | Zoloft Oral Solution, Zoloft tablets |
| NCT00644800 A Study of the Efficacy and Safety of Intramuscular Ziprasidone Followed by Oral Ziprasidone for the Treatment of Psychosis | Schizophrenia, Mania | P4 | Completed | 89 | Open-label | Ziprasidone |
| NCT00174330 Comparing Amlodipine/Atorvastatin Co-Administration To Amlodipine Alone In Patients With Hypertension And Dyslipidemia | Hypertension, Hyperlipidemia | P4 | Completed | 330 | RCT, Open-label | atorvastatin, amlodipine |
| NCT02918968 Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate Cancer | Prostate Cancer | P4 | Completed | 206 | RCT, Open-label | Enzalutamide, Flutamide |
| NCT01322867 A Bioequivalence Study Of A New Alprazolam Dropped Formulation Versus Alprazolam Tablets | Healthy | P4 | Completed | 30 | RCT, Open-label | alprazolam tablet, alprazolam oral solution |
| NCT00847483 Comparison of Latanoprost With Travoprost and Bimatoprost in Patients With Elevated IOP. A 12-weeks, Masked Evaluator, Phase IV Multi-center Study in the US | Glaucoma, Ocular Hypertension | P4 | Completed | 375 | RCT, Single-blind | latanoprost 0.005% ophthalmic solution, Travoprost 004% sterile ophthalmic solution, Bimatoprost .03% sterile ophthalmic solution |
| NCT00219570 Dalacin-T Gel Post Approval Study | Acne Vulgaris | P4 | Completed | 134 | RCT, Single-blind | clindamycin, nadifloxacin |
| NCT00640549 Atorvastatin and LDL Profile in Non-Insulin Dependent Diabetes Mellitus | Hyperlipidemia, Diabetes Mellitus, Type 2 | P4 | Terminated | 41 | RCT, Double-blind | Atorvastatin, Placebo |
| NCT01455428 Pregabalin for Treatment of Patients With Postherpetic Neuralgia (PHN) | Postherpetic Neuralgia ( PHN ) | P4 | Completed | 223 | RCT, Double-blind | Lyrica (pregabalin), Placebo |
| NCT00644982 A Comparison of Sertraline Versus Venlafaxine XR in the Treatment of Major Depression | Depressive Disorder, Major | P4 | Completed | 163 | RCT, Double-blind | sertraline, venlafaxine XR |
| NCT00917579 Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet | Hypercholesterolemia | P4 | Completed | 76 | RCT, Open-label | Atorvastatin, Atorvastatin |
| NCT00151463 QEQ Treatment Responsiveness Evaluation Study | Impotence | P4 | Completed | 100 | Open-label | sildenafil citrate |
| NCT00632385 Efficacy and Safety of Eletriptan for the Treatment of Migraine in Patients Not Satisfied With Rizatriptan Therapy | Migraine | P4 | Completed | 127 | Open-label | Eletriptan |
| NCT00143260 Study Of Men With Mild To Moderate Erectile Dysfunction To Evaluate The Efficacy Of Viagra 8 Hours Post-Dose | Impotence | P4 | Completed | 250 | RCT, Double-blind | Viagra (Sildenafil Citrate) 100 mg |
| NCT01298466 Primary Care Identification Of Patients With Chronic Neuropathic Low Back Pain Study | Low Back Pain, Neuralgia | P4 | Withdrawn | — | Open-label | Pregabalin |
| NCT00643799 Safety and Efficacy of Celecoxib Versus Naproxen in the 6-month Treatment of Knee Osteoarthritis | Osteoarthritis, Knee | P4 | Completed | 586 | RCT, Double-blind | Celecoxib, Naproxen, Placebo |
| NCT00137033 Celebrex Low Dose ASA Study Examining the Incidence of Gastroduodenal Ulcers in a Healthy Population | Peptic Ulcers | P4 | Completed | 605 | RCT, Double-blind | Celecoxib, Naproxen, ASA |
| NCT00647543 Atorvastatin Study For The Treatment Of High Cholesterol In Patients From Thailand | Dyslipidemias | P4 | Completed | 242 | Open-label | Atorvastatin, Atorvastatin, Atorvastatin |
| NCT00844376 Bioavailability Study for New Atorvastatin Formulation | Hypercholesterolemia | P4 | Completed | 12 | RCT, Open-label | Atorvastatin suspension, Lipitor |
| NCT00230568 EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) | Alzheimer's Disease | P4 | Completed | 100 | Open-label | Aricept |
| NCT00380874 Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer | Chemotherapy-Induced Peripheral Neuropathy | P4 | Terminated | 64 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00748566 One-Year Trial Of Oral Ziprasidone In Patients With Metabolic Syndrome | Schizophrenia and Disorders With Psychotic Features | P4 | Terminated | 172 | Open-label | Ziprasidone HCL (oral) |
| NCT00640627 Efficacy and Safety of Celecoxib Versus Placebo in the Treatment of Patients With Osteoarthritis of the Knee Who Were Unresponsive to Naproxen and Ibuprofen | Osteoarthritis, Knee | P4 | Completed | 380 | RCT, Double-blind | Celecoxib, Placebo |
| NCT00406315 Study Evaluating The Safety, Tolerability, And Efficacy Of Switching From Quetiapine To Ziprasidone | Schizophrenia, Schizoaffective Disorder | P4 | Completed | 255 | Open-label | ziprasidone |
| NCT00139776 Study Of "Continuous Use" Of Celecoxib Vs. "Usual or Intermittent Use" | Osteoarthritis, Knee, Osteoarthritis, Hip | P4 | Completed | 875 | RCT, Double-blind | Celecoxib, Celecoxib |
| NCT00407511 Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP | Diabetic Peripheral Neuropathic Pain (DPN), Postherpetic Neuralgia (PHN) | P4 | Completed | 121 | Open-label | Pregabalin |
| NCT00282932 Detrol LA In Men With Overactive Bladder. | Overactive Bladder (OAB) | P4 | Completed | 600 | RCT, Double-blind | Detrol LA |
| NCT00159809 Efficacy Study Measuring The Impact Of Treatment With Viagra On The Depressive Symptoms Of Men With Erectile Dysfunction | Impotence, Depression | P4 | Completed | 140 | RCT, Double-blind | Viagra (Sildenafil citrate) |
| NCT02060487 Effects of Oral Sildenafil on Mortality in Adults With PAH | Pulmonary Arterial Hypertension | P4 | Terminated | 385 | RCT, Double-blind | sildenafil citrate, sildenafil citrate, sildenafil citrate |
| NCT00290901 Celebrex vs Tramadol in the Treatment of Chronic Lower Back Pain. | Back Pain | P4 | Completed | 754 | RCT, Double-blind | Tramadol Hydrochloride 50mg, Celebrex 200mg |
| NCT00474175 Benzocaine Gel Toothache Dose-Response Study | Toothache | P4 | Completed | 577 | RCT, Double-blind | Placebo gel, benzocaine, benzocaine |
| NCT00143481 Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women | Urinary Incontinence | P4 | Completed | 400 | RCT, Double-blind | Tolterodine ER 4mg QD |
| NCT00633438 Effect of Celecoxib Versus Placebo Before and After Knee Surgery on Overall Use of Analgesics After Surgery | Arthroscopy | P4 | Completed | 204 | RCT, Double-blind | Celecoxib |
| NCT00630929 Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (Europe) | Osteoarthritis, Knee | P4 | Completed | 388 | RCT, Double-blind | Ibuprofen, Placebo, Celecoxib |
| NCT01838044 Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component | Chronic Low Back Pain With a Neuropathic Component | P4 | Terminated | 180 | RCT, Double-blind | pregabalin and celecoxib, Placebo and celecoxib |
| NCT00638807 Safety and Efficacy of Celecoxib Versus Placebo in the Treatment of Knee Osteoarthritis in Patients Who Were Unresponsive to Naproxen and Ibuprofen | Osteoarthritis, Knee | P4 | Completed | 388 | RCT, Double-blind | Celecoxib |
| NCT00442325 Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets | Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | P4 | Completed | 595 | Open-label | Atorvastatin (Lipitor) |
| NCT00584779 An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis | PK Properties Of Gabapentin In Subjects With Impaired Renal Function | P4 | Terminated | 8 | Open-label | Gabapentin, Gabapentin, Gabapentin, Gabapentin |
| NCT00411437 Effects Of Detrol LA On Memory And Cognition In Elderly Population | Memory, Cognition | P4 | Completed | 220 | RCT, Double-blind | Tolterodine ER, Oxybutynin ER |
| NCT00147654 Effect and Safety Of Detrol LA In Men With Overactive Bladder Symptoms With Or Without Bladder Outlet Obstruction | Urinary Incontinence | P4 | Completed | 830 | RCT, Double-blind | Tolterodine ER 4 mg QD, Tamsulosin 0.4 mg QD |
| NCT01030653 Pharmacokinetics of Voriconazole in Obese Subjects | Healthy | P4 | Completed | 10 | RCT, Open-label | Voriconazole low dose, Voriconazole high dose |
| NCT00646841 Effects of Doxazosin Gastrointestinal Therapeutic System on Ambulatory Blood Pressure and Cardiovascular Risk Factors in Uncontrolled Hypertensive Patients | Hypertension | P4 | Completed | 89 | Open-label | Doxazosin gastrointestinal therapeutic system (GITS) |
| NCT00359151 Celebrex Total Knee Arthroplasty Study | Osteoarthritis, Pain | P4 | Terminated | 22 | RCT, Double-blind | Celecoxib, Placebo |
| NCT00631696 Evaluation Of Sperm Production With Healthy Male Volunteers Receiving Lyrica Or Placebo | Healthy | P4 | Completed | 222 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00245258 Study to Evaluate Viagra's Ability to Provide a Better Sexual Experience Through Quality Erections and Satisfaction | Impotence | P4 | Completed | 312 | RCT, Double-blind | Sildenafil Citrate |
| NCT00477659 Neural Correlates In Mild Alzheimer's Disease | Alzheimer's Disease | P4 | Completed | 14 | Open-label | Donepezil hydrochloride |
| NCT00332761 Caduet in an Untreated Subject Population | Hypertension, Dyslipidemia | P4 | Completed | 220 | RCT, Double-blind | Caduet |
| NCT01995513 Safety Study of Continued Enzalutamide Treatment In Prostate Cancer Patients | Prostate Cancer | P4 | Completed | 509 | RCT, Double-blind | Enzalutamide, Abiraterone, Placebo for Enzalutamide, Prednisone |
| NCT00571064 The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility | Mild to Severe Alzheimer's Disease | P4 | Completed | 97 | Open-label | Donepezil HCl |
| NCT00677352 A Study Of Sertraline Compared With Paroxetine In The Treatment Of Panic Disorder | Panic Disorder | P4 | Completed | 321 | RCT, Double-blind | sertraline, Paroxetine |
| NCT00412113 A Multi-Risk Factor Strategy vs a Guideline-Based Approach in Achieving Blood Pressure and Lipid Goals in Hypertensives at Extra Risk | Dyslipidemia, Hypertension | P4 | Completed | 245 | RCT, Double-blind | Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination, Amlodipine besylate, Amlodipine besylate/atorvastatin calcium single pill combination |
| NCT00430716 To Assess The Efficacy and Safety Of Oral Sildenafil in the Treatment of Pulmonary Arterial Hypertension. | Pulmonary Arterial Hypertension | P4 | Terminated | 130 | RCT, Double-blind | Sildenafil citrate, Sildenafil citrate, Sildenafil citrate, Sildenafil citrate |
| NCT00635531 A Study to Evaluate the Use of Extended Release Alprazolam in the Treatment of Adolescents With Panic Disorder | Panic Disorder | P4 | Terminated | 16 | RCT, Double-blind | alprazolam XR |
| NCT01190007 Open Label Study To Evaluate The Long-Term Safety Profiles Of Caduet In Japanese Patients | Hypertension, Hypercholesterolemia | P4 | Completed | 159 | Open-label | Caduet |
| NCT00141141 Efficacy And Safety Study Of Atorvastatin Versus Simvastatin In Type 2 Diabetic Subjects With Hypercholesterolemia | Hypercholesterolemia | P4 | Completed | 383 | RCT, Open-label | Atorvastatin, Simvastatin |
| NCT00293176 The Evaluation of the Efficacy and Safety of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment (MCI) | Memory Loss | P4 | Completed | 821 | RCT, Double-blind | Donepezil Hydrochloride, Placebo |
| NCT00634348 A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients | Schizophrenia | P4 | Completed | 256 | RCT, Double-blind | Aripiprazole, Ziprasidone |
| NCT00654017 A Study Evaluating the Efficacy and Safety of Sildenafil in Patients With Erectile Dysfunction Receiving Hemodialysis | Erectile Disfunction, Hemodialysis | P4 | Completed | 100 | RCT, Double-blind | placebo, sildenafil |
| NCT00728988 Atorvastatin Pre-Treatment Study In Asian Patients With Acute Coronary Syndrome | Acute Coronary Syndrome | P4 | Completed | 499 | RCT, Open-label | Atorvastatin, Atorvastatin |
| NCT00174395 A Trial to Study of the Effects of Eletriptan 40mg on Mild vs Moderate to Severe Pain Intensity of Migraine | Migraine | P4 | Completed | 220 | RCT, Open-label | eletriptan |
| NCT00650429 A Study of the Efficacy and Safety of Ziprasidone for the Treatment of Acute Exacerbation of Schizophrenia or Schizoaffective Disorder | Schizophrenia, Schizoaffective Disorder | P4 | Completed | 28 | Open-label | Ziprasidone |
| NCT00644670 A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol | Dyslipidemias | P4 | Completed | 232 | RCT, Open-label | Atorvastatin, Atorvastatin |
| NCT00159757 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients | Schizophrenia | P4 | Terminated | 150 | Open-label | ziprazidone |
| NCT00323297 Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | P4 | Completed | 105 | RCT, Double-blind | Bosentan, Bosentan, Sildenafil Citrate |
| NCT00468650 A Multicenter, Open Label, To Evaluate The Efficacy And Satisfaction Of Patrex® In Men With Erectile Dysfunction. | Erectile Dysfunction | P4 | Completed | 117 | Open-label | sildenafil citrate |
| NCT00082589 The Purpose of This Study is to Determine if Eplerenone is Effective in Treatment of Mild to Moderate Heart Failure | Heart Failure, Congestive | P4 | Completed | 250 | RCT, Double-blind | Eplerenone |
| NCT01302938 Web-based Methodology Trial to Evaluate the Efficacy and Safety of Tolterodine ER in Subjects With Overactive Bladder | Overactive Bladder | P4 | Terminated | 18 | RCT, Double-blind | Tolterodine ER, Placebo |
| NCT04741204 Metformin Use to Reduce Disparities in Newly Diagnosed Breast Cancer | Breast Cancer Stage, Insulin Resistance | P4 | Withdrawn | — | Open-label | Metformin Extended Release Oral Tablet |
| NCT00640809 Comparison of Small Bowel Lesions Associated With Celecoxib Versus Ibuprofen Plus Omeprazole | Bowel Diseases, Inflammatory | P4 | Completed | 408 | RCT, Double-blind | Celecoxib, Ibuprofen plus Omeprazole |
| NCT00645320 A Study of Ziprasidone for the Treatment of Psychosis in Patients Who Had Already Had Benefits From Ziprasidone Treatment in a Previous Study | Pyschotic Disorders | P4 | Completed | 75 | Open-label | Ziprasidone |
| NCT00654082 A Study Evaluating the Efficacy and Safety of Sildenafil in Men With Traumatic Spinal Cord Injury and Erectile Dysfunction | Spinal Cord Injury, Erectile Dysfunction | P4 | Completed | 88 | RCT, Double-blind | sildenafil, placebo |
| NCT00301262 Impact Of Viagra On Sexual Satisfaction Of Men With Mild Erectile Dysfunction Who Are Sexually Dissatisfied | Impotence | P4 | Completed | 183 | RCT, Double-blind | Viagra (Sildenafil citrate) |
| NCT00140049 A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma | Glaucoma, Open Angle, Ocular Hypertension | P4 | Completed | 238 | RCT, Single-blind | Xalacom, Cosopt |
| NCT00648596 A Study to Evaluate Self-esteem and Relationships in Males With Erectile Dysfuntion | Erectile Dysfunction | P4 | Completed | 780 | RCT, Double-blind | sildenafil, placebo |
| NCT01977651 A Study to Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide | Metastatic Castration-resistant Prostate Cancer (mCRPC) | P4 | Completed | 424 | Open-label | Enzalutamide |
| NCT00620867 Efficacy and Safety of Celecoxib Versus Ibuprofen in the Treatment of Osteoarthritis of the Knee (United States) | Osteoarthritis, Knee | P4 | Completed | 393 | RCT, Double-blind | Ibuprofen, celecoxib |
| NCT00159718 Double Blind Atorvastatin Amlodipine Study | Angina | P4 | Completed | 360 | RCT, Double-blind | amlodipine, atorvastatin |
| NCT00634985 Safety and Efficacy of Eletriptan for the Treatment of Migraine in Subjects Unsuccessfully Treated With Nonsteroidal Anti-inflammatory Drugs | Migraine | P4 | Completed | 120 | Open-label | eletriptan |
| NCT01176968 Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction | Myocardial Infarction | P4 | Completed | 1,012 | RCT, Double-blind | Eplerenone, Placebo |
| NCT00902512 Study Of Bioavailability Of Two Sildenafil 100mg Oral Tablet Formulations | Healthy Males | P4 | Completed | 30 | RCT, Open-label | Treatment A, Blood samples for the analysis of sildenafil in plasma, Treatment B, Treatment C |
| NCT00649064 A Study of the Effects of Ziprasidone for the Treatment of Schizophrenia or Schizoaffective Disorder in Patients Who Were Switched From Other Antipsychotic Drugs | Schizoaffective Disorder, Schizophrenia | P4 | Completed | 46 | Open-label | Ziprasidone |
| NCT01257542 Acute Cough Study In Children | Common Cold, Infections, Upper Respiratory Tract | P4 | Terminated | 140 | RCT, Double-blind | Dextromethorphan, Placebo |
| NCT00647101 A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma | Glaucoma, Open-Angle, Ocular Hypertension | P4 | Completed | 600 | Open-label | Latanoprost |
| NCT00163202 Comparative Atorvastatin Pleiotropic Effects | Coronary Arteriosclerosis, Hypercholesterolemia | P4 | Completed | 330 | RCT, Double-blind | Atorvastatin |
| NCT00807846 A Study To Evaluate The Effects Of Celecoxib (Celebrex®) Or Naproxen On Blood Pressure In Pediatric Subjects | Arthritis, Juvenile Rheumatoid | P4 | Completed | 201 | RCT, Double-blind | Celecoxib, Naproxen |
| NCT00446797 Open Label Comparative Study On Celecoxib Efficacy And Safety Vs Non-Selective NSAID In Acute Pain Due To Ankle Sprain | Ankle Sprain | P4 | Completed | 278 | RCT, Open-label | Non-selective NSAIDS, Celecoxib |
| NCT00230789 Effect Of Detrol LA With Behavioral Intervention In Overactive Bladder Subjects Dissatisfied With Recent OAB Medication. | Urinary Incontinence | P4 | Completed | 417 | Open-label | Tolterodine ER 4 mg QD |
| NCT00137020 Clinical Effect Of Cross Titration Of Antipsychotics With Ziprasidone In Schizophrenia Or Schizoaffective Disorder | Schizophrenia, Psychotic Disorders | P4 | Completed | 294 | Open-label | ziprasidone |
| NCT00644956 A Randomized, Open-Label, Crossover, Multicenter, Single Dose Comparator Study Evaluating Onset Of Penile Rigidity In Men With Erectile Dysfunction Who Are Treated With Sildenafil And Tadalafil | Erectile Dysfunction | P4 | Completed | 56 | RCT, Open-label | tadalafil, sildenafil |
| NCT00143221 Effectiveness and Safety of Viagra in Men With ED and LUTS Due to Benign Prostatic Hyperplasia (BPH) | Impotence | P4 | Completed | 350 | RCT, Double-blind | Viagra, Placebo |
| NCT00143208 Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. | Glaucoma, Ocular Hypertension | P4 | Completed | 250 | Open-label | Xalacom |
| NCT00644631 A Multicenter, Randomized, Parallel Group, Double-Blind, Placebo Controlled, Flexible Dose Escalation Study To Evaluate Sexual And Relationship Satisfaction In The Female Partner Of Men With Erectile Dysfunction Treated With Sildenafil Citrate | Erectile Dysfunction | P4 | Completed | 300 | RCT, Double-blind | sildenafil, placebo |
| NCT00245596 Evaluation of the Index of Sexual Life Questionnaire | Impotence | P4 | Completed | 120 | Open-label | sildenafil |
| NCT00297973 Cardiovascular Risk Assessment in Patients Treated With Caduet | Hypertension | P4 | Completed | 1,442 | RCT, Open-label | — |
| NCT00785772 A Post-Marketing Clinical Pharmacokinetics Study Of Gabapentin In Japanese Epileptic Subjects With Renal Impairment | Renal Impairment | P4 | Terminated | 1 | Open-label | Gabapentin, Gabapentin, Gabapentin |
| NCT01020474 Adolescent Fibromyalgia Study | Fibromyalgia | P4 | Completed | 107 | RCT, Double-blind | placebo, pregabalin (Lyrica) |
| NCT00159692 Amlodipine Diabetic Hypertension Efficacy Response Trial | Hypertension | P4 | Completed | 739 | RCT, Double-blind | Amlodipine |
| NCT00351611 Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo | Epilepsies, Partial | P4 | Completed | 187 | RCT, Double-blind | Lyrica (pregabalin), placebo |
| NCT00159679 Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P4 | Completed | 167 | RCT, Double-blind | Pregabalin |
| NCT00624780 Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder | Generalized Anxiety Disorder | P4 | Completed | 615 | RCT, Double-blind | Pregabalin, Lorazepam, Pregabalin, Placebo |
| NCT02116582 A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer | Metastatic Castration-Resistant Prostate Cancer | P4 | Completed | 215 | Open-label | Enzalutamide |
| NCT00855738 A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice | Focal Epilepsy | P4 | Completed | 111 | Open-label | Gabapentin, Lamotrigine, Levetiracetam, Pregabalin, Oxcarbacepine, Tiagabine, Topiramate, Zonisamide |
| NCT01642407 Safety And Efficacy Of Sildenafil In Children With Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension, Hypertension, Pulmonary | P4 | Completed | 6 | Open-label | Sildenafil |
| NCT00150358 To Yield Further Information On The Efficacy And Safety Of Viagra Among Subjects With Arterial Hypertension . | Impotence, Hypertension | P4 | Completed | 253 | Open-label | Sildenafil Citrate |
| NCT00537940 Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures | Epilepsy, Partial Seizure Disorder | P4 | Completed | 482 | RCT, Double-blind | Pregabalin, Gabapentin |
| NCT00163150 Vasomotor Reactivity In Cerebral Small Vessel Disease And New Approach To Treat Lacunar Stroke | Cerebrovascular Accident, Hypercholesterolemia | P4 | Completed | 128 | RCT, Double-blind | Atorvastatin |
| NCT00917644 Bioequivalence Study Comparing A New 80 Mg Atorvastatin Tablet To A 80 Mg Atorvastatin Commercial Tablet | Hypercholesterolemia | P4 | Completed | 76 | RCT, Open-label | Atorvastatin |
| NCT00442845 Establish The Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets (ACTFAST) | Coronary Arteriosclerosis, Diabetes Mellitus, Type 2 | P4 | Completed | 2,080 | Open-label | Atorvastatin (Lipitor) |
| NCT00143377 Study to Determine The Effectiveness Of Detrusitol In Patients Diagnosed With OAB | Urinary Incontinence | P4 | Completed | 600 | RCT, Double-blind | tolterodine SR, overactive bladder |
| NCT00645281 A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder. | Urinary Bladder, Overactive | P4 | Completed | 896 | Open-label | tolterodine extended release |
| NCT00137397 A Study to Measure the Effect of Tolterodine Extended Release on the Thickness of the Bladder Wall in Patients With Overactive Bladder | Urinary Incontinence | P4 | Completed | 80 | RCT, Double-blind | Tolterodine ER, Placebo |
| NCT00540293 Lipitor Korean Atorvastatin Goal Achievement Across Risk Levels Study | Dyslipidemias | P4 | Completed | 425 | Open-label | Atorvastatin |
| NCT00645424 A Study To Evaluate The Safety And Efficacy Of Atorvastatin In Patients With Diabetes And High Cholesterol | Hyperlipidemias | P4 | Completed | 155 | RCT, Open-label | atorvastatin, atorvastatin, atorvastatin |
| NCT00635076 A Study to Assess the Long-term Use of Alprazolam Extended Release (XL) in the Treatment of Adolescents With Panic Disorder | Panic Disorder | P4 | Terminated | 3 | RCT, Double-blind | alprazolam XR |
| NCT00644709 A Study Of Atorvastatin For The Treatment Of High Cholesterol In Patients At High Risk Of Coronary Heart Disease (CHD) | Dyslipidemias | P4 | Completed | 196 | Open-label | Atorvastatin |
| NCT00147628 Assessment Of Sildenafil On Erectile Function And Intercourse Satisfaction And To Validate A New Subject Questionnaire | Impotence | P4 | Completed | 209 | RCT, Double-blind | sildenafil citrate, placebo for sildenafil citrate |
| NCT00640432 Safety And Efficacy Of Celecoxib Versus Sodium Diclofenac In The Treatment Of Acute Low Back Pain | Low Back Pain | P4 | Completed | 244 | RCT, Double-blind | Diclofenac, Celecoxib |
| NCT00644748 A Study on the Efficacy and Safety of Gabapentin in the Treatment of Patients With Painful Diabetic Neuropathy | Diabetic Neuropathies | P4 | Completed | 95 | Open-label | gabapentin |
| NCT00159666 Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia | Post-Herpetic Neuralgia | P4 | Completed | 255 | RCT, Double-blind | pregabalin |
| NCT02004613 Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery | Heart Disease | P4 | Completed | 798 | RCT, Double-blind | Dexmedetomidine, Placebo |
| NCT00596882 Message Priming and Enrollment in, and Response to, a Smoking Cessation Program: A Pilot Study | Smoking Cessation | P4 | Completed | 100 | RCT, Open-label | — |
| NCT00873730 Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain | Ankylosing Spondylitis | P4 | Completed | 108 | RCT, Double-blind | etanercept, etanercept/placebo |
| NCT00409344 Dexmedetomidine for Postoperative Sedation in Patients Undergoing Repair of Thoracoabdominal Aortic Aneurysms | Sedation, Respiration, Artificial | P4 | Terminated | — | RCT, Double-blind | Dexmedetomidine |
| NCT01104311 Strategy for Adequate Blood Pressure Lowering in the Patients With Intracranial Atherosclerosis | Brain Ischemia | P4 | Terminated | 132 | RCT, Single-blind | — |
| NCT04214197 Study of Crisaborole Ointment 2% in Mild to Moderate Atopic Dermatitis | Atopic Dermatitis | P4 | Unknown | 150 | Open-label | Crisaborole 2% Top Oint |
| NCT02228382 Safety And Efficacy Study Of Bosutinib In Patients With Philadelphia Chromosome Positive Chronic Myeloid Leukemia Previously Treated With One Or More Tyrosine Kinase Inhibitors | Previously Treated PH + CML | P4 | Terminated | 163 | Open-label | Bosutinib |
| NCT00169013 Gabapentin in Phantom and Stump Pain | Amputation of Lower Limb | P4 | Completed | — | RCT, Double-blind | Gabapentin |
| NCT00828113 Long-term Varenicline Treatment for Smoking Cessation | Smoking | P4 | Completed | 101 | RCT, Double-blind | varenicline, varenicline |
| NCT02464969 Apixaban for the Acute Treatment of Venous Thromboembolism in Children | Venous Thromboembolism | P4 | Completed | 229 | RCT, Open-label | Apixaban, Standard of Care |
| NCT00936065 Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis | Moderate to Severe Psoriasis | P4 | Completed | 60 | RCT, Open-label | Etanercept, Etanercept + Acitretin, Acitretin |
| NCT00195507 Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis | Psoriasis | P4 | Completed | 720 | RCT, Open-label | Etanercept |
| NCT00455364 Voriconazole as Prophylactic Therapy in Lung Transplant Recipients | Infection | P4 | Terminated | 20 | RCT, Open-label | Voriconazole |
| NCT00472641 Geodon in Weight Loss Study for Bipolar Disorders | Bipolar Disorder | P4 | Completed | 25 | Open-label | Ziprasidone/Geodon |
| NCT00999258 Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients | Glomerular Filtration Rate, Chronic Allograft Nephropathy | P4 | Unknown | 50 | RCT, Open-label | sirolimus |
| NCT00323635 A Comparison of Tolterodine and Placebo Treatments on Nocturnal Frequency and Sleep Quality in Women After Menopause. | Urinary Incontinence | P4 | Terminated | 19 | RCT, Double-blind | tolterodine |
| NCT00406107 Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion | Branch Retinal Vein Occlusion | P4 | Completed | 20 | RCT, Open-label | pegaptanib sodium (Macugen) |
| NCT00435487 Dalteparin Versus Unfractionated Heparin In Patients With Acute Coronary Syndrome | Angina, Unstable, Myocardial Infarction | P4 | Terminated | 173 | RCT, Open-label | Dalteparin ( Fragmin), Unfractionated heparin |
| NCT01189500 Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects | Pharmacokinetics | P4 | Completed | 30 | Open-label | Tamoxifen, Tamoxifen and Desvenlafaxine Succinate Sustained Release |
| NCT00643539 Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat | Tonsillitis | P4 | Completed | 360 | RCT, Open-label | Zithromax, Clamoxyl |
| NCT00195429 A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients | Kidney Failure, Graft vs Host Disease | P4 | Completed | 47 | RCT, Open-label | Tacrolimus, Sirolimus, prednisone |
| NCT00147524 Non-Comparative Study To Evaluate Changes In FMD After Quinapril Therapy In Hypertensive Women | Menopause, Hypertension | P4 | Completed | 70 | Open-label | quinapril |
| NCT00638053 A Study to Evaluate the Efficacy of Somatropin in Adults With Growth Hormone Deficiency Caused by Trauma and/or Head Injury | Brain Injuries, Growth Hormone Deficiency Dwarfism | P4 | Terminated | 100 | Open-label | — |
| NCT00368186 Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants. | Pneumococcal Infections | P4 | Terminated | 51 | Open-label | Pneumo 23 |
| NCT00827931 Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery | Biliary Tract Surgical Procedures, Pancreaticoduodenectomy | P4 | Completed | 94 | RCT, Open-label | Tranexamic acid + Standard of Care |
| NCT02935998 The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation | Schizophrenia | P4 | Unknown | 1,000 | Open-label | Ziprasidone |
| NCT01356472 Linezolid Alone or Combined With Carbapenem Against Methicillin-resistant Staphylococcus Aureus (MRSA) in Ventilator-associated Pneumonia | Methicillin-resistant Staphylococcus Aureus, Pneumonia, Ventilator-Associated | P4 | Unknown | 60 | RCT, Open-label | Imipenem/cilastatin |
| NCT02831855 Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis | Rheumatoid Arthritis | P4 | Completed | 694 | RCT, Double-blind | CP-690,550, Methotrexate, Placebo |
| NCT00657449 A Double-blind, Double-dummy, Multicenter, Randomized Study of the Efficacy and Tolerability of Valdecoxib 40 mg Versus Rofecoxib 50 mg in Treating the Symptoms of Ankle Sprain | Acute Pain | P4 | Terminated | 45 | RCT, Double-blind | valdecoxib, rofecoxib |
| NCT00432263 Treatment Of Adult Growth Hormone Deficiency After Traumatic Brain Injury. | Brain Injuries | P4 | Withdrawn | — | RCT, Double-blind | Genotropin (PN-180,307) Somatropin |
| NCT01200056 Virtual Histology Findings and Effects of Varying Doses of Atorvastatin Treatment | Coronary Disease, Ultrasonography, Interventional | P4 | Completed | 40 | RCT, Double-blind | Atorvastatin 10mg versus 40mg. |
| NCT00147602 Lipitor In The Prevention Of Stroke, For Patients Who Have Had A Previous Stroke | Cardiovascular Disease | P4 | Completed | 4,732 | RCT, Double-blind | atorvastatin |
| NCT00518375 Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus | Kidney Transplantation | P4 | Completed | 250 | RCT, Open-label | Rapamune® (Sirolimus), Neoral® (Cyclosporine), Corticosteroids |
| NCT00950170 Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting | Hemophilia A | P4 | Completed | 23 | Open-label | — |
| NCT00435747 Efficacy And Safety Of Parecoxib IV/IM 40 Mg Vs Placebo Following Sub Muscular Breast Augmentation | Pain, Postoperative | P4 | Withdrawn | — | RCT, Double-blind | PARECOXIB SODIUM |
| NCT00159848 Effect Of A Treatment Optimization Program To Improve Satisfaction With Viagra | Impotence | P4 | Completed | 8,000 | Open-label | — |
| NCT01783015 Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate | Rheumatoid Arthritis | P4 | Terminated | 16 | RCT, Double-blind | Etanercept, Etanercept, Placebo, Placebo |
| NCT01193582 A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria | Pneumococcal Infections | P4 | Completed | 505 | Open-label | Prevenar, Prevenar, Prevenar, Prevenar |
| NCT00858780 Study Comparing The Effect On Disease Activity When Reducing Or Discontinuing Etanercept In Subjects With RA | Rheumatoid Arthritis | P4 | Completed | 91 | RCT, Double-blind | Etanercept, Etanercept, Placebo |
| NCT01836276 Understanding Disparities in Quitting in African American and White Smokers | Smoking Cessation | P4 | Completed | 449 | Open-label | Varenicline |
| NCT02602704 Effectiveness of Bazedoxifene for Prevention of Glucocorticoid-induced Bone Loss in RA Patients | Arthritis, Rheumatoid | P4 | Completed | 114 | RCT, Open-label | Bazedoxifene, Calcium/Vit D |
| NCT00473174 Comparison of Awakening Versus Bedtime Dosing of Ramipril in Subjects With Essential Hypertension | Hypertension | P4 | Completed | 120 | RCT, Open-label | Ramipril |
| NCT02509026 Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA | Spondylitis, Ankylosing | P4 | Completed | 210 | Open-label | Etanercept |
| NCT00474708 Study Comparing the Efficacy of Venlafaxine XR Vs. SSRIs and Conventional Antidepressants in Depressed Patients | Major Depressive Disorder | P4 | Completed | 1,151 | RCT, Open-label | Effexor, SSRI |
| NCT00133770 Intravenous (IV) Pantoprazole in Erosive Esophagitis | Esophagitis | P4 | Completed | 20 | Open-label | pantoprazole |
| NCT00420303 Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy | Spondylarthropathies, Enthesitis | P4 | Completed | 24 | RCT, Double-blind | Etanercept |
| NCT00445328 Dalteparin vs Unfractionated Heparin For The Prevention Of Venous Thromboembolism (VTE) In Hospitalized Acutely Ill Medical Patients | Venous Thromboembolism | P4 | Terminated | 84 | RCT, Open-label | Dalteparin (Fragmin), Unfractionated heparin |
| NCT05687032 A Study of Inotuzumab Ozogamicin in Chinese Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia | Acute Lymphoblastic Leukemia | P4 | Completed | 44 | Open-label | inotuzumab ozogamicin |
| NCT00282217 Study Evaluating Sirolimus in the Treatment of Kidney Transplant | Kidney Failure, Kidney Diseases | P4 | Completed | 100 | Open-label | Sirolimus |
| NCT00343655 Evaluation of Atorvastatin Treatment on Carotid Plaque. | Cardiovascular Diseases | P3 | Terminated | 160 | RCT, Double-blind | Atorvastatin |
| NCT01441440 Venlafaxine ER Phase 3 Study for Major Depressive Disorder (MDD) | Major Depressive Disorder | P3 | Completed | 538 | RCT, Double-blind | venlafaxine ER 75 mg/day (fixed dose), venlafaxine ER 75 mg/day to 225 mg/day (flexible dose), Placebo |
| NCT04424511 Effects of Mass Drug Administration of Azithromycin on Mortality and Other Outcomes Among 1-11 Month Old Infants in Mali | Mortality | P3 | Completed | 149,201 | RCT, Double-blind | Placebo, Azithromycin |
| NCT01986270 Comparative Study of Oral Eletriptan (40mg and 80mg), Oral Sumatriptan (25mg and 50mg) and Placebo | Migraine With or Without Aura | P3 | Completed | 1,141 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 25 mg, Sumatriptan 50 mg |
| NCT06218069 Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor | NSCLC | P2P3 | Not Yet Recruiting | 20 | Open-label | Sasanlimab, [89Zr]Zr-crefmirlimab berdoxam |
| NCT00402038 Study of Methylnaltrexone (MNTX) for the Relief of Constipation | Advance Illness Patients With OIC | P3 | Completed | 134 | RCT, Double-blind | SC Methylnaltrexone, SC Placebo |
| NCT00333866 Randomized, Double-Blind, Placebo-Controlled Trial Of Pregabalin In Patients With Fibromyalgia. | Fibromyalgia | P3 | Completed | 747 | RCT, Double-blind | pregabalin, pregabalin, pregabalin, placebo |
| NCT00143130 Pregabalin In Partial Seizures Extension Study | Seizures | P3 | Completed | 227 | Open-label | Pregabalin |
| NCT00151489 Safety and Efficacy Study of Pregabalin in Fibromyalgia | Fibromyalgia | P3 | Completed | 1,020 | RCT, Double-blind | pregabalin, placebo |
| NCT01212991 A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer | Prostate Cancer | P3 | Completed | 1,717 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00976716 An Open-Label Study Of Celecoxib In Patients With Posttraumatic Pain | Pain | P3 | Completed | 80 | Open-label | Celecoxib |
| NCT00645398 A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia | Fibromyalgia | P3 | Completed | 751 | RCT, Double-blind | Pregabalin, Pregabalin, Pregabalin, Placebo |
| NCT00674752 A Polysomnographic Study Of Single-Dose Gabapentin In Transient Insomnia | Transient Insomnia | P3 | Completed | 377 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00141271 A Six-Week Study Evaluating The Efficacy And Safety Of Geodon In Patients With A Diagnosis Of Bipolar I Depression | Bipolar Disorder | P3 | Completed | 536 | RCT, Double-blind | Geodon (Ziprasidone), Geodon (Ziprasidone), Placebo |
| NCT00230776 A Controlled Pregabalin Trial In Fibromyalgia | Fibromyalgia | P3 | Completed | 740 | RCT, Double-blind | pregabalin, placebo |
| NCT00549549 Celebrex In Acute Gouty Arthritis Study | Arthritis, Gouty | P3 | Completed | 402 | RCT, Double-blind | Indomethacin, Celecoxib, Celecoxib, Celecoxib |
| NCT00143351 Mozart Relapse Study | Schizophrenia | P3 | Completed | 75 | Open-label | Ziprasidone |
| NCT00282997 A Safety Study Of Pregabalin In Fibromyalgia | Fibromyalgia | P3 | Completed | 500 | Open-label | pregabalin |
| NCT01152216 An Extension of the CONCERT Protocol (DIM18) | Alzheimer's Disease | P3 | Terminated | 672 | Open-label | Dimebon |
| NCT04501978 ACTIV-3: Therapeutics for Inpatients With COVID-19 | Covid19 | P3 | Completed | 2,753 | RCT, Double-blind | LY3819253, Placebo, Remdesivir, VIR-7831, BRII-196/BRII-198, AZD7442, MP0420, PF-07304814 |
| NCT00754013 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10 | Down Syndrome, Cognitive Dysfunction | P3 | Terminated | 9 | RCT, Double-blind | Aricept (Donepezil hydrochloride), Placebo |
| NCT00163241 Effect Of Celecoxib On Hip Osteoarthritis (OA) Progression | Osteoarthritis | P3 | Terminated | 666 | RCT, Double-blind | celecoxib |
| NCT01115855 Clinical Study Of Eplerenone In Japanese Patients With Chronic Heart Failure | Heart Failure | P3 | Completed | 221 | RCT, Double-blind | Eplerenone, Placebo |
| NCT00159887 Study to Assess the Longterm Safety of Sildenafil Citrate in Patients With Pulmonary Arterial Hypertension | Pulmonary Hypertension | P3 | Completed | 260 | Open-label | Sildenafil citrate |
| NCT00827606 Atorvastatin Three Year Pediatric Study | Familial Hypercholesterolemia | P3 | Completed | 272 | Open-label | atorvastatin |
| NCT00645372 A Study to Compare the Efficacy and Safety of Ziprasidone and Risperidone for the Treatment of Schizophrenia in Chinese Patients | Schizophrenia | P3 | Completed | 242 | RCT, Double-blind | Risperidone, Ziprasidone |
| NCT02288247 A Study to Assess the Benefit of Treatment Beyond Progression With Enzalutamide in Men Who Are Starting Treatment With Docetaxel After Worsening of Their Prostate Cancer When Taking Enzalutamide Alone | Metastatic Castration Resistant Prostate Cancer | P3 | Completed | 688 | RCT, Double-blind | Enzalutamide, Docetaxel, Prednisolone, Placebo |
| NCT00468845 Study Of The Efficacy And Safety Of Pregabalin Compared To Placebo For Treatment Of Post-Surgical Pain From Hysterectomy | Pain, Postoperative | P3 | Completed | 501 | RCT, Double-blind | pregabalin (Lyrica), pregabalin (Lyrica), matched placebo |
| NCT00383019 A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). | Glaucoma, Ocular Hypertension | P3 | Completed | 300 | RCT, Double-blind | Xalatan, Xalacom |
| NCT00141258 Pregabalin Epilepsy Add-On Trial | Partial Seizures | P3 | Completed | 178 | RCT, Double-blind | pregabalin |
| NCT01945775 A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) | Breast Neoplasms, BRCA 1 Gene Mutation | P3 | Completed | 431 | RCT, Open-label | talazoparib, Physician's-Choice |
| NCT01248416 Aromatase Inhibitors, Alone And In Combination With Growth Hormone In Adolescent Boys With Idiopathic Short Stature | Idiopathic Short Stature | P3 | Completed | 76 | RCT, Open-label | Aromatase Inhibitor, Growth Hormone, Aromatase Inhibitor and Growth Hormone |
| NCT00920946 A Safety and Efficacy Study of Dimebon in Patients With Huntington Disease | Huntington Disease | P3 | Completed | 403 | RCT, Double-blind | Dimebon |
| NCT01061372 12-Week Efficacy And Safety Of Pregabalin In Treating Restless Legs Syndrome (RLS) Subjects | Restless Legs Syndrome | P3 | Withdrawn | — | RCT, Double-blind | Placebo, pregabalin, pregabalin |
| NCT00219596 Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension | Glaucoma, Open Angle, Ocular Hypertension | P3 | Completed | 240 | RCT, Open-label | Xalacom, unfixed Latanoprost and Timolol |
| NCT00394901 A 13-Week, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Postherpetic Neuralgia | Neuralgia, Postherpetic | P3 | Completed | 372 | RCT, Double-blind | Placebo, Pregabalin, Pregabalin, Pregabalin |
| NCT00838110 A Phase 3 Study To Evaluate The Safety And Tolerability Of Dimebon Patients With Mild To Moderate Alzheimer's Disease | Alzheimer's Disease | P3 | Completed | 742 | RCT, Double-blind | Dimebon, Placebo, Dimebon, Placebo |
| NCT00151450 Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder | Anxiety | P3 | Completed | 390 | RCT, Double-blind | Pregabalin, Venlafaxine XR |
| NCT00666939 A Study of Single-Dose Gabapentin in Subjects With Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 773 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00401375 Study of Intravenous (IV) Methylnaltrexone Bromide (MNTX) in the Treatment of Post-Operative Ileus (POI) | Post-Operative Ileus (POI) | P3 | Completed | 524 | RCT, Double-blind | Methylnaltrexone, Placebo |
| NCT01864746 A Study of Palbociclib in Addition to Standard Endocrine Treatment in Hormone Receptor Positive Her2 Normal Patients With Residual Disease After Neoadjuvant Chemotherapy and Surgery | Breast Cancer, Hormonreceptor Positive | P3 | Completed | 1,250 | RCT, Double-blind | Palbociclib PD-0332991, Placebo |
| NCT00649844 A Study Comparing the Efficacy and Tolerability of Ziprasidone vs. Clozapine for the Treatment of Schizophrenia in Patients Who Continue to Have Symptoms on or Cannot Tolerate Other Antipsychotic Drugs | Schizophrenia | P3 | Completed | 147 | RCT, Double-blind | Clozapine, Ziprasidone |
| NCT00751049 A Study of Open Angle Glaucoma or Ocular Hypertension in Patients Within the United Kingdom | Ocular Hypertension, Open Angle Glaucoma | P3 | Completed | 294 | RCT, Double-blind | timolol, PhXA41 |
| NCT00659100 A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment | Transient Insomnia | P3 | Completed | 1,254 | Open-label | Gabapentin |
| NCT01463306 A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures | Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures | P3 | Completed | 605 | Open-label | Pregabalin |
| NCT00257166 Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) | Bipolar Disorder | P3 | Completed | 238 | RCT, Double-blind | Ziprasidone oral capsules, placebo oral capsules |
| NCT00716859 A Phase 3 Prospective, Randomized, Double-Masked, 12-Week, Parallel Group Study In Pediatric Subjects With Glaucoma. | Glaucoma | P3 | Completed | 139 | RCT, Double-blind | Timolol, latanoprost |
| NCT00645229 A Study of the Efficacy and Safety of Ziprasidone in Patients With Acute Exacerbation of Schizophrenia or Schizoaffective Disorder | Schizophrenia, Schizoaffective Disorder | P3 | Terminated | 1 | Open-label | Ziprasidone |
| NCT00553280 A Long-Term Study To Evaluate Safety And Efficacy Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 123 | Open-label | pregabalin |
| NCT00754052 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17 | Down Syndrome, Cognitive Dysfunction | P3 | Terminated | 8 | RCT, Double-blind | Aricept (donepezil hydrochloride), Aricept (donepezil hydrochloride), Placebo |
| NCT01057693 Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy | Diabetic Neuropathy, Painful | P3 | Completed | 633 | RCT, Double-blind | pregabalin (Lyrica), Placebo |
| NCT00483548 Adjunctive Ziprasidone in the Treatment of Bipolar I Depression | Bipolar Disorder, Depression, Bipolar | P3 | Completed | 298 | RCT, Double-blind | Ziprasidone, Placebo |
| NCT00232180 A Comparison Of Outcomes In Patients In New York Heart Association (NYHA) Class II Heart Failure When Treated With Eplerenone Or Placebo In Addition To Standard Heart Failure Medicines | Heart Failure | P3 | Completed | 2,743 | Open-label | Eplerenone |
| NCT02003924 Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | Nonmetastatic Castration-Resistant Prostate Cancer, Prostate Cancer | P3 | Completed | 1,401 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00151502 To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. | Alzheimer's Disease | P3 | Completed | 600 | RCT, Double-blind | Atorvastatin |
| NCT00830167 Randomized, Double-Blind, Placebo-Controlled Study Of Pregabalin In Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 498 | RCT, Double-blind | Placebo, Pregabalin |
| NCT00159874 A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension (PAH) In Children | Pulmonary Arterial Hypertension | P3 | Completed | 234 | RCT, Open-label | Sildenafil citrate, Sildenafil citrate, Sildenafil citrate |
| NCT00150280 Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery | Pain, Postoperative | P3 | Completed | 132 | RCT, Double-blind | celecoxib and ibuprofen SR |
| NCT01049217 Pregabalin Versus Placebo In The Treatment Of Neuropathic Pain Associated With HIV Neuropathy | Neuropathy | P3 | Terminated | 377 | RCT, Double-blind | pregabalin, placebo |
| NCT00402987 Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat | Pharyngitis | P3 | Completed | 269 | RCT, Double-blind | Celecoxib, Celecoxib, celecoxib, placebo |
| NCT01145417 Pregabalin Trial In HIV Neuropathic Pain | HIV-1 Infection, Neuropathic Pain | P3 | Terminated | 217 | Open-label | pregabalin (Lyrica) |
| NCT01113541 One-Year Trial of Oral Ziprasidone in Bipolar Patients With Metabolic Syndrome | Bipolar Disorder | P3 | Terminated | 13 | Open-label | Ziprasidone HCL (oral) |
| NCT00159653 A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma | Glaucoma, Open-Angle, Ocular Hypertension | P3 | Completed | 500 | RCT, Double-blind | Xalacom, Xalatan, Timolol |
| NCT00407745 A 17-Week Trial To Assess Pregabalin For The Treatment Of Nerve Pain Due To Spinal Cord Injury | Neuralgia, Spinal Cord Injuries | P3 | Completed | 220 | RCT, Double-blind | placebo, pregabalin |
| NCT01986088 Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study | Migraine With or Without Aura | P3 | Completed | 1,008 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg, Sumatriptan 50 mg, Sumatriptan 100 mg |
| NCT00645515 A Study Comparing the Safety and Efficacy of Ziprasidone and Risperidone for the Treatment of Chronic Schizophrenia | Schizophrenia | P3 | Terminated | 240 | RCT, Double-blind | Ziprasidone, Risperidone |
| NCT01964326 Actual Use Trial of Atorvastatin Calcium 10 mg | Hypercholesterolemia | P3 | Completed | 1,311 | Open-label | Atorvastatin calcium 10 mg |
| NCT01432236 A Phase 3b Multicenter Study of Pregabalin in Fibromyalgia Subjects Who Have Comorbid Depression | Fibromyalgia | P3 | Completed | 197 | RCT, Double-blind | Pregabalin, placebo |
| NCT00524030 Efficacy And Safety Study Of Pregabalin (Lyrica) As Monotherapy In Patients With Partial Seizures | Epilepsies, Partial | P3 | Terminated | 161 | RCT, Double-blind | pregabalin 600 mg/day, pregabalin 150 mg/day |
| NCT00372528 An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures | Epilepsy | P3 | Terminated | 21 | Open-label | pregabalin (LYRICA) |
| NCT00829374 Safety and Efficacy Study Evaluating Dimebon in Patients With Mild to Moderate Alzheimer's Disease on Donepezil | Alzheimer's Disease | P3 | Completed | 1,003 | RCT, Double-blind | Dimebon, Dimebon, Placebo comparator |
| NCT00631943 A Study to Evaluate the Efficacy and Safety of Pregabalin (Lyrica) for the Treatment of Nerve Pain | Neuralgia | P3 | Completed | 112 | Open-label | Pregabalin (Lyrica) |
| NCT01085266 An Extension of the HORIZON Protocol Evaluating the Safety of Dimebon (Latrepirdine) in Subjects With Huntington Disease | Huntington Disease | P3 | Terminated | 362 | Open-label | Dimebon (latrepirdine) |
| NCT01124877 Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) | Bipolar Disorder | P3 | Withdrawn | — | Open-label | ziprasidone oral capsules |
| NCT00974311 Safety and Efficacy Study of MDV3100 in Patients With Castration-Resistant Prostate Cancer Who Have Been Previously Treated With Docetaxel-based Chemotherapy | Castration-Resistant Prostate Cancer | P3 | Completed | 1,199 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00330785 Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia | Hypertension, Dyslipidemia | P3 | Completed | 1,250 | Open-label | Amlodipine/Atorvastatin |
| NCT01888497 Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers | Healthy | P3 | Completed | 59 | RCT, Double-blind | Gabapentin, Diphenhydramine citrate, Triazolam, Placebo |
| NCT03447132 Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to Fulvestrant | Breast Neoplasm Female | P3 | Completed | 354 | RCT, Double-blind | Fulvestrant 500mg, Palbociclib 125mg, Goserelin 3.6 MG, Placebos |
| NCT03047980 Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome | Sturge-Weber Syndrome | P2P3 | Completed | 10 | Open-label | Sirolimus |
| NCT01389596 A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years | Epilepsy, Partial Seizures | P3 | Completed | 295 | RCT, Double-blind | Pregabalin add-on therapy, Pregabalin add-on therapy, Pregabalin add-on therapy |
| NCT00096473 Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease | Alzheimer's Disease, Dementia | P3 | Completed | 229 | RCT, Double-blind | Donepezil hydrochloride |
| NCT00354081 WENBIT - Western Norway B Vitamin Intervention Trial | Coronary Artery Disease, Myocardial Infarction | P3 | Completed | 3,096 | RCT, Double-blind | folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), folic acid, vitamin B12 (cyanocobalamin), vitamin B6 (pyridoxine), placebo |
| NCT00530946 A Randomized Study To Evaluate Efficacy And Safety Of A Fixed Combination Therapy Of Amlodipine And Atorvastatin | Hypertension, Hypercholesterolemia | P3 | Completed | 165 | RCT, Open-label | Amlodipine 2.5mg/Atorvastatin 5mg, Amlodipine 2.5mg/Atorvastatin 10mg, Amlodipine 5mg/Atorvastatin 5mg, Amlodipine 5mg/Atorvastatin 10mg |
| NCT00666575 A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness | Transient Insomnia | P3 | Completed | 2,105 | RCT, Double-blind | Gabapentin, Placebo |
| NCT00667108 A Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 784 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00415623 A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient | Hypertension | P3 | Completed | 305 | RCT, Double-blind | Amlodipine, Amlodipine |
| NCT01485887 Venlafaxine ER Long-Term Extension Study for Major Depressive Disorder (MDD) | Major Depressive Disorder | P3 | Completed | 50 | Open-label | Venlafaxine ER |
| NCT00368745 Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use. | Generalized Anxiety Disorder | P3 | Completed | 108 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00644605 A Study to Assess the Efficacy and Safety of 20, 40, and 80mg of Sildenafil Three Times a Day in the Treatment of Pulmonary Arterial Hypertension | Hypertension, Pulmonary | P3 | Completed | 275 | RCT, Double-blind | sildenafil, sildenafil, placebo, sildenafil |
| NCT00800267 A Study of Glaucoma or Ocular Hypertension in Patients Within the United States | Ocular Hypertension, Glaucoma | P3 | Completed | 418 | RCT, Double-blind | latanoprost 0.005%, fixed combination latanoprost-timolol, timolol 0.5% |
| NCT00991276 Polysomnography Study Of Pregabalin And Pramipexole Versus Placebo In Patients With Restless Legs Syndrome And Associated Sleep Disturbance | Restless Legs Syndrome | P3 | Completed | 85 | RCT, Double-blind | pregabalin, placebo, pramipexole |
| NCT00265382 Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia | Schizophrenia | P3 | Terminated | 221 | Open-label | Ziprasidone oral capsules |
| NCT00666770 A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Transient Insomnia | P3 | Completed | 309 | RCT, Double-blind | Gabapentin, Gabapentin, Placebo |
| NCT00232141 Study of Pregabalin Versus Placebo in the Treatment of Nerve Pain Associated With HIV Neuropathy | HIV Infections, Peripheral Neuropathy | P3 | Completed | 302 | RCT, Double-blind | pregabalin, Placebo |
| NCT00280566 Safety and Maintenance of Effect of Ziprasidone Plus a Mood Stabilizer in Bipolar I Disorder (Manic or Mixed) | Bipolar Mania, Bipolar Disorder | P3 | Completed | 584 | RCT, Double-blind | Placebo, Ziprasidone Oral Capsule |
| NCT00346034 This Study is An Open-Label Trial Of Pregabalin In Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 357 | Open-label | Pregabalin |
| NCT00883740 Effects Of Pregabalin (Lyrica) On Sleep Maintenance In Subjects With Fibromyalgia | Fibromyalgia, Sleep Disorders | P3 | Completed | 119 | RCT, Double-blind | Pregabalin, Placebo |
| NCT00723606 A Randomized, Open-Label, Multi-Center Study To Evaluate The Efficacy And Safety Of Intramuscular Ziprasidone In Patients With Agitation | Schizophrenia | P3 | Completed | 376 | RCT, Open-label | Intramuscular ziprasidone mesylate, Intramuscular haloperidol |
| NCT02677896 A Study of Enzalutamide Plus Androgen Deprivation Therapy (ADT) Versus Placebo Plus ADT in Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC) | Metastatic Hormone Sensitive Prostate Cancer | P3 | Completed | 1,150 | RCT, Double-blind | Enzalutamide, Placebo |
| NCT00230763 Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure | Glaucoma, Primary Open Angle (POAG), Ocular Hypertension | P3 | Completed | 396 | Open-label | LATANOPROST 0.005% / TIMOLOL 0.5% FIXED COMBINATION |
| NCT00905437 Study To Investigate The Effectiveness Of Pregabalin For Management Of Patients Undergoing Total Hip Replacement | Pain, Perioperative | P3 | Terminated | 72 | RCT, Double-blind | Placebo, Pregabalin |
| NCT01747915 A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures. | Generalized Tonic Clonic Seizures | P3 | Completed | 219 | RCT, Double-blind | Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo |
| NCT02075047 Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder | Bipolar Disorder | P3 | Terminated | 171 | RCT, Double-blind | placebo oral capsules, ziprasidone oral capsules |
| NCT01989936 Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral Sumatriptan | Migraine With or Without Aura | P3 | Completed | 446 | RCT, Double-blind | Placebo, Eletriptan 40 mg, Eletriptan 80 mg |
| NCT00413010 Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD). | Generalized Anxiety Disorder | P3 | Completed | 356 | RCT, Double-blind | pregabalin, placebo |
| NCT01720524 A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn | Pulmonary Hypertension, Familial Persistent, of the Newborn | P3 | Completed | 59 | RCT, Double-blind | placebo, iv sildenafil |
| NCT00147589 A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. | Hypertension | P3 | Completed | 320 | RCT, Double-blind | Eplerenone |
| NCT01271933 Study Of A Controlled Release Formulation Of Pregabalin In Fibromyalgia Patients | Fibromyalgia | P3 | Completed | 441 | RCT, Double-blind | pregabalin, placebo |
| NCT00662558 A Six Week Study Of The Pain Relieving Effects Of Celecoxib 200 Mg Twice Daily Compared To Tramadol 50 Mg Four Times Daily In Patients With Chronic Low Back Pain | Low Back Pain | P3 | Completed | 802 | RCT, Double-blind | celecoxib, tramadol HCL |
| NCT00282464 A Six-week Flexible Dose Study Evaluating the Efficacy and Safety of Geodon in Patients With Bipolar I Depression. | Bipolar Disorder | P3 | Completed | 392 | RCT, Double-blind | Placebo, Geodon (Ziprasidone) |
| NCT00150371 Canadians Achieve Cholesterol Targets Fast With Atorvastatin Stratified Titration | Hypercholesterolemia | P3 | Completed | 1,100 | Open-label | atorvastatin |
| NCT01744106 A Multicenter Study of Pseudoephedrine for the Temporary Relief of Nasal Congestion in Children With the Common Cold | Nasal Congestion Associated With the Common Cold | P3 | Completed | 565 | RCT, Double-blind | pseudoephedrine hydrochloride 30 mg tablets, Placebo tablets |
| NCT03768726 Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder | Bipolar Disorder | P3 | Terminated | 23 | Open-label | Ziprasidone, Placebo |
| NCT00143156 Pregabalin vs Placebo in Treatment of Neuropathic Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathies | P3 | Completed | 450 | RCT, Double-blind | pregabalin |
| NCT00954590 A Safety and Efficacy Study Evaluating Dimebon (Latrepirdine) in Patients With Moderate to Severe Alzheimer's Disease | Moderate to Severe Alzheimer | P3 | Terminated | 89 | RCT, Double-blind | Dimebon (latrepirdine), Placebo |
| NCT01599754 Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients | Clear Cell Renal Carcinoma | P3 | Terminated | 724 | RCT, Double-blind | Axitinib, Placebo |
| NCT00280059 Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy | Epilepsy, Partial | P3 | Completed | 660 | RCT, Double-blind | Pregabalin, Lamotrigine |
| NCT00159770 Effect And Safety Of Ziprasidone Compared To Other Atypical Antipsychotic Drug In Schizophrenic Patients | Schizophrenia, Schizoaffective Disorder | P3 | Completed | 290 | RCT, Open-label | ziprasidone versus olanzapine , risperidone or quetiapine |
| NCT00265330 Safety and Tolerability of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed) | Bipolar Disorder | P3 | Completed | 169 | Open-label | Ziprasidone oral capsules |
| NCT02072824 A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures. | Partial Onset Seizures | P3 | Completed | 175 | RCT, Double-blind | Pregabalin Dose Level 1, Pregabalin Dose Level 2, Placebo |
| NCT01117220 Safety And Efficacy Of Ziprasidone In Children And Adolescents With Bipolar I Disorder (Manic Or Mixed) (Protocol A1281196) | Bipolar Disorder | P3 | Withdrawn | — | RCT, Double-blind | Placebo, Ziprasidone Oral Capsules |
| NCT01387607 A Study For Pregabalin In Patients With Fibromyalgia | Fibromyalgia | P3 | Completed | 343 | RCT, Double-blind | pregabalin, placebo |
| NCT00145444 Kahn Study; Investigation Of The Efficacy Of Ziprasidone Versus Olanzapine In The Management Of Recent-Onset Psychosis; A Flexible-Dose, Parallel Group, Double-Blind Study | Schizophrenia, Psychotic Disorders | P3 | Completed | 100 | RCT, Double-blind | olanzapine, ziprasidone |
| NCT00257192 Safety And Efficacy Of Ziprasidone In Adolescents With Schizophrenia | Schizophrenia | P3 | Terminated | 284 | RCT, Double-blind | placebo, Ziprasidone oral capsules |
| NCT00174447 Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031 | Schizophrenia | P3 | Completed | 43 | Open-label | Ziprasidone |
| NCT00219544 Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain. | Neuropathic Pain | P3 | Completed | 158 | RCT, Double-blind | Pregabalin (Lyrica), Pregabalin (Lyrica), Pregabalin (Lyrica), Placebo |
| NCT00002339 A Study of Fluconazole in the Treatment of Fungal Infections of the Throat in Patients With Weakened Immune Systems | Candidiasis, Esophageal, HIV Infections | P3 | Completed | 100 | — | Fluconazole |
| NCT00282971 A Clinical Trial Assessing The Impact Of Inhaled Insulin On Glucose Control In Patients With Type 2 Diabetes Mellitus | Diabetes Mellitus Type 2 | P3 | Terminated | 354 | RCT, Open-label | Inhaled Insulin (Exubera) |
| NCT00434044 Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis | Ankylosing Spondylitis | P3 | Completed | 150 | RCT, Double-blind | Enbrel (etanercept) |
| NCT00393471 Study Comparing Etanercept Plus Methotrexate to Either Etanercept or Methotrexate Alone in Rheumatoid Arthritis. | Active Rheumatoid Arthritis | P3 | Completed | 615 | RCT, Double-blind | Etanercept |
| NCT00930033 Clinical Trial to Assess the Importance of Nephrectomy | Metastatic Renal Cell Carcinoma | P3 | Completed | 452 | RCT, Open-label | — |
| NCT00329147 Study Evaluating the Effects of DVS SR and Paroxetine on the Pharmacokinetics of Desipramine in Healthy Subjects | Depression | P3 | Completed | 20 | RCT, Open-label | desvenlafaxine SR, desipramine, paroxetine |
| NCT00220363 A Multicenter Trial to Investigate Fesoterodine Sustained Release in Overactive Bladder Syndrome | Overactive Bladder Syndrome | P3 | Completed | — | RCT, Double-blind | SPM 907 |
| NCT05371652 A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants | Acute Migraine | P3 | Completed | 241 | Open-label | Rimegepant 75mg Orally Disintegrating Tablets (ODT) |
| NCT02297438 A Study Of Palbociclib (PD-0332991) + Letrozole VS. Placebo+ Letrozole For 1st Line Treatment Of Asian Postmenopausal Women With ER+/HER2- Advanced Breast Cancer [PALOMA-4] | Breast Neoplasms | P3 | Completed | 340 | RCT, Double-blind | Palbociclib, Letrozole, Placebo, Letrozole |
| NCT01830855 A Trial to Assess the Lot Consistency, Safety, Tolerability and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Subjects Aged ≥10 to <19 Years | Meningococcal Vaccine | P3 | Completed | 3,596 | RCT, Double-blind | rLP2086, rLP2086, rLP2086, Havrix (HAV), Saline |
| NCT00932893 An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene | Carcinoma, Non-Small-Cell Lung | P3 | Completed | 347 | RCT, Open-label | PF-02341066, Pemetrexed, Docetaxel |
| NCT03571607 A Safety And Immunogenicity Study Of A 13-valent Pneumococcal Conjugate Vaccine In Japanese Subjects Aged 6 To 64 Years. | Pneumococcal Infections | P3 | Completed | 206 | Open-label | 13-valent pneumococcal conjugate vaccine |
| NCT03135834 A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age. | Meningococcal Vaccine | P3 | Completed | 1,610 | RCT, Double-blind | MenABCWY, Saline, rLP2086, MenACWY-CRM |
| NCT01241591 A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis | Psoriasis | P3 | Completed | 1,101 | RCT, Double-blind | CP 690,550 5 mg, CP 690,550 10 mg, Etanercept 50 mg |
| NCT02130557 A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia | Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive | P3 | Completed | 536 | RCT, Open-label | Bosutinib, Imatinib |
| NCT01499277 Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections | Complicated Skin and Soft Tissue Infection | P3 | Completed | 802 | RCT, Double-blind | Ceftaroline fosamil, Vancomycin, Aztreonam |
| NCT04697381 Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS | Prader-Willi Syndrome | P3 | Completed | 33 | Open-label | somatropin - GH naïve pediatric cohort, somatropin - GH treated cohort, somatropin - adult cohort |
| NCT01945034 5% Topical Ibuprofen (IBU) for Ankle Sprain | Ankle Injuries | P3 | Completed | 304 | RCT, Double-blind | Topical IBU twice daily, Placebo twice daily, Topical IBU three times daily, Placebo three times daily |
| NCT05780541 PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial) | COVID-19 | P3 | Terminated | 58 | RCT, Double-blind | PF-07304814, Placebo, Remdesivir |
| NCT00220376 Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP584) for the Treatment of Overactive Bladder Syndrome | Overactive Bladder Syndrome | P3 | Completed | — | Open-label | SPM 907 |
| NCT00617760 Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®) | Neisseria Meningitidis (Bacterial Meningitis), Invasive Pneumococcal Disease (IPD) | P3 | Completed | 330 | RCT, Open-label | Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7), 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7), Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) |
| NCT01900899 Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children | Infections, Meningococcal | P3 | Completed | 184 | RCT, Open-label | — |
| NCT03423199 PAlbociclib Plus Tamoxifen for the Treatment of Hormone Receptor-positive, HER2-negative Advanced Breast Cancer Women - Asian studY | Breast Neoplasms | P3 | Unknown | 180 | RCT, Double-blind | Palbociclib, Placebo, Tamoxifen, Goserelin |
| NCT00005093 Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer | Lung Cancer | P3 | Completed | — | RCT | gemcitabine hydrochloride, tacedinaline |
| NCT02458287 Efficacy, Safety, Tolerability And Actual Use Study Of Bococizumab And An Autoinjector (Pre-Filled Pen) In Subjects With Hyperlipidemia Or Dyslipidemia | Hyperlipidemia | P3 | Completed | 299 | RCT, Double-blind | Bococizumab 150mg, Bococizumab 75mg, Bococizumab 150mg placebo, Bococizumab 75mg placebo |
| NCT00283842 Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy | Diabetic Neuropathies, Pain | P3 | Terminated | 408 | RCT, Double-blind | DVS SR, Placebo |
| NCT00904995 Beta Glucan Assay in Patients Receiving Voriconazole Prophylaxis | Leukemia, Fungal Infection | P3 | Completed | 23 | RCT, Open-label | Voriconazole, Voriconazole |
| NCT05408429 Safety and Immunogenicity of 20vPnC in Toddlers With 2 Prior Doses of Prevenar 13 | Pneumococcal Disease | P3 | Completed | 356 | RCT, Double-blind | 20-valent pneumococcal conjugate vaccine, 13-valent pneumococcal conjugate vaccine |
| NCT00277823 Study Evaluating Desvenlafaxine Sustained-Release (DVS-SR) in Adult Outpatients With Major Depressive Disorder | Major Depressive Disorder | P3 | Completed | 480 | RCT, Double-blind | DVS-SR 50 mg, DVS-SR 100 mg, Placebo |
| NCT00868296 Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD) | Gastroesophageal Reflux | P3 | Completed | 58 | Open-label | pantoprazole |
| NCT00245973 Study Evaluating Bifeprunox in Bipolar Depression | Depression Bipolar | P3 | Completed | 380 | RCT, Double-blind | Bifeprunox |
| NCT00421031 Study Evaluating the Safety & Efficacy of DVS-223 SR for Relief of Vasomotor Symptoms Associated With Menopause | Vasomotor Symptoms | P3 | Completed | 540 | RCT, Double-blind | DVS-233 SR |
| NCT02709486 Study of the Analgesic Efficacy and Safety of Subcutaneous Tanezumab in Subjects With Osteoarthritis of the Hip or Knee. | Osteoarthritis, Hip, Osteoarthritis, Knee | P3 | Completed | 849 | RCT, Double-blind | Tanezumab, Tanezumab, Placebo |
| NCT00267267 A Clinical Trial Comparing Torcetrapib/Atorvastatin to Ezetimibe/Simvastatin In Subjects With A Cholesterol Disorder. | Hyperlipidemia, Dyslipidemia | P3 | Terminated | 1,784 | RCT, Double-blind | torcetrapib/atorvastatin, ezetimibe/simvastatin |
| NCT02603432 A Study Of Avelumab In Patients With Locally Advanced Or Metastatic Urothelial Cancer (JAVELIN Bladder 100) | Urothelial Cancer | P3 | Completed | 700 | RCT, Open-label | Avelumab, Following the planned interim analysis for this study: Avelumab |
| NCT00228410 Study Comparing Tigecycline and Vancomycin With Aztreonam in Complicated Skin and Skin Structure Infections | Skin Diseases, Infectious | P3 | Completed | 503 | RCT, Double-blind | Tigecycline, vancomycin with aztreonam |
| NCT00355589 Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension | Hypertension, Blood Pressure, High | P3 | Completed | — | RCT, Double-blind | Ramipril and hydrochlorothiazide |
| NCT03137368 A Study to Evaluate Exemestane Tablets Combined With Ovarian Function Suppression/Ablation in Treatment of Premenopausal Breast Cancer Patients With CYP2D6*10 Mutations （STEP） | CYP2D6 Polymorphism | P3 | Unknown | 300 | RCT, Open-label | Exemestane Tablets, Tamoxifen |
| NCT00219635 Assessment Of Efficacy and Safety UK-390,957 In Men With Premature Ejaculation | Ejaculation | P2P3 | Completed | 138 | RCT, Double-blind | UK-390,957 |
| NCT00611026 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder. | Overactive Bladder | P3 | Completed | 2,417 | RCT, Double-blind | Tolterodine ER, Placebo, Fesoterodine |
| NCT00396214 Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic Patients | Schizophrenia | P3 | Terminated | 83 | RCT, Double-blind | Bifeprunox, Quetiapine, Bifeprunox |
| NCT00225511 Study Evaluating Effexor XR for Major Depression. | Depression | P3 | Completed | 590 | Double-blind | Effexor XR, Milnacipran |
| NCT01768481 Intima Media Thickness Regression in Dyslipidemic Teenagers | Obesity, Dyslipidemia | P3 | Completed | 16 | RCT, Double-blind | Atorvastatin, sugar pill |
| NCT00791492 An Extension of Study Fx-005 Evaluating Long-Term Safety And Clinical Outcomes Of Fx-1006A In Patients With Transthyretin Amyloid Polyneuropathy | Familial Amyloid Polyneuropathy, ATTR-PN | P2P3 | Completed | 86 | Open-label | Fx-1006A |
| NCT00079989 Study Evaluating Tigecycline in Selected Serious Infections Due to Resistant Gram-Negative Organisms | Gram-Negative Bacterial Infections | P3 | Completed | 115 | Open-label | tigecycline |
| NCT01680250 Sirolimus for Massive Polycystic Liver | Polycystic Kidney Diseases | P2P3 | Unknown | 44 | Open-label | Sirolimus |
| NCT00375674 A Clinical Trial Comparing Efficacy And Safety Of Sunitinib Versus Placebo For TheTreatment Of Patients At High Risk Of Recurrent Renal Cell Cancer | Kidney Neoplasms | P3 | Completed | 674 | RCT, Double-blind | Sunitinib malate |
| NCT03192215 AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke | Stroke | P3 | Terminated | 1,015 | RCT, Double-blind | Apixaban, Aspirin |
| NCT01052012 Bupivacaine Effectiveness and Safety in SABER® Trial | Postoperative Pain, Abdominal Surgery | P3 | Completed | 331 | RCT, Double-blind | SABER-Bupivacaine, Bupivacaine HCl, SABER-Placebo |
| NCT03835975 Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination | Pneumococcal Disease | P3 | Completed | 875 | RCT, Open-label | 13vPnC, PPSV23, 20vPnC |
| NCT04574362 Safety and Efficacy Trial of BHV3000 (Rimegepant) 75 mg for the Acute Treatment of Migraine | Acute Migraine | P3 | Completed | 1,648 | RCT, Double-blind | Rimegepant, Placebo |
| NCT00084227 Azithromycin Plus Chloroquine Versus Atovaquone-Proguanil For The Treatment Of Uncomplicated Plasmodium Falciparum Malaria In South America | Malaria, Falciparum | P2P3 | Completed | 244 | RCT, Double-blind | Azithromycin/Chloroquine, Atovaquone/Proguanil |
| NCT00111449 Evaluating the Safety of Etanercept 50 mg Twice Weekly in Subjects With Psoriasis | Psoriasis | P3 | Completed | 600 | RCT, Double-blind | Etanercept |
| NCT00676091 Study Evaluating 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants in Brazil | Vaccines, Pneumococcal Conjugate Vaccine | P3 | Completed | 354 | RCT, Double-blind | 13-Valent Pneumococcal Conjugate Vaccine (13vPnC), 7-Valent Pneumococcal Conjugate Vaccine (7vPnc) |
| NCT00065468 Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma | Carcinoma, Renal Cell, Kidney Neoplasms | P3 | Completed | 626 | RCT, Open-label | Interferon Alfa, CCI-779, Interferon Alfa and CCI-779 |
| NCT03732638 Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults | Migraine | P2P3 | Completed | 1,590 | RCT, Double-blind | Rimegepant, Placebo |
| NCT00830063 Tanezumab In Osteoarthritis Of The Knee (2) | Arthritis, Osteoarthritis | P3 | Completed | 832 | RCT, Double-blind | tanezumab 10 mg, tanezumab 5 mg, naproxen |
| NCT01172821 Evaluation of Tiotropium 2.5 and 5 mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo and Salmeterol HydroFluoroAlkane (HFA) Metered Dose Inhaler (MDI) (50 mcg Twice Daily) in Patient With Moderate Persistent Asthma II | Asthma | P3 | Completed | 1,032 | RCT, Double-blind | placebo, placebo, placebo, tiotropium Respimat® low dose, placebo, tiotropium Respimat® high dose, 50 mcg salmeterol HFA MDI, placebo |
| NCT04360187 Crisaborole for Chinese and Japanese Subjects (≥2 Years of Age) With Mild to Moderate Atopic Dermatitis | Atopic Dermatitis | P3 | Completed | 391 | RCT, Double-blind | Crisaborole Ointment, Crisaborole Placebo Vehicle |
| NCT03918629 Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study | Clostridium Difficile Associated Disease | P3 | Completed | 1,994 | RCT, Double-blind | Clostridium difficile, Placebo |
| NCT00445679 Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD | Depressive Disorder, Major | P3 | Completed | 807 | RCT, Double-blind | DVS SR, Paroxetine |
| NCT00384072 Study Evaluating the Safety and Efficacy of Bazedoxifene in Postmenopausal Asian Women | Postmenopause, Osteoporosis | P3 | Completed | 500 | RCT, Double-blind | bazedoxifene BZA-20 |
| NCT00645242 A Study Of Diflucan In Children With Ringworm Of The Scalp | Tinea Capitis | P3 | Completed | 185 | Open-label | fluconazole |
| NCT01942174 VACcination In Methotrexate Treated Rheumatoid Arthritis Patients | Rheumatoid Arthritis | P3 | Completed | 276 | RCT, Open-label | Prevenar 13, Pneumo23 / Pneumovax, Methotrexate - Immediate, Methotrexate - Delay |
| NCT02400567 Efficacy of Letrozole + Palbociclib Combination as Neoadjuvant Treatment of Stage II-IIIA PAM 50 ROR-defined Low or Intermediate Risk Luminal Breast Cancer, in Postmenopausal Women | Neoadjuvant Operable Breast Cancer | P2 | Completed | 125 | RCT, Open-label | Fluorouracile, Epirubicin, Cyclophosphamide, Letrozole, Palbociclib |
| NCT00640458 Study to Investigate Effect of Sildenafil on Clitoral Engorgement as Measured by Magnetic Resonance Imaging (MRI) in Pre-menopausal Women With Female Sexual Arousal Disorder | Female Sexual Arousal Disorder | P2 | Completed | 20 | RCT, Double-blind | Sildenafil 100 mg, Placebo |
| NCT00993148 Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 | HIV-1 Infection, HIV Infections | P2 | Completed | 25 | Open-label | maraviroc, darunavir, ritonavir |
| NCT00746967 An Open-Label, Extension Study Evaluating the Safety, Toleration, and Efficacy of Sildenafil in Women With Sexual Arousal Disorder | Sexual Dysfunctions, Psychological, Sexual Arousal Disorder | P2 | Completed | 267 | Open-label | sildenafil |
| NCT00675025 Evaluating The Safety Of Donepezil Hydrochloride (Aricept) For Up To 1 Year In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome - Follow-Up To A 10-Week, Double-Blind, Placebo-Controlled Trial | Down Syndrome | P2 | Terminated | 117 | Open-label | Donepezil hydrochloride (Aricept) |
| NCT02124668 A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy | Castration-Resistant Prostate Cancer, Prostate Cancer | P2 | Completed | 30 | Open-label | Enzalutamide |
| NCT00548717 Sirolimus, Mycophenolate Mofetil and Bortezomib as Graft-Versus-Host Disease (GVHD) Prophylaxis After Reduced Intensity Conditioning (RIC) Hematopoietic Stem Cell Transplantation | Graft-vs-Host Disease | P2 | Terminated | 15 | Open-label | Sirolimus, Mycophenolate mofetil, Bortezomib |
| NCT05574010 A Study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of KAN-101 in Celiac Disease (ACeD-it) | Celiac Disease | P1P2 | Terminated | 128 | RCT, Double-blind | Cohort 1 in Part A, Cohort 2 in Part A, Group 2 in Part B and Part C, Group 3 in Part B and Part C, Group 4 in Part B and Part C |
| NCT02841267 A Trial of PF-06252616 in Ambulatory Participants With LGMD2I | LGMD2I | P1P2 | Completed | 19 | Open-label | PF 06252616 |
| NCT04609566 Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors | Melanoma, Non-small Cell Lung Cancer | P2 | Completed | 161 | Open-label | brentuximab vedotin, pembrolizumab |
| NCT02836028 A Study Evaluating Talazoparib in Relapsed Ovarian, Fallopian Tube, and Peritoneal Cancer | Ovarian Cancer | P2 | Withdrawn | — | RCT, Open-label | Talazoparib, Temozolomide |
| NCT00634933 Study Evaluating 2 Dosing Regimens Of TRU-015 In Rheumatoid Arthritis | Arthritis, Rheumatoid | P2 | Terminated | 222 | RCT, Double-blind | TRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone, TRU-015, Methylprednisolone, Prednisone |
| NCT01091103 Determine Effect of Enzalutamide (MDV3100) on the Androgen Signaling Pathway in Correlation With the Anti-tumor Effects of Enzalutamide | Metastatic Progressive Castration-resistant Prostate Cancer | P2 | Completed | 60 | Open-label | Enzalutamide |
| NCT00437281 Safety, Tolerability, and Pharmacokinetic Study of Pregabalin in Pediatric Patients With Partial Onset Seizures | Epilepsies, Partial | P1P2 | Completed | 65 | RCT, Double-blind | Placebo, Pregabalin |
| NCT00645034 A Study to Investigate the Effects on Blood Pressure and Pulse Rate of a Single 100mg Dose of Sildenafil in Patients With Benign Prostatic Hyperplasia Who Are Being Treated With Doxazosin | Benign Prostatic Hyperplasia | P2 | Completed | 20 | RCT, Double-blind | placebo, sildenafil |
| NCT03054363 Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer | Breast Cancer | P1P2 | Completed | 42 | RCT, Open-label | Tucatinib in Combination with Palbociclib and Letrozole, Tucatinib in Combination with Palbociclib and Letrozole |
| NCT04849364 Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer | Breast Cancer, Triple Negative Breast Cancer | P2 | Terminated | 52 | Open-label | Capecitabine, Talazoparib, Pembrolizumab, Inavolisib |
| NCT01889238 Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer | Advanced, Androgen Receptor Positive Triple Negative Breast Cancer | P2 | Completed | 118 | Open-label | Enzalutamide |
| NCT04690855 A Study to Evaluate TAlazoparib, Radiotherapy and Atezolizumab in gBRCA 1/2 Negative Patients With PD-L1+ Metastatic Triple Negative Breast Cancer | Breast Cancer, Triple Negative Breast Cancer | P2 | Terminated | 1 | Open-label | Talazoparib, Atezolizumab |
| NCT00640146 Study of Subcutaneous Methylnaltrexone (MNTX) in the Treatment of Opioid-Induced Constipation During Rehabilitation After Orthopedic Procedures | Opioid-induced Constipation | P2 | Completed | 37 | RCT, Double-blind | Methylnaltrexone bromide, Placebo |
| NCT01650194 A Study to Determine Safety and Tolerability of Enzalutamide (MDV3100) in Combination With Abiraterone Acetate in Bone Metastatic Castration-Resistant Prostate Cancer Patients | Metastatic Castration-Resistant Prostate Cancer | P2 | Completed | 60 | Open-label | enzalutamide, abiraterone acetate, prednisone |
| NCT03148795 A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer | Prostate Cancer | P2 | Completed | 128 | Open-label | Talazoparib |
| NCT00354978 Study of FOLFIRI Plus Bevacizumab in Colorectal Cancer Patients | Colorectal Cancer | P2 | Completed | 49 | Open-label | 5-Fluorouracil, Bevacizumab, Leucovorin, Irinotecan |
| NCT05935748 Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) | ccRCC, Clear Cell Renal Cell Carcinoma | P2 | Terminated | 18 | RCT, Open-label | NKT2152, palbociclib |
| NCT00979953 Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee | Osteoarthritis of the Knee | P2 | Completed | 408 | RCT, Double-blind | ADL5859, ADL5747, Oxycodone CR, Placebo |
| NCT04052204 Avelumab With Bempegaldesleukin With or Without Talazoparib or Enzalutamide in Advanced or Metastatic Solid Tumors | Squamous Cell Carcinoma of the Head and Neck (SCCHN), Metastatic Castration Resistant Prostate Cancer (mCRPC) | P1P2 | Terminated | 3 | Open-label | avelumab, Bempegaldesleukin, talazoparib, enzalutamide |
| NCT02034916 A Phase 2, 2-Stage, 2-Cohort Study of Talazoparib (BMN 673), in Locally Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (ABRAZO Study) | Breast Neoplasms, BRCA 1 Gene Mutation | P2 | Terminated | 84 | Open-label | talazoparib |
| NCT05549505 A Trial Using ARV-471 or Anastrozole in Post-Menopausal Women With Breast Cancer Prior to Surgery | Breast Cancer | P2 | Completed | 152 | RCT, Open-label | ARV-471, Anastrozole |
| NCT00570128 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome | Down Syndrome | P2 | Completed | 129 | RCT, Double-blind | Donepezil HCl, Placebo |
| NCT00245609 Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure | Dental Anxiety | P2 | Completed | 90 | RCT, Double-blind | Pregabalin, Alprazolam, Placebo |
| NCT02007512 Efficacy and Safety Study of Enzalutamide in Combination With Exemestane in Patients With Advanced Breast Cancer | Breast Cancer | P2 | Completed | 247 | RCT, Double-blind | Enzalutamide, exemestane, Placebo (for enzalutamide), exemestane |
| NCT00636246 A Comparison of Sertraline-reboxetine Combination Therapy Versus Sertraline or Reboxetine Monotherapy in the Treatment of Major Depression. | Depressive Disorder, Major | P2 | Completed | 510 | RCT, Double-blind | sertraline/[S,S]-reboxetine, sertraline/[S,S]-reboxetine, sertraline, sertraline, sertraline/[S,S]-reboxetine, Placebo, sertraline/[S,S]-reboxetine, [S,S]-reboxetine monotherapy |
| NCT02840721 Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis. | Colitis, Ulcerative | P2 | Completed | 50 | Open-label | PF-06480605 |
| NCT00483262 Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma | Multiple Myeloma | P1P2 | Completed | 63 | Open-label | CCI-779, Bortezomib |
| NCT02296801 A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | Breast Cancer, Breast Carcinoma | P2 | Completed | 307 | RCT, Open-label | Letrozole, palbociclib |
| NCT04824937 Telaglenastat + Talazoparib In Prostate Cancer | Prostate Cancer Metastatic | P2 | Unknown | 30 | Open-label | Telaglenastat, Talazoparib |
| NCT01058642 Study to Assess the Efficacy, Safety, and Tolerability of ADL5747 in Participants With Postherpetic Neuralgia | Postherpetic Neuralgia | P2 | Terminated | 41 | RCT, Double-blind | ADL5747, Placebo, Pregabalin |
| NCT01288911 A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer | Prostatic Neoplasms | P2 | Completed | 375 | RCT, Double-blind | enzalutamide, bicalutamide |
| NCT00650611 A Study of the Safety and Tolerability of Oral Ziprasidone in Children and Teens With Psychotic Disorders | Schizophrenia, Bipolar Disorder | P2 | Completed | 63 | RCT, Open-label | Ziprasidone, Ziprasidone |
| NCT02091960 A Study to Assess the Efficacy and Safety of Enzalutamide With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2 Positive (HER2+), Androgen Receptor Positive (AR+) Metastatic or Locally Advanced Breast Cancer | HER2 Amplified, Advanced Breast Cancer | P2 | Completed | 103 | Open-label | Enzalutamide, Trastuzumab |
| NCT04569032 A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression | Peripheral T-cell Lymphoma | P2 | Completed | 82 | Open-label | brentuximab vedotin, cyclophosphamide, doxorubicin, prednisone |
| NCT01030406 Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users | Opioid Abuse | P2 | Completed | 49 | RCT, Double-blind | 40/0mg taken first, 80/0mg taken first, 40/240mg taken first, 80/480mg taken first, 0/0mg taken first |
| NCT01664923 Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer | Prostate Cancer | P2 | Completed | 396 | RCT, Double-blind | Enzalutamide, Bicalutamide |
| NCT00143429 Corneal Versus Conjunctival Delivery Using a Delivery Device | Glaucoma, Open-Angle, Ocular Hypertension | P2 | Withdrawn | — | RCT, Single-blind | Xalatan |
| NCT02384382 A Positron Emission Tomography/Computed Tomography (PET/CT) Bone Imaging Study in Patients Receiving Enzalutamide for Castration-Resistant Prostate Cancer (CRPC) | Prostate Carcinoma Metastatic to the Bone, Castration Resistant Prostate Cancer | P2 | Completed | 23 | Open-label | Enzalutamide |
| NCT00141310 Sildenafil Citrate for the Treatment of Established Pre-Eclampsia | Pre-eclampsia | P2 | Terminated | 76 | RCT, Double-blind | Sildenafil citrate |
| NCT01379144 A Study Comparing The Efficacy, Safety And Tolerability Of Latanoprost 75, 100 And 125 ug/ml To Xalatan In The Treatment Of Primary Open-Angle Glaucoma And Ocular Hypertension | Primary Open Angle Glaucoma, Ocular Hypertension | P2 | Completed | 282 | RCT, Double-blind | latanoprost 75 ug, latanoprost 100 ug, latanoprost 125 ug, latanoprost 50 ug |
| NCT01547299 Study of Enzalutamide (Formerly MDV3100) as a Neoadjuvant Therapy for Patients Undergoing Prostatectomy for Localized Prostate Cancer | Prostate Cancer | P2 | Completed | 52 | RCT, Open-label | Enzalutamide, Leuprolide, Dutasteride |
| NCT01281917 Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma | Non-Hodgkins Lymphoma | P2 | Completed | 40 | Open-label | Velcade, Temsirolimus |
| NCT00679523 Safety and Efficacy Study of Subjects With Onychomycosis of the Great Toenail | Onychomycosis | P2 | Completed | 60 | RCT, Open-label | AN2690 Solution, 5.0%, AN2690 Solution, 7.5% |
| NCT01254656 A Long Term Safety Study Of Lersivirine For The Treatment Of HIV-1 Infection In Subjects Who Have Completed Treatment With Lersivirine In Studies A5271015 And A5271022 | HIV-1 | P2 | Terminated | 108 | Open-label | lersivirine, lersivirine, efavirenz, lersivirine, lersivirine, etravirine |
| NCT03258398 A Study to Evaluate eFT508 Alone and in Combination With Avelumab in Subjects With MSS Colorectal Cancer | Microsatellite Stable Relapsed or Refractory Colorectal Cancer | P2 | Completed | 56 | RCT, Open-label | eFT508, Avelumab |
| NCT02039336 Dacomitinib Plus PD-0325901 in Advanced KRAS Mutant NSCLC | Colorectal Cancer | P1P2 | Completed | 35 | Open-label | Dacomitinib, PD-0325901, Docetaxel |
| NCT00599638 A Study To Compare Pregabalin/PF-00489791 Combination Versus Pregabalin Alone In Post-Herpetic Neuralgia | Postherpetic Neuralgia | P2 | Completed | 72 | RCT, Double-blind | pregabalin, pregabalin/PF-00489791, Placebo |
| NCT05879458 Ritlecitinib in CTCL | CTCL, Mycosis Fungoides | P2 | Terminated | 7 | Open-label | Ritlecitinib |
| NCT00556049 Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma | Renal Cell Carcinoma, Neoplasm Metastases | P2 | Completed | 72 | Open-label | Gemcitabine, Sunitinib |
| NCT01331291 Bosutinib in Adult Patients With Recurrent Glioblastoma | Glioblastoma | P2 | Completed | 36 | Open-label | bosutinib |
| NCT03973918 Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG | High Grade Glioma, BRAF V600E | P2 | Terminated | 5 | Open-label | Encorafenib, Binimetinib, Research Bloods, Tumor Tissue |
| NCT00463060 Sutent and Radiation as Treatment for Limited Extent Metastatic Cancer | Cancer | P1P2 | Completed | 47 | Open-label | sunitinib malate (Sutent) |
| NCT00334685 [S,S]-Reboxetine Add-On Trial | Pain | P2 | Terminated | 136 | RCT, Double-blind | [S,S]-Reboxetine + Pregabalin, Pregabalin |
| NCT03722966 Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO) | Smoking Cessation | P2 | Terminated | 34 | RCT, Open-label | Varenicline, Oral Nicotine Replacement Therapy (NRT) |
| NCT01042795 Trial of Adjuvant Sutent for Patients With High Risk Urothelial Carcinoma After Neoadjuvant Chemotherapy and Cystectomy | Urothelial Carcinoma, Bladder Cancer | P2 | Terminated | 7 | Open-label | Sunitinib |
| NCT00853112 A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension | Hypertension, Pulmonary | P2 | Terminated | 48 | RCT, Double-blind | PF-00489791, PF-00489791, PF-00489791, PF-00489791, PF-00489791, placebo, sildenafil |
| NCT00070629 CPG 7909 Injection in Non-Small Cell Lung Cancer | Carcinoma, Non-Small Cell Lung | P2 | Completed | 116 | RCT, Open-label | CPG 7909, Chemotherapy, Chemotherapy |
| NCT05014412 A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment | Multiple Myeloma | P2 | Completed | 86 | Open-label | Elranatamab |
| NCT03715829 A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects | Active Non-segmental Vitiligo | P2 | Completed | 366 | RCT, Double-blind | PF-06651600, PF-06651600, PF-06651600, PF-06651600, PF-06651600, placebo, PF06700841 |
| NCT01781572 A Phase Ib/II Study of LEE011 in Combination With MEK162 in Patients With NRAS Mutant Melanoma | Locally Advanced or Metastatic NRAS Mutant Melanoma | P1P2 | Completed | 102 | Open-label | LEE011, MEK162 |
| NCT03185481 Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations | Parkinson's Disease With Motor Fluctuations | P2 | Terminated | 5 | RCT, Double-blind | 1 mg QD to 15 mg QD PF-06649751, 3 mg QD to 15 mg QD PF-06649751, 7 mg QD to 15 mg QD PF-06649751, 15 mg QD PF-06649751, 1 mg QD to 7 mg QD PF-06649751 (if de-escalated in parent study), 3 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study), 7 mg QD to 7 mg QD PF-06649751 (de-escalated in parent study), 15 mg QD de-escalated to 7 mg QD PF-06649751 in parent study remain at 7 mg QD |
| NCT03205267 Phase II Study Testing the Tolerability and the Efficacy of Bosutinib in Chronic Phase CML Patients | Chronic Myelogenous Leukaemia | P2 | Unknown | 127 | Open-label | Bosulif |
| NCT00073034 Study Evaluating EAA-090 in Adult Outpatients With Neuropathic Pain Associated With Diabetic Neuropathy | Diabetes Mellitus, Diabetic Neuropathy, Painful | P2 | Terminated | — | RCT, Double-blind | EAA-090 |
| NCT00679601 Absorption and Systemic Study of AN2690 in Patients With Moderate to Severe Onychomycosis (ADME II) | Onychomycosis | P2 | Completed | 20 | Open-label | AN2690 |
| NCT00141128 Evaluation Of A Novel Methodology In The Assessment Of Urethral Function Using SS-RBX. | Urinary Incontinence, Stress | P2 | Completed | 18 | RCT, Double-blind | SS-RBX |
| NCT00074854 A Clinical Efficacy Study Of An Oral Tyrosine Kinase Inhibitor Of VEGFR-2 Given In Combination With Chemotherapy | Lung Neoplasms | P1P2 | Completed | 87 | RCT, Open-label | CP-547,632 |
| NCT04915950 A Study to Assess the Effect of Oral Temanogrel on Digital Blood Flow in Adult Participants With Raynaud's Phenomenon Secondary to Systemic Sclerosis | Raynaud's Phenomenon Secondary to Systemic Sclerosis | P2 | Terminated | 13 | RCT, Double-blind | Temanogrel, Placebo |
| NCT04051996 GLAD-AML - Glasdegib (Pf-04449913) With Two Standard Decitabine Regimens for Older Patients With Poor-risk Acute Myeloid Leukemia | ACUTE MYELOID LEUKEMIA | P2 | Terminated | 1 | RCT, Single-blind | Glasdegib, Decitabine |
| NCT01351662 Balancing Lupus Experiences With Stress Strategies | Systemic Lupus Erythematosus | P1P2 | Completed | 30 | RCT, Single-blind | — |
| NCT03776175 A Study To Assess Pharmacodynamics, Safety And Tolerability Of PF-05221304 And PF-06865571 Co-Administered For 6 Weeks In Adults With Non-Alcoholic Fatty Liver Disease. | Non-Alcoholic Fatty Liver Disease (NAFLD) | P2 | Completed | 99 | RCT, Double-blind | PF-05221304 Monotherapy, PF-06865571 Monotherapy, Placebo, PF-05221304 and PF-06865571 Combination |
| NCT02713763 Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib | Pancreatic Neuroendocrine Tumour Metastatic | P2 | Completed | 11 | Open-label | Sunitinib |
| NCT00668863 Study Of Sunitinib With FOLFIRI In Colorectal Cancer | Unresectable or Metastatic Colorectal Cancer | P2 | Completed | 71 | Open-label | FOLFIRI (The combination regimen of Irinotecan, l-Leucovorin and 5-Fluorouracil), Sunitinib |
| NCT01265030 A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis | Desmoid Tumor | P1P2 | Completed | 9 | Open-label | Sirolimus |
| NCT00924664 Long Term Safety Study of Tanezumab in Chronic Low Back Pain | Low Back Pain | P2 | Terminated | 849 | RCT, Double-blind | Tanezumab 20 mg, Tanezumab 10 mg |
| NCT05076006 Dual JAK1/TYK2 Inhibitor for Cicatricial Alopecia | Cicatricial Alopecia | P2 | Completed | 50 | RCT, Double-blind | PF-06700841, Placebo |
| NCT00054886 Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer | Kidney Neoplasms | P2 | Completed | 63 | Open-label | SU-011,248 |
| NCT02928575 Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma | Glioblastoma Multiforme | P2 | Unknown | 45 | Open-label | Sunitinib, Temozolomide |
| NCT01096966 Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain | Chronic Low Back Pain | P2 | Completed | 263 | RCT, Double-blind | Bupivacaine TTS (Bupivacaine Patch), Placebo patch |
| NCT00453895 Sunitinib in Refractory Adrenocortical Carcinoma | Adrenocortical Carcinoma | P2 | Completed | 39 | Open-label | Sunitinib |
| NCT02676154 Fesoterodine for Amelioration of Autonomic Dysreflexia (AD) Following Spinal Cord Injury (SCI) | Autonomic Dysreflexia | P2 | Completed | 15 | Open-label | Fesoterodine |
| NCT02226172 Single-Agent Glasdegib In Patients With Myelofibrosis Previously Treated With Ruxolitinib | Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis | P2 | Terminated | 21 | RCT, Double-blind | Glasdegib (PF-04449913), Placebo |
| NCT00192179 A Phase II, Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine, CAIV-T in Healthy Children and Adolescents Ages 6 to Less Than 18 Years. | Influenza | P2 | Completed | 240 | RCT, Double-blind | Cold-adapted influenza vaccine trivalent (CAIV-T), Placebo |
| NCT00566397 A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease | Alzheimer's Disease | P2 | Completed | 402 | RCT, Double-blind | PF-04494700, PF-04494700, Placebo |
| NCT03498196 A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer | Bladder Cancer, Metastatic Bladder Cancer | P1P2 | Terminated | 1 | Open-label | Avelumab |
| NCT00550810 Sutent Maintenance After Response to Taxotere | Prostate Cancer, Hormone Refractory | P2 | Unknown | 30 | Open-label | Sunitinib (SU011248) |
| NCT00999518 A Study To Investigate Tanezumab In Patients With Interstitial Cystitis/ Painful Bladder Syndrome | Cystitis, Interstitial | P2 | Terminated | 205 | RCT, Double-blind | Tanezumab, Tanezumab, Tanezumab, Tanezumab |
| NCT05038982 Efficacy of Abrocitinib for Reducing Pruritus in Adults With Prurigo Nodularis and Chronic Pruritus of Unknown Origin | Prurigo Nodularis, Pruritus | P2 | Completed | 20 | Open-label | Abrocitinib |
| NCT01649180 NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma | Renal Cell Carcinoma | P2 | Terminated | 3 | Open-label | Axitinib |
| NCT03617666 Avelumab in the Frontline Treatment of Advanced Classical Hodgkin Lymphoma - a Window Study | Hodgkin Lymphoma | P2 | Unknown | 49 | Open-label | Avelumab |
| NCT02057341 A Study of ARRY-371797 in Patients With LMNA-Related Dilated Cardiomyopathy | LMNA-Related Dilated Cardiomyopathy | P2 | Completed | 12 | RCT, Open-label | ARRY-371797, p38 inhibitor; oral |
| NCT00913627 Study Evaluating Ibuprofen 600 mg Extended Release (ER) For Dental Pain | Pain | P2 | Completed | 196 | RCT, Double-blind | ibuprofen, ibuprofen, naproxen, Placebo |
| NCT01413516 Varenicline In-Patient Study | Smoking Cessation | P2 | Completed | 17 | RCT, Double-blind | Placebo, Varenicline |
| NCT03088930 Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung Cancer | Lung Cancer, Nonsmall Cell | P2 | Completed | 3 | Open-label | Crizotinib |
| NCT00618007 Effect of PF-00734200 in Subjects With Type 2 Diabetes | Diabetes Mellitus, Type 2 | P2 | Completed | 289 | RCT, Double-blind | PF-00734200 30 mg QD, PF-00734200 20 mg QD, Placebo |
| NCT00649311 A Study To Evaluate The Efficacy Of Eplerenone Compared With Losartan For The Treatment Of Patients With Mild To Moderate Hypertension | Hypertension | P2 | Terminated | 248 | RCT, Double-blind | eplerenone, Losartan |
| NCT00063219 Study Evaluating MAC-321 in Non-small Cell Lung Cancer Refractory to Platinum-based Therapy | Carcinoma, Non-Small-Cell Lung, Lung Neoplasms | P2 | Completed | 48 | Open-label | MAC-321 |
| NCT01393639 Study Comparing Doses Of An Experimental Glucocorticoid Compound To Prednisone And Placebo In Rheumatoid Arthritis | Rheumatoid Arthritis | P2 | Completed | 323 | RCT, Double-blind | PF-04171327, PF-04171327, PF-04171327, PF-04171327, prednisone |
| NCT01070706 Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and Sunitinib | Breast Cancer | P1P2 | Completed | 15 | Open-label | Paclitaxel,Gemcitabine,Sunitinib |
| NCT01111448 Temsirolimus in Myelodysplastic Syndrome (MDS) | Myelodysplastic Syndrome | P2 | Terminated | 20 | Open-label | Temsirolimus |
| NCT00987948 Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels | HIV Infections | P2 | Completed | 15 | Open-label | maraviroc (Selzentry) |
| NCT04440176 A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules | Meningococcal Vaccine | P2 | Completed | 309 | RCT, Double-blind | MenABCWY, Saline |
| NCT05052697 A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA Vaccine Against Influenza | Influenza, Human | P1P2 | Completed | 1,158 | RCT, Double-blind | mIRV, bIRV AB, qIRV, QIV, bIRV AA, bIRV BB |
| NCT00134550 Improving Diabetic Foot Ulcers With Atorvastatin | Foot Ulcer, Diabetes | P2 | Completed | 13 | RCT, Open-label | Atorvastatin (10 mg or 80 mg) |
| NCT00381706 Combination Chemotherapy and Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer | Esophageal Cancer | P2 | Completed | 245 | RCT, Open-label | cetuximab, ECF, IC, FOLFOX |
| NCT05703607 A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults | Shingles, Herpes Zoster Infection | P1P2 | Terminated | 485 | RCT, Double-blind | Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection, Candidate 1: PF-07915234: VZV modRNA Suspension for Injection, Candidate 2: PF-07921188: VZV modRNA Suspension for Injection, Candidate 3: PF-07921186: VZV modRNA Suspension for Injection, Shingrix, Candidate 2: PF-07921188: VZV modRNA Powder for Suspension for Injection |
| NCT00258492 Restless Legs Syndrome Exercise Intervention | Restless Legs Syndrome, Insomnia | P1P2 | Unknown | 30 | RCT, Open-label | — |
| NCT04163419 Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis | Schwannomatosis, Pain | P2 | Unknown | 9 | RCT, Double-blind | Tanezumab, Placebo |
| NCT00600600 Tigecycline for Treatment of Rapidly Growing Mycobacteria | Mycobacterium Abscessus Lung Disease, Rapidly Growing Mycobacterial Lung Disease | P2 | Completed | 8 | Open-label | Tigecycline |
| NCT00780806 Safety And Blood Collection Study Of Meningococcal B Rlp2086 Vaccine In Adults | Meningitis, Meningococcal | P1P2 | Completed | 60 | RCT, Open-label | meningococcal B rLP2086 vaccine candidate |
| NCT00603512 Comparison Of 4 CP-690,550 Doses Vs. Placebo, Each Combined With Methotrexate, For The Treatment Of Rheumatoid Arthritis in Japan | Arthritis, Rheumatoid | P2 | Completed | 140 | RCT, Double-blind | Placebo, CP-690,550, CP-690,550, CP-690,550, CP-690,550 |
| NCT00056381 Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 | Neutropenia | P1P2 | Completed | 25 | Open-label | Anidulafungin |
| NCT00635401 A Study of the Efficacy and Safety of Varenicline in Japanese Smokers Motivated to Quit Smoking | Smoking | P2 | Completed | 30 | Open-label | Varenicline |
| NCT01934023 Effects of Varenicline on Plasticity in Schizophrenia | Schizophrenia | P2 | Completed | 24 | RCT, Double-blind | Varenicline, Placebo |
| NCT03288324 Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus | Cutaneous Lupus, Systemic Lupus Erythematosus | P1P2 | Completed | 13 | Open-label | Tofacitinib |
| NCT01927341 Phase Ib/II Study of Efficacy and Safety of MEK162 and Panitumumab, in Adult mCRC Patients With Mutant or Wild-type RAS Tumors | Metastatic Colorectal Cancer | P1P2 | Completed | 53 | Open-label | MEK162, Panitumumab |
| NCT05463575 Ketohexokinase Inhibition in NAFLD | NAFLD | P2 | Completed | 15 | RCT, Double-blind | Ketohexokinase inhibition |
| NCT00348673 A Study in Asymptomatic HIV Infected Patients to Investigate Pharmacodynamics, Pharmacokinetics, Safety and Toleration of UK-453,061 | HIV-1 | P2 | Completed | 49 | RCT, Double-blind | UK-453,061, UK-453,061 |
| NCT04493203 Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced Melanoma | Advanced Melanoma, Unresectable Melanoma | P2 | Completed | 31 | Open-label | Nivolumab, Axitinib |
| NCT01712061 A Phase 2 Multi-Center Study To Evaluate The Efficacy And Safety Of A Chemokine CCR2/5 Receptor Antagonist In Adults With Type 2 Diabetes And Overt Nephropathy | Diabetic Nephropathy | P2 | Completed | 226 | RCT, Double-blind | PF-04634817, Placebo |
| NCT01126866 Curative Resectability of Not Optimally Resectable Liver and/or Lung Metastases From Colorectal Carcinoma (CRC) Under Intensified Chemotherapy | Colorectal Carcinoma | P2 | Terminated | 35 | Open-label | intensified chemotherapy (FOLFOXIRI/Bevacizumab) |
| NCT00826514 An Efficacy And Safety Study Of Tanezumab For The Treatment Of Pain Associated With Chronic Abacterial Prostatitis | Chronic Prostatitis With Chronic Pelvic Pain Syndrome | P2 | Completed | 62 | RCT, Double-blind | Tanezumab, Placebo |
| NCT00089648 SU011248 In The Treatment Of Patients With Bevacizumab (Avastin)-Refractory Metastatic Renal Cell Carcinoma | Carcinoma, Renal Cell | P2 | Completed | 61 | Open-label | Sunitinib |
| NCT00631618 Clinical Trial of Sutent to Treat Metastatic Melanoma | Metastatic Melanoma | P2 | Completed | 12 | Open-label | Sutent (sunitinib) |
| NCT00276159 Study of Immune Response Modifier in the Treatment of Hematologic Malignancies | Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia | P2 | Terminated | 6 | Open-label | 852A |
| NCT00174343 Exemestane As Treatment In Neoadjuvant Setting For Operable Breast Cancer Patients | Breast Neoplasms | P2 | Completed | 46 | Open-label | exemestane (Aromasin®) |
| NCT00768664 Open-Label Trial Of Oral PF-00299804 By Continuous Dosing In Patients With Recurrent Or Metastatic Head And Neck Squamous Cell Cancer | Head and Neck Neoplasms | P2 | Completed | 69 | Open-label | PF-00299804 |
| NCT01945021 Phase II Safety and Efficacy Study of Crizotinib in East Asian Patients With ROS1 Positive, ALK Negative Advanced NSCLC | Non Small Cell Lung Cancer, ROS1 Proto Oncogene | P2 | Completed | 129 | Open-label | Crizotinib |
| NCT00076011 Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Renal Cell Carcinoma | Kidney Neoplasms | P2 | Completed | 52 | Open-label | Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor |
| NCT00942747 Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma | Recurrent or Refractory Primary CNS Lymphoma | P2 | Unknown | 37 | Open-label | temsirolimus |
| NCT01287897 A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy | Crohn's Disease | P2 | Completed | 250 | RCT, Double-blind | PF-04236921 SC injection, PF-04236921 SC injection, PF-04236921 SC injection |
| NCT06465368 A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause | Breast Cancer | P2 | Completed | 121 | RCT, Open-label | PF-07220060, letrozole |
| NCT00094094 Anti-angiogenesis Agent AG-013736 in Patients With Advanced Non-Small Cell Lung Cancer | Lung Neoplasms, Carcinoma, Non-small Cell Lung | P2 | Completed | 32 | Open-label | axitinib |
| NCT00265551 Study Evaluating SCA-136 in Subjects With Acute Exacerbations of Schizophrenia | Schizophrenia | P2 | Completed | 300 | RCT, Double-blind | SCA-136 (200 mg), SCA-136 (400 mg), olanzapine (15 mg), placebo |
| NCT00150241 A Seven-Week Dose-Ranging Study of CP-526,555 Compared With Placebo and Zyban for Smoking Cessation | Smoking Cessation | P2 | Completed | 625 | RCT, Double-blind | CP-526,555 (varenicline) |
| NCT00139711 Three Combinations Of Docetaxel And Irinotecan For Recurrent Or Metastatic Non Small Cell Lung Cancer | Carcinoma, Non-Small-Cell Lung | P2 | Completed | 138 | RCT, Open-label | Irinotecan, Docetaxel |
| NCT00538616 Precedex Versus Propofol-Awakening for Reducing Brain Injury Expansion | Brain Injury, Intracranial Pressure | P1P2 | Completed | 8 | RCT, Single-blind | Dexmedetomidine, Propofol |
| NCT01152450 A Randomised, Double- Blind, Placebo Controlled, Cross-over Efficacy and Safety Comparison of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for Four Weeks in Patients With Moderate Persistent Asthma | Asthma | P2 | Completed | 94 | RCT, Double-blind | Tiotropium 2.5 µg b.i.d, Placebo, Tiotropium 5 µg q.d. |
| NCT03531918 Gemtuzumab Ozogamicin With G-CSF, Cladribine, Cytarabine & Mitoxantrone for Untreated AML & High-Grade Myeloid Neoplasm | Acute Myeloid Leukemia | P1P2 | Completed | 66 | Open-label | Cladribine, Cytarabine, Gemtuzumab Ozogamicin, Recombinant Granulocyte Colony-Stimulating Factor, Mitoxantrone Hydrochloride |
| NCT00925106 Pharmacokinetics Of Celecoxib Test Formulations | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | Celebrex capsule, Test formulation D1, Test formulation D2, Test formulation D3 |
| NCT01291524 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted At Bedtime Or Immediately Following A 400-500 or 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 330 mg, 400 to 500 calorie, Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, bedtime, Pregabalin immediate release, 300 mg |
| NCT01443169 A 5-treatment, Study in Healthy Volunteers to Assess The Safety, Tolerability, and Pharmacokinetics of Four Controlled Release (CR) Pregabalin Tablet Formulations and the Immediate Release (IR) Formulation Administered Fasted | Healthy | P1 | Completed | 16 | RCT, Open-label | Sequence 1 - Treatment A: Controlled Release Pregabalin, Sequence 1 - Treatment B: Controlled Release Pregabalin, Sequence 1 - Treatment C:Controlled Release Pregabalin, Sequence 1 - Treatment D: Controlled Release Pregabalin, Sequence 1 - Treatment E: Immediate Release Pregabalin, Sequence 2 - Treatment B: Controlled Release Pregabalin, Sequence 2 - Treatment D: Controlled Release Pregabalin, Sequence 2 - Treatment A: Controlled Release Pregabalin, Sequence 2 - Treatment C: Controlled Release Pregabalin, Sequence 2 - Treatment E: Immediate Release Pregabalin, Sequence 3 - Treatment C: Controlled Release Pregabalin, Sequence 3 - Treatment A: Controlled Release Pregabalin, Sequence 3 - Treatment D: Controlled Release Pregabalin, Sequence 3 - Treatment B: Controlled Release Pregabalin, Sequence 3 - Treatment E: Immediate Release Pregabalin, Sequence 4 - Treatment D: Controlled Release Pregabalin, Sequence 4 - Treatment C: Controlled Release Pregabalin, Sequence 4 - Treatment B: Controlled Release Pregabalin, Sequence 4 - Treatment A: Controlled Release Pregabalin, Sequence 4 - Treatment E: Immediate Release Pregabalin |
| NCT00975481 A Study To Evaluate The Abuse Potential Of Single Oral Doses Of Dimebon (Latrepirdine) In Healthy Recreational Polydrug Users | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 36 | RCT, Double-blind | dimebon, dimebon, dimebon, placebo, alprazolam, alprazolam |
| NCT00990613 A Study Evaluating The Absorption Of Dimebon Into The Body From A Dimebon Solution Applied To The Skin | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 19 | RCT, Double-blind | Dimebon IR, Dimebon Transdermal, Dimebon Transdermal, Dimebon IR, Dimebon Transdermal |
| NCT00758004 Bioequivalence Study Of Pediatric Appropriate Formulation | Hypercholesterolemia | P1 | Completed | 76 | RCT, Open-label | Atorvastatin, Atorvastatin pediatric appropriate formulation |
| NCT01004614 Bioequivalence Study For 5 Mg Amlodipine Orally-Disintegrating Tablet | Healthy | P1 | Completed | 48 | RCT, Open-label | Amlodipine, Amlodipine, Amlodipine, Amlodipine |
| NCT00860119 Bioequivalence of Alprazolam Sublingual vs Oral Tablets | Healthy | P1 | Completed | 23 | RCT, Open-label | alprazolam sublingual tablet, alprazolam oral tablet |
| NCT00824590 A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Function | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 20 | Open-label | Dimebon, Dimebon |
| NCT00821444 Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules | Healthy | P1 | Completed | 11 | RCT, Open-label | ziprasidone, B16 Fasted, B16 Fed |
| NCT01122953 Bioequivalence Study Of PHENYTOIN Suspension Made By Pfizer, Versus EPAMIN® Made By McNeil LA LLC In Healthy Volunteers Under Fasting Conditions | Healthy | P1 | Completed | 34 | RCT, Open-label | Phenytoin, Epamin |
| NCT01046162 A Study Of Two Oral Preparations Of 2 Mg Alprazolam In Healthy Volunteers Under Fasting Conditions | Healthy | P1 | Withdrawn | — | RCT, Open-label | Alprazolam, Alprazolam |
| NCT01989143 Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Intravenous and Multiple Subcutaneous and Intravenous Doses of PF-06480605 in Healthy Subjects. | Healthy | P1 | Completed | 92 | RCT, Double-blind | PF-06480605, Placebo, PF-06480605, Placebo, PF-06480605, Placebo |
| NCT00481728 Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate. | Overactive Bladder | P1 | Completed | 28 | RCT, Double-blind | Tolterodine |
| NCT00788047 A Phase 1 Study To Evaluate The Effect Of Dimebon On The Pharmacokinetics Of Dextromethorphan | Huntington Disease, Alzheimer Disease | P1 | Completed | 14 | RCT, Open-label | Dextromethorphan, Dimebon + Dextromethorphan |
| NCT00904748 A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate | Erectile Dysfunction | P1 | Completed | 47 | RCT, Open-label | sildenafil citrate 100 mg CT, sildenafil citrate 100 mg CT, Viagra® |
| NCT01202435 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule | Healthy | P1 | Completed | 18 | RCT, Open-label | Pregabalin controlled release, 82.5 mg, Pregabalin immediate release, 25 mg |
| NCT06549816 A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors | Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck | P1 | Completed | 6 | Open-label | sigvotatug vedotin |
| NCT05743036 ZN-c3 in Adult Participants With Metastatic Colorectal Cancer | Metastatic Colorectal Cancer | P1 | Terminated | 44 | RCT, Open-label | ZN-c3, Encorafenib, Cetuximab |
| NCT01202422 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of Two Controlled Release Pregabalin Tablets As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 165 mg, Pregabalin controlled release, 330 mg, Pregabalin immediate release, 150 mg |
| NCT00510718 A Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate Cancer | Prostate Cancer, Hormone Refractory Prostate Cancer | P1 | Completed | 140 | Open-label | MDV3100 |
| NCT05538312 A Study to Understand the Effect of Itraconazole on the Levels of a Study Medicine Called ARV-471 in Healthy Adults | Healthy | P1 | Completed | 12 | Open-label | vepdegestrant, Itraconazole |
| NCT01080612 A Study To Assess The Pharmacokinetics, Safety, And Tolerability Of A Pregabalin Controlled Release Formulation Administered Following Various Sized Caloric Meals As Compared To The Pregabalin Immediate Release Formulation | Healthy | P1 | Completed | 24 | RCT, Open-label | 330 mg pregabalin controlled release, 330 mg pregabalin controlled release, 330 mg pregabalin controlled release, 300 mg pregabalin immediate release |
| NCT01027117 A Relative Bioavailability Study of Revatio for the Crushed Tablets, Extemporaneously Prepared Formulation, and the Intact Tablets at 20 mg Dose in Healthy Volunteers | Healthy | P1 | Completed | 18 | RCT, Open-label | Revatio, Revatio, Revatio |
| NCT00831532 Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [Pf-01913539] In Subjects With Hepatic Impairment And Normal Hepatic Function | Hepatic Failure | P1 | Completed | 23 | Open-label | Dimebon, Dimebon, Dimebon, Dimebon |
| NCT00871806 Pharmacokinetics of Two Eletriptan Oral Formulations Given With and Without Water and the Commercial Tablet Formulation Given With Water | Healthy Volunteers | P1 | Completed | 20 | RCT, Open-label | Commercial tablet with water, ODT #1 without water, ODT #2 without water, ODT #1 with water, ODT #2 with water |
| NCT01342198 An Investigation of the Effects of Erythromycin on the Pharmacokinetics of the Pregabalin Controlled Release Tablet | Healthy | P1 | Completed | 18 | RCT, Open-label | Pregabalin controlled release, 330 mg, Pregabalin controlled release, 330 mg, erythromycin |
| NCT02725112 Bioavailability Study of Pregabalin Extended Release Formulation With Various Release Rates in Healthy Volunteers | Healthy | P1 | Completed | 25 | RCT, Open-label | Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER, Pregabalin ER |
| NCT00831506 Dimebon (PF-01913539)-Digoxin Drug-Drug Interaction Study In Healthy Subjects | Alzheimer Disease, Huntington Disease | P1 | Completed | 12 | RCT, Double-blind | digoxin, digoxin, dimebon |
| NCT00866463 A Study to Compare the Blood Levels of Sildenafil Following Administration of an Experimental Tablet vs. the Conventional Oral Tablet in Healthy Subjects | Erectile Dysfunction | P1 | Completed | 18 | RCT, Open-label | Sildenafil, Sildenafil, Sildenafil |
| NCT01247805 A Pivotal Bioequivalence Study Between The Sildenafil Powder For Oral Suspension (10 Mg/Ml) And The Sildenafil 10 Mg Immediate Release (IR) Tablet Relative To The Revatio 20 Mg IR Tablet In Healthy Volunteers Under Fasting Conditions | Pulmonary Arterial Hypertention | P1 | Completed | 42 | RCT, Open-label | sildenafil citrate, Sildenafil citrate, sildenafil citrate |
| NCT01008527 Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100 | Melanoma | P1 | Completed | 22 | Open-label | CP 870,893, Peptides, Oncovir poly IC:LC |
| NCT01254383 Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Versus To Viagra® Oral Tablet. | Erectile Dysfunction | P1 | Completed | 36 | RCT, Open-label | Sildenafil Tablet, Sildenafil ODT, Sildenafil ODT |
| NCT00987779 Bioequivalence Study Of Gabapentin Between Tablet And Liquid Formulation And The Food Effect Study Of Liquid Formulation | Healthy | P1 | Completed | 26 | RCT, Open-label | Gabapentin, Gabapentin |
| NCT03042910 A Study to Assess the Effects of Talazoparib on Cardiac Repolarization in Patients With Advanced Solid Tumors | Solid Tumor | P1 | Completed | 38 | Open-label | Talazoparib |
| NCT00760474 An fMRI Study Of Brain Response In Patients With Fibromyalgia | Fibromyalgia | P1 | Completed | 27 | RCT, Double-blind | Pregabalin, then placebo, Placebo, then pregabalin |
| NCT00739999 8-Week PK/PD Atorvastatin Study In Children And Adolescents With Heterozygous Familial Hypercholesterolemia | Pediatric Heterozygous Hypercholesterolemia | P1 | Completed | 39 | Open-label | Atorvastatin, Atorvastatin |
| NCT02997176 An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) | Advanced Solid Tumors | P1 | Completed | 38 | Open-label | Talazoparib |
| NCT00998036 Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors | Triple Negative Breast Cancer | P1 | Completed | 9 | Open-label | Temsirolimus, Cisplatin, Erlotinib |
| NCT01286987 Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors | Advanced or Recurrent Solid Tumors, Breast Neoplasms | P1 | Completed | 113 | Open-label | Talazoparib |
| NCT02651623 Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects | Healthy | P1 | Completed | 54 | RCT, Double-blind | Sertraline, Moxifloxacin, Drug - Placebo |
| NCT04498520 Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic Cancer | Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | P1 | Withdrawn | — | Open-label | Abexinostat Tosylate, Fulvestrant, Palbociclib |
| NCT00990223 Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity | Healthy Volunteers | P1 | Completed | 20 | RCT, Double-blind | Eplerenone or Placebo |
| NCT00506805 Safety And Pharmacology Study Of SNX-5422 Mesylate In Subjects With Refractory Solid Tumor Malignancies | Cancer | P1 | Completed | 44 | Open-label | SNX-5422 |
| NCT04391868 A Bioequivalence Study of Sildenafil Citrate Orally-Disintegrating Film Dosage Form | Healthy | P1 | Withdrawn | — | RCT, Open-label | Viagra Tablet, Sildenafil Citrate ODF, Sildenafil Citrate ODF |
| NCT00813241 A Pilot Open-Label Crossover Bioavailability Study of Celecoxib in Healthy Volunteers | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | celecoxib reference formulation, celecoxib test formulation A1, celecoxib test formulation B2, celecoxib test formulation C1 |
| NCT03861403 A Dose Escalation and Expansion Study of TRX518 in Combination With Cyclophosphamide Plus Avelumab in Advanced Solid Tumors | Solid Tumors, Advanced Triple Negative Breast Cancer | P1 | Terminated | 10 | Open-label | TRX518, Cyclophosphamide, Avelumab |
| NCT01177293 Bioavailability Study Comparing 10 mg Amlodipine Besylate Orally Disintegrating Tablets (ODT) And 10 mg Amlodipine Besylate Capsules | Healthy Volunteers | P1 | Completed | 14 | RCT, Open-label | Amlodipine - reference, Amlodipine ODT - test |
| NCT00950404 Bioavailability of 3 Sildenafil Oral Disintegrating Tablet Formulations Compared to the Standard Oral Tablet | Healthy Volunteers | P1 | Completed | 16 | RCT, Open-label | Viagra 50 mg tablet, Formulation B ODT tablet 50 mg, Formulation C ODT tablet 50 mg, Formulation D ODT tablet 50 mg |
| NCT00654940 A Study To Assess The Ability Of A Crossover Study Design To Detect The Efficacy Of Pregabalin In Post-Traumatic Neuropathic Pain Patients | Nerve Pain | P1 | Completed | 25 | RCT, Double-blind | Pregabalin (Lyrica), Placebo |
| NCT01656798 Food Effect Study For New Formulation | Healthy | P1 | Completed | 12 | RCT, Open-label | sildenafil citrate, sildenafil citrate |
| NCT05652660 A Study to Understand the Effect of a Study Medicine Called ARV-471 on Rosuvastatin in Healthy Adults | Healthy | P1 | Completed | 12 | Open-label | ARV-471, Rosuvastatin |
| NCT05930925 A Study to Understand How the Study Medicine Called ARV-471 is Processed in Healthy Adults | Healthy | P1 | Completed | 12 | RCT, Open-label | [phenyl-14C]ARV-471, [oxoisoindolin-14C]ARV-471 |
| NCT02207504 Crizotinib in Combination With Enzalutamide in Metastatic Castration-resistant Prostate Cancer | Castration-resistant Prostate Cancer | P1 | Completed | 24 | Open-label | Crizotinib, Enzalutamide |
| NCT03070548 A Study of Talazoparib in Patients With Advanced Solid Tumors | Advanced Solid Tumors | P1 | Completed | 6 | Open-label | Talazoparib |
| NCT02997163 An Open-Label Pharmacokinetics and Safety Study of Talazoparib | Advanced Solid Tumors | P1 | Completed | 34 | Open-label | Talazoparib |
| NCT04703920 Talazoparib in Combination With Belinostat for Metastatic Breast Cancer, Metastatic Castration Resistant Prostate Cancer, and Metastatic Ovarian Cancer | Metastatic Breast Cancer, Metastatic Castration-resistant Prostate Cancer | P1 | Completed | 26 | Open-label | Talazoparib, Belinostat |
| NCT00810316 Evaluate Pharmacokinetics Of Two Different Pharmaceutical Oral Formulations Of Alprazolam And A Clonazepam Tablet In Mexican Healthy Population | Pharmacokinetics | P1 | Completed | 24 | RCT, Single-blind | Alprazolam, Alprazolam XR, Clonazepam |
| NCT00777517 Bioequivalence Study On Pediatric Appropriate Formulation | Hypercholesterolemia | P1 | Completed | 76 | RCT, Open-label | Lipitor, Atorvastatin pediatric formulation |
| NCT06275841 A Study to Learn If the Study Medicine Esomeprazole Changes How the Body Processes the Other Study Medicine Vepdegestrant | Healthy | P1 | Completed | 12 | Open-label | vepdegestrant, esomeprazole |
| NCT00638742 A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. | Glaucoma, Ocular Hypertension | P1 | Completed | 47 | Open-label | latanoprost |
| NCT00931073 A Phase I Study To Estimate The Effect Of Ketoconazole And Omeprazole On The Pharmacokinetics Of Dimebon In Healthy Subjects Who Are Normal Or Poor CYP2D6 Metabolizers | Alzheimer's Disease, Huntington's Disease | P1 | Completed | 24 | Open-label | Dimebon alone, Dimebon + Ketoconazole, Dimebon + Omeprazole |
| NCT06911788 A Study to Learn How a Tablet Compared With an IV Infusion of the Study Medicine Called Vepdegestrant is Taken up Into the Blood in Healthy Adults | Healthy Participants | P1 | Completed | 10 | Open-label | Vepdegestrant (Reference), Vepdegestrant (Test) |
| NCT01321671 Investigation Of Absorption And Pharmacokinetics Of A Single Dose Of Controlled Release Pregabalin Tablet Administered Fasted In The Evening or Immediately Following A 600-750 Calorie Evening Meal As Compared To Single Dose Of Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 24 | RCT, Open-label | Pregabalin controlled release, 330 mg, 600- 750 calorie, Pregabalin controlled release, 330 mg, fasted, Pregabalin immediate release, 300 mg |
| NCT01257516 An Investigation Of The Absorption And Pharmacokinetics Of Multiple Doses Of A Controlled Release Pregabalin Tablet As Compared To Multiple Doses Of The Immediate Release Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 18 | RCT, Open-label | Pregabalin immediate release, 300 mg, Pregabalin controlled release, 330 mg |
| NCT05732428 A Study to Learn About the Study Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Advanced Breast Cancer in China | Breast Cancer | P1 | Completed | 9 | Open-label | ARV-471 |
| NCT00907322 A Phase 1 Trial To Assess The Safety And Pharmacokinetics Of Single, Ascending, Oral Doses Of Dimebon In Healthy Adults | Healthy Volunteers | P1 | Completed | 12 | RCT, Double-blind | Dimebon, Dimebon, Dimebon, Dimebon |
| NCT05501769 ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer | Breast Cancer | P1 | Completed | 32 | Open-label | ARV-471 in combination with Everolimus |
| NCT06347861 A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults | Healthy | P1 | Completed | 52 | RCT, Open-label | single dose of vepdegestrant as tablet formulation (Treatment A), single dose of vepdegestrant as tablet formulation (Treatment B), single dose of vepdegestrant as tablet formulation (Treatment C) |
| NCT01285505 Bioequivalence of a New and a Commercial Alprazolam Sublingual Formulation | Healthy | P1 | Withdrawn | — | RCT, Open-label | alprazolam commercial sublingual formulation, alprazolam test sublingual tablet |
| NCT01235195 A Study Comparing the Drug Exposure in Humans After Administration of a 50 mg Tablet of Sertraline Hydrochloride as Compared to a 50 mg Capsule of Sertraline Hydrochloride Under Fasted (Nonfed) Conditions | Healthy | P1 | Completed | 30 | RCT, Open-label | sertraline hydrochloride, sertraline hydrochloride |
| NCT01027689 Bioequivalence of a New Sublingual and a Reference Alprazolam Immediate Release Tablet Formulation | Healthy | P1 | Withdrawn | — | RCT, Open-label | alprazolam commercial immediate release oral tablet, alprazolam test sublingual tablet |
| NCT01270815 An Investigation Of The Absorption And Pharmacokinetics Of A Single Dose Of A Controlled Release (CR) Pregabalin Tablet Following Various Sized Lunches As Compared To A Single Dose Of The Immediate Release (IR) Pregabalin Capsule In Healthy Volunteers | Healthy | P1 | Completed | 28 | RCT, Open-label | Pregabalin controlled release, 330 mg, 400 to 500 calories, Pregabalin controlled release, 330 mg, 600 to 750 calories, Pregabalin controlled release, 330 mg, 800 to 1000 calories, Pregabalin immediate release, 300 mg |
| NCT01399840 Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies | Acute Myeloid Leukemia, Myelodysplastic Syndrome | P1 | Completed | 33 | Open-label | BMN 673 |
| NCT01355068 A Study to Assess if Epanutin Infatabs 50 mg From Germany Are Similar to Dilantin Infatabs 50 mg From Australia | Healthy | P1 | Completed | 26 | RCT, Open-label | Epanutin Infatabs (Phenytoin), Dilantin Infatabs (Phenytoin) |
| NCT00988624 A Study In Healthy Volunteers To Estimate The Pharmacokinetics Of Four Modified-Release Formulations Of Dimebon (Latrepirdine) | Alzheimer's Disease, Huntington Disease | P1 | Completed | 20 | RCT, Open-label | Dimebon IR Tablet, Dimebon MR1, Dimebon MR2, Dimebon MR3, Dimebon MR4 |
| NCT01122940 Bioequivalence Study Of Phenytoin Suspension Versus Epamin® In 34 Healthy Volunteers. | Healthy | P1 | Completed | 32 | RCT, Open-label | Epamin: Reference Drug, Phenytoin: Study Drug |
| NCT01330472 An Bioequivalence Study Of Xanax Extended Release Tablets From Two Different Manufacturing Sites | Healthy Subjects | P1 | Completed | 16 | RCT, Open-label | Xanax XR tablets 3 mg (sourced from Caugus), Xanax XR tablets 3 mg (sourced from Barceloneta) |
| NCT06005688 A Study to Understand the Effects of Carbamazepine on How Vepdegestrant is Processed in Healthy Participants | Healthy Participants | P1 | Completed | 12 | Open-label | Vepdegestrant, Carbamazepine |
| NCT01139515 Eletriptan Pharmacokinetics In Korean Males | Healthy | P1 | Completed | 16 | RCT, Open-label | Eletriptan commercial tablet, Eletriptan commercial tablet, Eletriptan commercial tablet, Eletriptan commercial tablet |
| NCT04176367 An Bioequivalence Study Comparing Nicergoline 10 mg Tablet Manufactured in China With Nicergoline 10 mg Tablet Manufactured in Italy Under Fasted and Fed Conditions in Healthy Chinese Participants | Pharmacokinetics | P1 | Completed | 40 | RCT, Open-label | Nicergoline from China, Nicergoline from Italy |
| NCT04269538 Evaluation of Safety, Tolerability and Pharmacokinetics of Single Dose of PF-06480605 in Japanese Healthy Participants | Healthy | P1 | Completed | 16 | RCT, Double-blind | PF-06480605, Placebo |
| NCT01419041 A Study to Evaluate The Pharmacokinetics Of Crizotinib (PF-02341066) In Subjects With Impaired Renal Function | Renal Impairment | P1 | Completed | 16 | RCT, Open-label | crizotinib, crizotinib |
| NCT03916250 Evaluation of Skin Irritation Potential With PF-06700841 Cream Formulation Using Negative Control in Adult Japanese Healthy Participants | Healthy | P1 | Completed | 20 | RCT, Double-blind | PF-06700841 cream, White petrolatum |
| NCT00836082 A Multiple Dose Trial Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-04457845 in Healthy Volunteers | Acute Pain, Chronic Pain | P1 | Completed | 41 | RCT, Double-blind | PF-04457845, FAAH inhibitor, PF-04457845, FAAH inhibitor, PF-04457845, FAAH inhibitor, PF-04457845, FAAH inhibitor, PF-04457845, FAAH inhibitor, PF-04457845, FAAH inhibitor |
| NCT02603419 Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS) | Hodgkins Lymphoma | P1 | Terminated | 34 | RCT, Open-label | Avelumab, Avelumab, Avelumab, Avelumab, Avelumab, Avelumab |
| NCT05498701 A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food | Healthy | P1 | Completed | 22 | RCT, Open-label | Tafamidis free acid tablet (Test), Tafamidis meglumine capsule (Reference) |
| NCT01185184 Pharmacokinetics And Safety Study Of Two CP-690,550 Controlled Release Formulation Following Single Dose In Healthy Volunteers | Healthy | P1 | Completed | 12 | RCT, Open-label | CP-690,550 |
| NCT01745055 Co-Administration Of Methotrexate And CP-690,550 | Rheumatoid Arthritis | P1 | Completed | 12 | Open-label | CP-690,550 (tofacitinib), Methotrexate (MTX) |
| NCT01290900 A Single-centre, Randomised, Double-blind, Placebo-controlled, Four Way Crossover Phase I Study to Investigate the Effect on QT/QTc Interval of Ceftazidime NXL104 or Ceftaroline Fosamil NXL104, Compared With Placebo, Using Moxifloxacin (Avelox®) as a Positive Control, in Healthy Male Volunteers | Healthy Male Volunteers | P1 | Completed | 54 | RCT, Double-blind | NXL104, Ceftaroline, Placebo Infusion, Ceftazidime, Moxifloxacin |
| NCT03937258 A Study to Assess Pharmacokinetics of PF-04965842 and Its Metabolites and Effect of Probenecid in Healthy Participants | Healthy | P1 | Completed | 12 | RCT, Open-label | PF-04965842, Probenecid |
| NCT00454649 Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor | Neoplasms | P1 | Completed | 102 | Open-label | Axitinib + Paclitaxel + Carboplatin (Cohort 1), Axitinib + Paclitaxel + Carboplatin (Cohort 2), Axitinib + Paclitaxel + Carboplatin (Cohort 3), Axitinib + Paclitaxel (Cohort 4), Axitinib + Docetaxel + Carboplatin (Cohort 4a), Axitinib + Docetaxel (Cohort 5), Axitinib + Capecitabine (Cohort 6), Axitinib + Capecitabine (Cohort 7), Axitinib + Gemcitabine + Cisplatin (Cohort 8), Axitinib + Pemetrexed + Cisplatin (Cohort 9) |
| NCT00661765 A Single Dose Study Investigating the Absorption and Elimination as Well as the Tolerability of Varenicline Transdermal Delivery System (e.g., a Patch) as Compared to Oral Varenicline in Adult Smokers. | Smoking Cessation | P1 | Completed | 18 | RCT, Open-label | varenicline tartrate, varenicline free base |
| NCT00456898 Study Evaluating the Potential of DVS SR to Inhibit the CYP2D6 Pathway | Depressive Disorder, Major, Diabetic Neuropathies | P1 | Completed | 40 | RCT, Open-label | desvenlafaxine sustained release (DVS SR), Paroxetine, Codeine |
| NCT01213355 Scopolamine Challenge Study | Healthy | P1 | Completed | 38 | RCT, Double-blind | Placebo, Scopolamine, PF-05212377, Scopolamine, PF-05212377, scopolamine, PF-05212377, scopolamine, Donepezil, Scopolamine |
| NCT01637285 A Pharmacokinetic Study of CVX-096 (PF-04856883) in Healthy Volunteers | Healthy | P1 | Completed | 49 | RCT, Open-label | PF-04856883, PF-04856883, PF-04856883, PF-04856883 |
| NCT04126044 A SINGLE-DOSE, 2-ARM, PHARMACOKINETIC STUDY OF PF-06439535 (CN) AND EUROPEAN UNION SOURCED BEVACIZUMAB IN CHINESE HEALTHY MALE VOLUNTEERS | Pharmacokinetics | P1 | Withdrawn | — | RCT, Double-blind | PF-06439535 (CN), bevacizumab - EU |
| NCT00547014 First Safety Study in Humans of a Single Dose of CPG 52364 | Healthy Volunteers | P1 | Completed | 61 | RCT, Double-blind | Placebo Comparator: Cohort 1 Placebo, 52364 3 mg, Placebo Comparator: Cohorts 2, 3, 4 & 5 Two subjects each arm will be assigned to receive placebo, 52364 10 mg, 52364 30 mg, 52364 100 mg, 52364 1 mg |
| NCT00970593 Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin | Diabetes Mellitus | P1 | Completed | 92 | RCT, Double-blind | OAP-189, placebo comparator |
| NCT05873764 A Study to Learn About Effect of Sisunatovir in Healthy Adult Male Participants | Respiratory Syncytial Virus Infections | P1 | Completed | 9 | Open-label | 200 mg RV521/78 µCi [ 14C]-RV521. |
| NCT03916393 PF-06651600 Taste Study. | Healthy Participants | P1 | Completed | 10 | RCT, Single-blind | PF-06651600 20 mg |
| NCT01034748 A Radiolabeled Mass Balance Study Of [14C]PF-00299804 In Healthy Male Volunteers | Carcinoma, Non-Small-Cell Lung | P1 | Completed | 6 | Open-label | [14C]PF00299804 |
| NCT01537497 A Study To Evaluate The Effects Of PF-05175157 In Healthy Volunteers | Diabetes Mellitus, Type 2 | P1 | Completed | 31 | RCT, Double-blind | PF-05175157, PF-05175157, PF-05175157, Placebo |
| NCT01634789 A Pilot Bioavailability Study of 3 Test Tablet Formulations of Bazedoxifene Compared With A Reference Tablet Formulation of Bazedoxifene/Conjugated Estrogens in Healthy Postmenopausal Women | Healthy | P1 | Terminated | 2 | RCT, Open-label | bazedoxifene, bazedoxifene, bazedoxifene, bazedoxifene/conjugated estrogens |
| NCT03929510 Study to Characterize Absorption, Distribution, Metabolism and Excretion of 14C PF-06651600 and to Evaluate the Absolute Oral Bioavailability and Fraction Absorbed of PF-06651600. | Healthy Volunteers | P1 | Completed | 6 | Open-label | 14C-PF-06651600, 14C-PF-06651600 IV, PF-06651600 |
| NCT01105533 A Dose Finding Study Of A New Medication, PF-00337210 That Will Possibly Decrease Blood Supply To Tumors | Neoplasm | P1 | Completed | 46 | Open-label | PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210, PF-00337210 |
| NCT01443208 Pharmacokinetics and Safety of Desvenlafaxine in Korean Healthy Subjects Following Single and Multiple Oral Doses of Desvenlafaxine Succinate Sustained Release Tablet | Major Depressive Disorder | P1 | Completed | 36 | RCT, Double-blind | desvenlafaxine, desvenlafaxine, desvenlafaxine |
| NCT00397176 Study Evaluating Safety, Tolerability, and PK of DVS SR in Healthy Japanese Women | Vasomotor Symptoms | P1 | Completed | 32 | RCT, Single-blind | desvenlafaxine succinate sustained release (DVS SR) |
| NCT01058824 Relative Bioavailability Study Of Two Lincomycin Hydrochloride Hard Gelatinous Capsule | Bacterial Infections | P1 | Completed | 36 | RCT, Open-label | Lincomycin, Lincomycin |
| NCT01298518 A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients | Type 2 Diabetes Patients | P1 | Completed | 48 | RCT, Double-blind | PF-04620110, PF-04620110, Placebo |
| NCT05441215 A Study to Learn About the Medicine (PF-07321332 or Nirmatrelvir/Ritonavir) in Healthy Lactating Women | Healthy Participants | P1 | Completed | 8 | Open-label | nirmatrelvir, ritonavir |
| NCT06003829 A Study to Learn About the Tastes of Different Suspensions With the Study Medicine (PF-07923568) in Healthy Adult Participants. | Healthy | P1 | Completed | 12 | RCT, Single-blind | Sinsunatovir |
| NCT05061277 Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Recifercept in Healthy Chinese Participants | Healthy | P1 | Withdrawn | — | Open-label | Recifercept |
| NCT01965600 A Study To Evaluate The Safety And Effects On The Body Of An Investigational Drug Using An Endotoxin-Induced Inflammatory Response Model | Healthy | P1 | Terminated | 23 | RCT, Double-blind | PF-06282999, Placebo, PF-06282999, Placebo |
| NCT04044053 Relative Bioavailability Study of a Modified-Release Formulation of PF-06865571 in Healthy Adult Participants | Healthy Participants | P1 | Completed | 12 | RCT, Open-label | PF-06865571 400 mg Immediate Release (IR) in Fed State, PF-06865571 50 mg Modified Release (MR) in Fed State, PF-06865571 400 mg MR in Fed State, PF-06865571 400 mg MR in Fasted State |
| NCT06273839 A Study to Learn How Different Forms of Study Medicine Tafamidis Are Taken Up Into The Blood in Healthy Adults | Healthy | P1 | Completed | 12 | RCT, Open-label | Tafamidis 61 mg free acid tablet (Test 1), Tafamidis 70 mg free acid tablet (Test 1), Tafamidis 61 mg free acid capsule (Reference) |
| NCT00663065 A Study of the Safety of PAZ-417 in Healthy Elderly Adults | Healthy | P1 | Terminated | 40 | RCT, Double-blind | PAZ-417 |
| NCT01297595 Relative Bioavailability Of A Crizotinib Oral Liquid Formulation To Crizotinib Formulated Capsule | Healthy | P1 | Completed | 22 | RCT, Open-label | crizotinib |
| NCT02110342 A Study To Understand How Radiolabelled PF-04449913 Is Taken Up By The Body, Broken Down And Then Removed From The Body | Healthy | P1 | Completed | 6 | Open-label | [14C] PF-04449913 |
| NCT02430545 Understanding The Effect Of A Strong CYP3A4 Inducer On Glasdegib Pharmacokinetics | Healthy Volunteers | P1 | Completed | 12 | Open-label | Glasdegib, Rifampin |
| NCT00959881 Study Evaluating The Coadministration of Begacestat And Donepezil | Healthy Subjects | P1 | Completed | 47 | RCT, Double-blind | Donepezil plus placebo, Donepezil, Begacestat |
| NCT01186757 Multiple Dose Healthy Volunteer Study of PF-03715455. | Healthy Volunteers | P1 | Completed | 36 | RCT, Double-blind | PF-03715455, PF-03715455, PF-03715455, Placebo |
| NCT01456507 Healthy Volunteers Study to Estimate the Effects of Food on the Bioavailability of Oxycodone and Naltrexone/6- Β -Naltrexol From a Extended Release Formulation of Oxycodone With Sequestered Naltrexone | Healthy | P1 | Completed | 24 | RCT, Open-label | ALO-02 (Oxycodone Naltrexone), ALO-02 (Oxycodone Naltrexone), ALO-02 (Oxycodone Naltrexone) |
| NCT01061411 Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery | Clear Cell Sarcoma of the Kidney, Recurrent Renal Cell Carcinoma | P1 | Completed | 16 | Open-label | Dalteparin, Sunitinib Malate |
| NCT00875628 A Study To Investigate Safety, Tolerability, And Pharmacokinetics Of PF-00868554 In Japanese Healthy Adult Volunteers | Healthy Volunteers | P1 | Terminated | 24 | RCT, Double-blind | PF-00868554 or Placebo, PF-00868554 or Placebo, PF-00868554 or Placebo |
| NCT02058277 A Drug Interaction Study Between Bosutinib And Aprepitant In Healthy Volunteers | Healthy | P1 | Completed | 20 | Open-label | bosutinib or bosutinib + aprepitant |
| NCT00174512 A Methodological Open Label Cross-Over Controlled Study To Assess The Effect Of Drugs On Ventricular Repolarization and QT Interval At Fixed Heart Rate Under Autonomic Blockade | Patients With Pace Makers But no Evidence of Ischemic Heart Disease | P1 | Completed | 36 | RCT, Open-label | GTN, Moxifloxacin |
| NCT01723254 A Study To Assess The Safety And Tolerability Of Different Doses Of PF-06444753 And PF-06444752 In Subjects With Allergic Rhinitis | Allergic Rhinitis | P1 | Completed | 190 | RCT, Double-blind | IGE-1, IGE-2, Saline |
| NCT01563497 A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State | Pain | P1 | Completed | 12 | RCT, Open-label | PF-05089771, PF-05089771, PF-05089771 |
| NCT03961997 Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants | Adult, Drug Interactions | P1 | Completed | 16 | Open-label | Lorlatinib 50 mg, Lorlatinib 75 mg, Lorlatinib 100 mg |
| NCT05960032 A Study to Learn About the Study Medicine Called Zavegepant in Healthy Chinese Adult Participants | Healthy | P1 | Completed | 13 | Open-label | Zavegepant |
| NCT04535167 First-In-Human Study To Evaluate Safety, Tolerability, And Pharmacokinetics Following Single Ascending And Multiple Ascending Doses of PF-07304814 In Hospitalized Participants With COVID-19. | Viral Disease | P1 | Completed | 26 | RCT, Double-blind | PF-07304814, Placebo |
| NCT00479700 Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Subjects | Alzheimer Disease | P1 | Completed | 80 | RCT, Double-blind | SAM-531 |
| NCT00991016 Single and Multiple Dose Safety, Tolerability, and Pharmacokinetics Study of PF-04805712 in Healthy Volunteers | Healthy Volunteers | P1 | Terminated | 61 | RCT, Double-blind | PF-04805712 |
| NCT03309202 Study of PF-05221304 in Subjects With Varying Degrees of Hepatic Impairment | Hepatic Impairment | P1 | Completed | 24 | Open-label | PF-05221304 |
| NCT01049841 Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors | Pediatric Solid Tumors | P1 | Completed | 23 | Open-label | perifosine + temsirolimus |
| NCT00255996 Evaluation Of Linezolid Pk Profile In Burns Patients | Burns | P1 | Completed | 16 | Open-label | linezolid |
| NCT00593008 Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | Pancreatic Adenocarcinoma | P1 | Terminated | 5 | Open-label | Temsirolimus, Gemcitabine |
| NCT03821480 Diflucan Bioequivalence Study For Transferring The Manufacture | Bioequivalence | P1 | Completed | 28 | RCT, Open-label | Test drug, Reference drug |
| NCT00737113 Recombinant Human Growth Hormone (RH-GH) For Accelerating Immune Reconstitution Post Unrelated Cord Blood Transplant | Allogeneic Stem Cell Transplantation | P1 | Terminated | 14 | Open-label | Genotropin (Recombinant Human Growth Hormone) |
| NCT01821079 A Healthy Volunteer Study To Assess Relative Bioavailability Of Powder-In-Capsule And A Tablet Formulation And The Effect Of Food On The Pharmacokinetics Of The Tablet Formulation | Healthy | P1 | Completed | 12 | RCT, Open-label | PF-05175157, PF-05175157, PF-05175157, PF-05175157 |
| NCT01530529 A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999 | Healthy | P1 | Completed | 12 | RCT, Open-label | PF-05180999, PF-05180999, PF-05180999, PF-05180999 |
| NCT02659631 PF-06671008 Dose Escalation Study in Advanced Solid Tumors | Neoplasms | P1 | Terminated | 28 | Open-label | PF-06671008, PF-06671008 |
| NCT01151345 Bioequivalence Study Of Diltiazem In 60 Mg Tablets As Tilazem 60® Made by Pfizer, S.A. De C.V., Versus Angiotrofin® 60 Mg Made by Amstrong Laboratorios De Mexico, S.A. De C.V. | Healthy | P1 | Completed | 26 | RCT, Open-label | TILACEM, ANGIOTROFIN |
| NCT02084875 A Study To Evaluate The Effect Of Food On The Behavior Of Tofacitinib Modified Release 11 Milligram Tablets In Healthy Western And Japanese Volunteers | Healthy | P1 | Completed | 24 | RCT, Open-label | tofacitinib modified-release (MR) formulation, tofacitinib modified-release (MR) formulation |
| NCT06392230 A Study to Learn How the Medicine Called [14C] PF-06821497 is Taken up Into and Removed From the Body. | Healthy Participants | P1 | Completed | 6 | Open-label | Oral [14C] PF-06821497, Oral PF-06821497, IV [14C] PF-06821497 |
| NCT00550381 Study Evaluating the Safety, Tolerability, and Pharmacokinetics (PK) of HKI-357 Administered Orally to Healthy Subjects | Healthy | P1 | Completed | 72 | RCT, Double-blind | HKI-357 |
| NCT05064332 A Study To Estimate The Effect of PF-06650833 On The Pharmacokinetics (PK) of Oral Contraceptive (OC) | Healthy | P1 | Completed | 10 | Open-label | PF-06650833, Ethinyl estradiol (EE) and levonogestrel (LN) |
| NCT01358565 Pharmacokinetics Of Orally Administered Fx-1006A In Subjects With Hepatic Dysfunction | Mild Hepatic Dysfunction, Moderate Hepatic Dysfunction | P1 | Completed | 16 | Open-label | Fx-1006A, Fx-1006A |
| NCT02170012 A Study In Healthy Elderly People To Evaluate Safety, Toleration, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses Of PF-06743649 | Healthy Elderly | P1 | Terminated | 24 | RCT, Double-blind | PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo, PF-06743649, Placebo |
| NCT01155258 Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors | Extensive Stage Small Cell Lung Cancer, Hereditary Paraganglioma | P1 | Completed | 19 | Open-label | temsirolimus, vinorelbine ditartrate |
| NCT03112148 PK Study in Adult Healthy Volunteers to Assess QD Dosing With the Selected Age-appropriate MR Formulations | Healthy | P1 | Completed | 24 | RCT, Open-label | 10 mg dose MR formulations,10 mg dose of tofacitinib IR solution |
| NCT00736697 Study Evaluating The Effect Of High-Fat Meal On Bioavailability And Pharmacokinetics Of Single Dose Of Moxidectin | Infection | P1 | Completed | 54 | RCT, Open-label | moxidectin |
| NCT03002649 Study of Tofacitinib in Refractory Dermatomyositis | Dermatomyositis | P1 | Completed | 10 | Open-label | Tofacitinib |
| NCT00641225 Study Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid Arthritis | Rheumatoid Arthritis | P1 | Completed | 60 | Open-label | SBI-087 |
| NCT03626415 A Hepatic Impairment Study for PF-04965842. | Hepatic Impairment | P1 | Completed | 24 | Open-label | PF-04965842 |
| NCT00786240 Phase1, Single Dose, Crossover Study to Determine Bioequivalence | Healthy | P1 | Completed | 37 | RCT, Open-label | Fesoterodine, Fesoterodine |
| NCT04395950 Effects of ACC Inhibitor on Lipid and Lipoprotein Metabolism | NASH (Nonalcoholic Steatohepatitis), NAFLD (Nonalcoholic Fatty Liver Disease) | P1 | Withdrawn | — | Single-blind | PF-05221304, Placebo |
| NCT00472836 Study Examining The Effect Of Renal Impairment On Safety, Toleration And How The Body Processes An Experimental Drug | Obesity | P1 | Completed | 17 | Open-label | CP-945,598, CP-945,598 |
| NCT00783328 A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors | Neoplasms | P1 | Completed | 13 | Open-label | PF-00299804 |
| NCT02766621 Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of Compound PF-06823859 | Healthy | P1 | Completed | 62 | RCT, Double-blind | PF-06823859, Placebo injection SC/IV |
| NCT04987944 Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma | Asthma | P1 | Terminated | 45 | RCT, Single-blind | Zavegepant, Placebo |
| NCT01920399 A Phase I Study to Assess the Safety, Tolerability and PK of Ceftazidime-Avibactam in Healthy Chinese Subjects | Healthy Volunteers | P1 | Completed | 42 | RCT, Double-blind | CAZ-AVI, 0.9% Normal Saline |
| NCT00800280 Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body | Generalized Anxiety Disorder | P1 | Terminated | 12 | RCT, Open-label | PD 0332334, PD 0332334, cimetidine |
| NCT03636503 Rituximab + Immunotherapy in Follicular Lymphoma | Follicular Lymphoma | P1 | Terminated | 24 | Open-label | Rituximab, Utomilumab, Avelumab, PF04518600 |
| NCT00618124 A Study To Find The Best Doses Of SU011248 (Sunitinib) And Capecitabine When These Drugs Are Administered Together | Solid Tumors, Breast Cancer | P1 | Completed | 77 | Open-label | SU011248; Capecitabine |
| NCT01775189 A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted | Healthy | P1 | Completed | 45 | RCT, Double-blind | ALO-02 weight-matched placebo, crushed ALO-02 30 mg/3.6 mg, oxycodone weight-matched placebo, crushed oxycodone IR 30 mg |
| NCT01893346 Safety and Tolerability of Ceftazidime-Avibactam for Pediatric Patients With Suspected or Confirmed Infections | Systemic Infections | P1 | Completed | 35 | Open-label | CAZ-AVI |
| NCT04866225 A Study in Healthy Adult Male Participants to Assess Absorption, Distribution, Metabolism and Excretion (ADME) of Radiolabeled PF-06865571. | Healthy Participants | P1 | Completed | 6 | Open-label | Oral [14C]PF-06865571, Oral PF-06865571, IV [14C]PF-06865571 |
| NCT00827489 Study Evaluating HTC-867 in Healthy Young and Elderly Subjects | Healthy Subjects | P1 | Terminated | 72 | RCT, Double-blind | HTC-867 |
| NCT01462851 A Study To Observe Safety And Concentrations Of PF-05297909 And Proteins In Both Blood And Cerebrospinal Fluid After A Single Dose Of PF-05297909 In Healthy Adults | Healthy | P1 | Completed | 51 | RCT, Double-blind | PF-05297909 25 mg, PF-05297909 100 mg, PF-05297909 250 mg, PF-05297909 525 mg, PF-05297909 525 mg |
| NCT02070939 Study To Evaluate Safety And Tolerability Of Single And Multiple Ascending Doses Of PF- 06260414 In Healthy Western And Japanese Male Subjects | Healthy | P1 | Completed | 72 | RCT, Double-blind | PF-06260414, Placebo, PF-06260414, Placebo, PF-06260414, Placebo |
| NCT02211261 A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus | Type 2 Diabetes Mellitus | P1 | Completed | 84 | RCT, Double-blind | PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo, PF-06293620, Placebo |
| NCT05554237 A Study to Learn About the Study Medicine Called CTB+AVP in Healthy Adult People. | Healthy | P1 | Completed | 42 | RCT, Double-blind | Placebo, PF-07612577, PF-06264006 |
| NCT00384917 Study to Determine the Impact of Multiple Doses of Ketoconazole on Single-Dose Pharmacokinetics of HCV-796 | Healthy | P1 | Completed | 24 | Open-label | Ketoconazole |
| NCT01097876 A Study To Evaluate The Safety, Tolerability And Plasma Drug Levels Of PF-04447943 When Administered With Donepezil To Healthy Volunteer Subjects | Healthy | P1 | Completed | 24 | RCT, Double-blind | PF-04447943 25 mg, Placebo PF |
| NCT00547560 Study Evaluating Multiple Doses Of GSI-953 Within The Elderly Population | Healthy | P1 | Completed | 49 | RCT, Double-blind | GSI-953 |
| NCT01894776 A Drug Interaction Study Investigating the Effect of Rifabutin on the Pharmacokinetics of Maraviroc | HIV Infection, HIV-1 Infection | P1 | Completed | 15 | Open-label | Rifabutin, Maraviroc |
| NCT00379860 Study Evaluation LXR-623 in Healthy Adults | Healthy Subjects | P1 | Terminated | — | RCT, Double-blind | LXR-623 |
| NCT01217918 Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects | Healthy | P1 | Completed | 30 | RCT, Double-blind | 1 mg, 5 mg, 10 mg |
| NCT02306876 A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males | Healthy | P1 | Terminated | 77 | RCT, Double-blind | PF-06412562 3mg BID, PF-06412562 15mg BID |
| NCT01268163 The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer | Cancer | P1 | Completed | 32 | RCT, Double-blind | European Taxotere®, American Taxotere®, Hospira Docetaxel Injection |
| NCT00518492 Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500 | Healthy | P1 | Completed | 73 | Open-label | — |
| NCT02697864 A Study Comparing Amounts of Tafamidis In The Blood Without Food | Healthy | P1 | Completed | 12 | RCT, Open-label | tafamidis |
| NCT01772264 Safety And Tolerability Study Of BID Titration Scheme With PF-05089771 | Healthy | P1 | Completed | 40 | RCT, Double-blind | PF-05089771, Placebo |
| NCT06659250 A Study to Learn How Different Amounts and Forms of the Study Medicine Called PF-06414300 Act in Healthy Adults | Healthy Participants | P1 | Completed | 63 | RCT, Double-blind | PF-06414300, Placebo |
| NCT05434091 A First-In-Human Study of the Study Medicine, Called PF-07291177, in Healthy Adult Participants | Healthy Participants | P1 | Withdrawn | — | RCT, Double-blind | PF-07291177, Placebo |
| NCT00091689 Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions | Melanoma | P1 | Completed | — | Open-label | 852A |
| NCT02629289 A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Healthy Participants | Neutropenia | P1 | Completed | 153 | RCT, Open-label | HSP-130, US-approved Neulasta, EU-approved Neulasta |
| NCT00457769 Aricept to Improve Functional Tasks in Vascular Dementia | Stroke, Vascular Dementia | P1 | Unknown | 18 | RCT, Open-label | Donepezil and self-generated memory training, Donepezil and experimenter-administered memory training |
| NCT01146327 A Multiple Dose Study Of PF-04620110 In Healthy Overweight Or Obese Subjects | Healthy | P1 | Completed | 60 | RCT, Double-blind | PF-04620110, PF-04620110, PF-04620110, PF-04620110, Placebo |
| NCT00800722 A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks. | Port Wine Stain | P1 | Completed | 21 | Open-label | Rapamycin Treatment of Port Wine Stain |
| NCT00509756 Study Evaluating FXR-450 in Healthy Japanese Men | Healthy | P1 | Terminated | 56 | RCT, Double-blind | FXR-450, Placebo |
| NCT00988598 A Brief Study To Evaluate The Safety, Tolerability, And Blood Levels Of Multiple Doses Of PF-044467943 Or Placebo In Combination With Donepezil In Subjects With Mild To Moderate Alzheimer's Disease | Alzheimer's Disease | P1 | Completed | 15 | RCT, Double-blind | PF-04447943, Placebo |
| NCT01127906 Study To Assess The Effect Of PF-04531083 On Heat Pain In Healthy Volunteers With Ultraviolet Light Sensitized Skin | Healthy | P1 | Completed | 36 | RCT, Double-blind | PF-04531083 100mg, PF-04531083 2000mg, Placebo suspension, Placebo tablet, Oxycodone 20mg |
| NCT04018274 Effect of PF-06651600 on the Pharmacokinetics of Oral Contraceptive Steroids | Healthy | P1 | Completed | 29 | RCT, Open-label | PF-06651600, Ethinyl estradiol (EE) and levonorgestrel(LN) |
| NCT00978341 Study to Determine if a Reduction in Pain Can be Measured in Spinal Cord Injured Patients Using a New Study Design | Spinal Cord Injuries | N/A | Terminated | 15 | RCT, Double-blind | Pregabalin, Placebo for pregabalin |
| NCT01150903 Identification of Underlying Conditions in Men Prescribed a PDE5 Inhibitor | Erectile Dysfunction, Cardiovascular Diseases | Completed | 98,832 | — | — | |
| NCT01279850 Safety And Efficacy In Long Term Use Of Lyrica (Regulatory Post Marketing Commitment Plan) | Neuropathic Pain | Completed | 891 | — | Pregabalin (Lyrica) capsule | |
| NCT04836221 Comorbidities And Reducing inEquitieS | Cancer, Breast, Diabetes Mellitus | N/A | Completed | 63 | Open-label | — |
| NCT00567268 Drug Use Investigation Of Gabapentin | Epilepsies, Partial | Completed | 1,273 | — | Gabapentin | |
| NCT05968599 A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer | Prostatic Neoplasms, Castration-Resistant | Completed | 2,731 | — | Enzalutamide, Abiraterone acetate | |
| NCT01265719 Long-Term Non-Interventional Latanoprost Study | Glaucoma, Ocular Hypertension | Completed | 175 | — | — | |
| NCT02273908 PROs in Chronic Low Back Pain Patients With Accompanying Lower Limb Pain (Neuropathic Component) Treated With Pregabalin | Low-Back Pain | Completed | 331 | — | — | |
| NCT06151418 A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces | Prostatic Neoplasms | Completed | 2,313 | — | Novel hormonal therapy | |
| NCT01441401 Safety and Efficacy of Gabapen for Pediatric (Regulatory Post Marketing Commitment Plan) | Epilepsies, Partial | Completed | 82 | — | gabapentin | |
| NCT01209624 Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma | Low Tension Glaucoma | Completed | 902 | — | — | |
| NCT01191008 Long Term Use Of Xalacom In Patients Glaucoma Or Ocular Hypertension | Glaucoma, Ocular Hypertension | Completed | 661 | — | Latanoprost-timolol maleate fixed combination ophthalmic solution | |
| NCT01078285 Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor | Medication Non-Adherence | Completed | 500 | — | — | |
| NCT00579670 Treatment of Schizophrenic Patients With Ziprasidone | Schizophrenia | Completed | 450 | — | Ziprasidone | |
| NCT02944344 Four Conversations RCT | Breast Cancer | N/A | Completed | 357 | RCT, Open-label | — |
| NCT02669771 Long-Term Specified Drug Use-Results Survey for Xtandi Capsule | Castration-resistant Prostate Cancer | Completed | 1,018 | — | enzalutamide | |
| NCT01206361 Real World Data Study Assessing The Persistency Of Xalacom And The Other Fixed Dose Combination Products, Duotrav And Ganfort, In The United Kingdom | Glaucoma, Ocular Hypertension | Completed | 2,015 | — | XALACOM, Duotrav, Ganfort | |
| NCT05700396 Breast Cancer Survivor Educational Intervention | Breast Cancer, Breast Neoplasms | N/A | Completed | 7 | Open-label | — |
| NCT05546125 a Non-interventional Study of Sildenafil in the Treatment of Pulmonary Arterial Hypertension (PAH) in Adults From China | Pulmonary Arterial Hypertension (PAH) | Completed | 100 | — | — | |
| NCT00946114 To Provide Sildenafil Therapy To Eligible Adult Patients With Pulmonary Arterial Hypertension For 112 Weeks | Pulmonary Hypertension | Completed | 32 | — | sildenafil, sildenafil | |
| NCT03723954 Heart Rate Variations of Golf Fans During the 2018 the Ryder Cup | Heart Rate | Completed | 47 | — | — | |
| NCT00579254 Real Life Experience With Caduet In Patients With Cardiovascular Risk Factors | Hypertension and Cardiovascular Risk Factors | Terminated | 112 | — | CADUET (AMLODIPINE 5 mg/ATORVASTATIN 10 mg or 20 mg) | |
| NCT01304641 Cardiovascular Events Based On Statin Initiation In The Elderly | Cardiovascular, Dyslipidemia | Completed | 31,603 | — | — | |
| NCT05902494 HER2 and LA/mUC: A Multi-country Chart Review Cohort Study | Urothelial Carcinoma | Completed | 389 | — | — | |
| NCT00334750 Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada | Glaucoma, Open-Angle, Ocular Hypertension | Completed | 410 | — | — | |
| NCT01108900 A Study Of The Evaluation Of Patients Opulation With Erectile Dysfunction, Treated With Sildenafil | Erectile Dysfunction | Completed | 100 | — | sildenafil | |
| NCT05114902 PCV13 Impact on Pneumococcal Nasopharyngeal Carriage Study | Community-acquired Pneumonia | Unknown | 451 | — | — | |
| NCT01252563 Amlodipine 10mg Drug Use Investigation | Hypertension | Completed | 14,141 | — | Amlodipine | |
| NCT01897740 Sildenafil Therapy For Subjects Who Derive Clinical Benefit From Continued Treatment With Sildenafil | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | sildenafil | |
| NCT01107743 Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) | Hypertension, Angina Pectoris | Completed | 1,291 | — | Amlodipine/Atorvastatin | |
| NCT01003886 A Post Marketing Surveillance Study Of Doxazosin Mesylate GITS Among Filipino Patients With Benign Prostatic Hyperplasia (BPH) | Prostatic Hyperplasia | Completed | 989 | — | Doxazosin mesylate GITS | |
| NCT00605865 Drug Use Investigation of Jzoloft. | Panic Disorder, Depression | Completed | 2,272 | — | Sertraline hydrochloride | |
| NCT00797186 Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus | Type 2 Diabetes, Microvascular Dysfunction | N/A | Unknown | 150 | Open-label | — |
| NCT00768573 Taste Test of a New Formulation of Sildenafil (Revatio) | None Volunteer | Completed | 4 | — | sildenafil | |
| NCT01524796 NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark | Peripheral Neuropathic Pain | Completed | 128 | — | — | |
| NCT03342690 Drug Use Investigation of Selara Tablets (an Investigation for Chronic Heart Failure) | Chronic Heart Failure | Completed | 1,165 | — | Eplerenone | |
| NCT00599768 Development and Validation for Taiwan Version ID Pain Questionnaire (ID Pain-T) and DN4 Questionnaire. | Neuralgia, Nerve Pain | Completed | 325 | — | — | |
| NCT01220180 Lyrica (Pregabalin) Korean Post Marketing Surveillance Study | Epilepsy, Neuropathic Pain | Completed | 4,175 | — | pregabalin (Lyrica), pregabalin (Lyrica), pregabalin (Lyrica) | |
| NCT00874185 Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk | Erectile Dysfunction | Completed | 720 | — | — | |
| NCT01280747 Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study | Fibromyalgia, Painful Diabetic Peripheral Neuropathy | Terminated | 42 | — | — | |
| NCT00709787 Epidemiological Study In Hypertensive Patients: Assessment Of Risk Factors Prevalence And Of Patients' Management | Hypertension | Completed | 899 | — | — | |
| NCT06607393 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS3] | Metastatic Nonsmall Cell Lung Cancer | Completed | 851 | — | Pembrolizumab, Pemetrexed, Cisplatin, Carboplatin | |
| NCT02922179 Descriptive Analysis of Long- and Intermediate-Acting Insulin in Adult Diabetics | Diabetes | Completed | 103,951 | — | Long- and intermediate- acting insulins | |
| NCT01841905 Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's Disease | Alzheimer's Disease | Unknown | 60 | — | — | |
| NCT01243138 Africa and Middle East Cardiovascular Epidemiological Study | Obesity, Smoking | Completed | 4,386 | — | — | |
| NCT00892008 A Post Marketing Surveillance Study On Pregabalin (Lyrica) On Efficacy, Safety And Tolerability Of Pregabalin | Neuropathic Pain | Completed | 2,278 | — | Pregabalin | |
| NCT00486252 Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® | Glaucoma,Open-Angle, Ocular Hypertension | Completed | 996 | — | — | |
| NCT01607593 A Retrospective And Multicenter Survey To Investigate The Dosage, Efficacy And Safety Of Sertraline In Posttraumatic Stress Disorder Patients | Posttraumatic Stress Disorder | Completed | 123 | — | sertraline (Zoloft) | |
| NCT01365585 Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | Completed | 227 | — | sildenafil citrate | |
| NCT00822471 Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library | Diabetes, Cardiovascular Disease | N/A | Completed | 360 | Open-label | — |
| NCT05034289 Promoting INformed Approaches in Precision Oncology and ImmuNoTherapy | Clinical Trials, Immunotherapy | N/A | Completed | 81 | Open-label | — |
| NCT00673660 Observational Study On Compliance Of Statin Treatment Of Patients With High Blood Cholesterol Levels | Dyslipidemia | Completed | 375 | — | — | |
| NCT01236261 Prospective Population Study on Candidemia in Spain | Fungemia | Completed | 730 | — | — | |
| NCT00922987 Clinical Study With Lyrica In Patients Suffering From Epilepsy | Neuralgia, Epilepsy | Completed | 286 | — | Lyrica (pregabalin) | |
| NCT00993915 Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular Complications | Cardiovascular Diseases, Coronary Artery Disease | Completed | 687 | — | Atorvastatin | |
| NCT01792622 Patient Reported Outcomes in Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension | Withdrawn | — | — | — | |
| NCT00584519 Control of Metabolic and Cardiovascular Risk in Patients With Schizophrenia and Overweight | Schizophrenia | Completed | 430 | — | — | |
| NCT02958527 Drug Use Investigation Of Effexor (SECONDARY DATA COLLECTION STUDY; SAFETY AND EFFICACY OF EFFEXOR.UNDER JAPANESE MEDICAL PRACTICE) | Depression/Depressed State | Completed | 1,408 | — | venlafaxine | |
| NCT00454883 Non-interventional Study of Ziprasidone in the Treatment of Bipolar and Schizoaffective Disorders. | Affective Psychosis, Bipolar, Mania | Completed | 379 | — | ziprasidone | |
| NCT04175262 Clinical Outcomes For Patients With Metastatic Renal Cell Carcinoma (mRCC) Who Received Sunitinib After 1st Line Immune-oncology (IO) Treatments | Metastatic Renal Cell Carcinoma (mRCC) | Completed | 102 | — | sunitinib | |
| NCT01053429 A Non-Interventional Post-Marketing Surveillance Study to Evaluate the Safety and Efficacy of Zeldox Capsule | Bipolar Disorder, Schizophrenia | Completed | 3,391 | — | ziprasidone | |
| NCT01227395 Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients | HIV Infection | Completed | 476 | — | Azithromycin | |
| NCT01085461 Assessment of Suicidality in Epilepsy - Rating Tools | Epilepsy | Completed | 200 | — | — | |
| NCT01168323 Spaced Education to Optimize Prostate Cancer Screening | Prostate Cancer | N/A | Completed | 95 | RCT, Open-label | — |
| NCT01488578 Tolterodine Drug Use Investigation.(Post Marketing Commitment Plan) | Overactive Bladder | Completed | 11,157 | — | Tolterodine tartrate | |
| NCT00541476 Non-Interventional Study In Patients With Peripheral Or Central Neuropathic Pain Treated With Lyrica | Neuralgia | Completed | 746 | — | — | |
| NCT06585189 CARE Initiative: Real-world Emulation of the KEYNOTE-189 Trial [DS4] | Metastatic Non Small Cell Lung Cancer | Completed | 304 | — | Pembrolizumab, Pemetrexed, Cisplatin, Carboplatin | |
| NCT02565615 Atorvastatin Effectiveness and Safety in Cardiology Patients in Real World Setting | Coronary Artery Disease, Hypercholesterolemia, Hypertension | Completed | 5,115 | — | — | |
| NCT00584961 BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder | Bipolar Disorder | Completed | 553 | — | — | |
| NCT06607601 CARE Initiative: Real-world Emulation of the PALOMA-2 Trial | Metastatic Breast Cancer | Completed | 724 | — | Palbociclib, Letrozole | |
| NCT00749775 Selara Drug Use Investigation (Regulatory Post Marketing Commitment Plan) | Hypertension | Completed | 3,338 | — | Selara | |
| NCT00866983 Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil | Pulmonary Arterial Hypertension | NO_LONGER_AVAILABLE | — | — | sildenafil (Revatio) 20 mg TID | |
| NCT07086651 A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC), Cancer of the Prostate | Completed | 1,300 | — | Enzalutamide, Apalutamide | |
| NCT00002082 Azithromycin in the Treatment of Cryptosporidiosis in Patients With Acquired Immune Deficiency Syndrome (AIDS): A Randomized, Multi-Center, Placebo-Controlled, Double-Blind Study | Cryptosporidiosis, HIV Infections | N/A | Completed | — | Double-blind | Azithromycin |
| NCT00338741 Rebif® Pregnancy Registry | Multiple Sclerosis | Completed | 36 | — | — | |
| NCT00932165 Special Investigation For Patients With Renal And/Or Hepatic Disorders On Aromasin | Breast Neoplasms | Completed | 451 | — | Exemestane | |
| NCT02104557 Post Marketing Surveillance Study For Sayana® | Product Surveillance, Postmarketing | Completed | 362 | — | — | |
| NCT05403307 A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil | COVID-19 | Completed | 757 | — | Pfizer/BioNTech BNT162b2 mRNA COVID-19 vaccine, CoronaVac COVID-19 vaccine | |
| NCT00770887 Self Administration of Subcutaneous Depot Medroxyprogesterone Acetate | Fertility | Completed | 50 | — | — | |
| NCT01005706 Sirolimus Conversions in African-American Renal Transplant Recipients | Absence; Kidney | N/A | Completed | 40 | RCT, Open-label | rapamune, mycophenolate mofetil and steroid, tacrolimus, sirolimus and steroid |
| NCT01053065 The Multicenter Atorvastatin Plaque Stabilization (MAPS) Study | Symptomatic Carotid Stenosis, Hypercholesterolemia | N/A | Completed | 60 | RCT, Single-blind | Atorvastatin - Cholestyramine - Sitosterol |
| NCT00293709 Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists | Arthritis, Psoriatic, Psoriasis | Completed | 129 | — | etanercept | |
| NCT02315755 Observational Study Evaluating The Efficacy And Effects On Quality Of Life Of Targeted Treatments Following TKIs In mRCC | Renal Cell Carcinoma | Completed | 102 | — | — | |
| NCT00123058 Comparison of Two Programs to Improve Blood Pressure Treatment Adherence | Cardiovascular Diseases, Heart Diseases | N/A | Completed | 777 | RCT, Single-blind | — |
| NCT07320326 ASPIRE: A Registry Study Of Chinese Patients With TCE-RRMM Treated By Elranatamab | TCE-RRMM | Not Yet Recruiting | 159 | — | Elranatamab | |
| NCT01297348 Study Of Lybrel In Relation To Venous Thromboembolism | Venous Thrombosis, Pulmonary Embolism | Completed | 598,682 | — | 90ug levonorgestrel / 20 ug ethinyl estradiol, Oral Contraceptives containing 20 ug of ethinyl estradiol | |
| NCT01677065 A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers | Healthy | Completed | 14 | — | Oxycodone controlled-release test formulation, Immediate-release reference drug | |
| NCT04889495 A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer | Non-small Cell Lung Cancer, Metastatic Colorectal Cancer | Withdrawn | — | — | Zirabev | |
| NCT02174367 An Observational Cohort Study Evaluating Fatty Liver Disease and Liver Fibrosis in Moderate to Severe Psoriasis | Psoriasis Chronic, Liver Fibrosis | Unknown | 400 | — | — | |
| NCT02264665 OPALINE : A Study Of Morbidity And Mortality At 2 Years | Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive | Completed | 144 | — | sunitinib, everolimus, chemotherapies recommended in france | |
| NCT01704573 Nicotinic Receptor Levels After Stopping Smoking | Nicotine Addiction | Completed | 20 | — | 2-[18F]-fluro-3-[2(S)-2-azethidinylmethoxy]-pyridine | |
| NCT00483028 A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI | Alzheimer's Disease | N/A | Completed | 38 | RCT, Double-blind | donezepil (Aricept) |
| NCT01319656 Integration of Chronic Disease Rehabilitation Services Into Primary Care | Cardiovascular Disease, Heart Failure | N/A | Completed | 326 | Open-label | — |
| NCT01247311 Vitamin D and the Health of Blood Vessels in Kidney Disease | Chronic Kidney Disease (CKD) | N/A | Completed | 129 | RCT, Double-blind | — |
| NCT03559530 Acinetobacter Baumannii-related Osteomyelitis: Clinical and Epidemiological Characterization | Osteomyelitis | Completed | 262 | — | Antimicrobial | |
| NCT00724828 Study Evaluating Streptococcus Pneumoniae Serotype Carriage Rate for Nasopharyngeal Carriage in Filipino Children | Pneumonia, Bacterial | Completed | 500 | — | — | |
| NCT01317134 Endothelial Function in Patients With Pulmonary Arterial Hypertension | Hypertension, Pulmonary, Pulmonary Arterial Hypertension | N/A | Completed | 90 | Open-label | Blood Test |
| NCT05796245 A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis | Arthritis, Rheumatoid, Colitis, Ulcerative | Completed | 2,207 | — | — | |
| NCT02792504 Post Marketing Surveillance To Observe Safety And Efficacy Of Duavive | Severe Vasomotor Symptom Associated With Menopause | Completed | 669 | — | — | |
| NCT00480636 Fragmin In The Treatment Of Acute Deep-Vein Thrombosis With Or Without Pulmonary Embolism In Cancer Patients | Acute Deep Vein Thrombosis | Completed | 102 | — | Fragmin (dalteparin sodium ) | |
| NCT04307134 Besponsa Post Marketing Surveillance Study | Hematologic Malignancy | Completed | 108 | — | Inotuzumab ozogamicin | |
| NCT00747643 Varenicline Effects on Cue Reactivity and Smoking Reward/Reinforcement | Tobacco Dependence | N/A | Completed | 163 | RCT, Double-blind | varenicline, placebo |
| NCT00163618 Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children | Encephalitis, Tick-borne | Completed | — | — | Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl | |
| NCT04331340 Management of LUTS by Community Pharmacists | Lower Urinary Tract Symptoms | N/A | Completed | 64 | RCT, Single-blind | — |
| NCT06624020 A Study to Learn About How Medicines Called CDK4/6 Inhibitors Are Used in People With Advanced or Metastatic Breast Cancer in Australia | Breast Neoplasms | Completed | 1,128 | — | — | |
| NCT04823650 Monitoring Activity And Gait In Children | Child, Preschool, Child | Completed | 87 | — | — | |
| NCT01643928 Rheumatoid Arthritis Extension Trial For Subjects Who Have Participated In Other PF-05280586 Trials (REFLECTIONS B328-04) | Rheumatoid Arthritis | N/A | Completed | 185 | RCT, Double-blind | Rituximab-Pfizer (PF-05280586) x 3 courses, Rituximab-EU+ Rituximab-Pfizer x 2 Courses, Rituximab-US + Rituximab-Pfizer x 2 Courses |
| NCT02465892 Pillars4Life Trial | Breast Cancer, Lung Cancer | N/A | Completed | 284 | RCT | — |
| NCT01367834 Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome | Turner Syndrome | N/A | Completed | 17 | RCT, Open-label | somatotropin |
| NCT04724421 Expanded Access Protocol for Adults and Pediatric Patients With Sickle Cell Disease Who Have No Alternative Treatment Options | Sickle Cell Disease | NO_LONGER_AVAILABLE | — | — | Voxelotor | |
| NCT06743334 Secondary Databased Post-marketing Surveillance Study of BNT162b2 | COVID-19, SARS-CoV-2 | Completed | 1 | — | Tozinameran (BNT162b2), Tozinameran (BNT162b2) / Riltozinameran (BNT162b2 OMI BA.1), Tozinameran (BNT162b2) / Famtozinameran (BNT162b2 OMI BA.4-5) | |
| NCT03527563 Study on Internet Medical Models for the Management of Patients With Hypertension in China | Hypertension | N/A | Unknown | 958 | RCT, Open-label | — |
| NCT05671328 Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia | Ventilator Associated Pneumonia, Pulmonary Aspergillosis Invasive | Completed | 263 | — | — | |
| NCT03178071 Expanded Access For Lorlatinib For Patients With Non Small Cell Lung Cancer ALK Positive or ROS1 Positive | Non Small Cell Lung Cancer ALK Positive or ROS1 Positive | NO_LONGER_AVAILABLE | — | — | Lorlatinib | |
| NCT04721821 Comparative Effectiveness Of Tumor Necrosis Factor Inhibitors And Tofacitinib Use In Earlier Lines Of Therapy And Use As Monotherapy. | Arthritis Rheumatoid | Completed | 7,807 | — | Tofacitinib | |
| NCT04198844 The Effectiveness and Safety of Apixaban in NVAF Patients With History of Osteoporosis and/or Fracture: A Nation-wide Population Based Study | Atrial Fibrillation | Withdrawn | — | — | warfarin, apixaban | |
| NCT00418405 Hanyang University Medical Center Arthritis Network | Arthritis, Rheumatoid | Unknown | 1,500 | — | — | |
| NCT02017795 Asthma Self-management Via Application of Telehealth | Asthma, Mixed Asthma With Acute Exacerbation | N/A | Unknown | 100 | RCT, Double-blind | — |
| NCT01445873 Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH) | Pulmonary Arterial Hypertension | Completed | 36 | — | Sitaxentan sodium | |
| NCT00122083 An Evaluation of the Effectiveness of a Simple Marketing Intervention in Changing Student Attitudes to Depression | Depression | N/A | Completed | 1,680 | RCT, Open-label | — |
| NCT00550329 Bioequivalence Study Of Glucotrol XL 2.5 Mg Tablets | Diabetes Mellitus, Non-Insulin-Dependent, Hyperglycemia | Completed | 32 | — | Glipizide GITS | |
| NCT05139680 A Study to Examine the Clinical Effectiveness of Tafamidis in Patients With Mixed Phenotype Hereditary Transthyretin Amyloidosis | Hereditary Transthyretin Amyloidosis (ATTRv) Cardiomyopathy (CM), Mixed Phenotype | Completed | 10 | — | tafamidis | |
| NCT06790420 RITUXIMAB BS Intravenous Infusion 100mg・500mg [Pfizer] Post-marketing Database Study | Lymphoma | Completed | 1 | — | Rituximab Pfizer, Rituxan | |
| NCT00906074 Study Evaluating Severe Surgical Site Infections (SSIs) Following Contaminated Or Dirty-infected Abdominal Surgery | Surgical Wound Infection, Postoperative Wound Infection | Completed | 180 | — | — | |
| NCT00889603 Non-Interventional Study With Aricept® Evess | Alzheimer's Disease, Vascular Dementia | Completed | 370 | — | Aricept® Evess | |
| NCT03353532 Staphylococcus Aureus Surgical Site Infection Multinational Epidemiology in Europe | Staphylococcus Aureus, Wound Infection, Surgical | Completed | 178,902 | — | — | |
| NCT01521884 Study Looking at Longitudinal Changes in Fatigue and Health Status in Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous Anti-TNF-α Therapy | Rheumatoid Arthritis | Completed | 62 | — | — | |
| NCT00189033 Dietary Interventions in Irritable Bowel Syndrome: Soluble, Insoluble or no Fibre? | Colonic Diseases, Functional | N/A | Completed | 285 | RCT, Double-blind | psyllium fibre (dietary supplement), wheat bran (dietary supplement), rice wheat (placebo) |
| NCT00927043 Study Evaluating Renal Cell Carcinoma Risk Factors | Carcinoma, Renal Cell | Completed | 145 | — | — | |
| NCT01322633 Risk of Cancer Among Pantoprazole Users | Esophagitis | Completed | 61,864 | — | — | |
| NCT01544621 Escape Smoke Project: Non-Intervention Non-Drug Multicenter Study on the Real-life Effectiveness of Smoking Cessation in General Practice in Denmark | Smoking Cessation | Completed | 544 | — | — | |
| NCT00913406 Effect of Lutein in S-26 Gold On Growth And Safety | Healthy | N/A | Completed | 232 | RCT, Double-blind | — |
| NCT01732406 Acromegaly Treatment Quality of Life Study | Acromegaly | Completed | 126 | — | — | |
| NCT03900520 Pneumonia Research and Vaccine Impact League | Pneumonia | Completed | 6,004 | — | — | |
| NCT00471874 Study Evaluating Health Related Utility in Rheumatoid Arthritis | Rheumatoid Arthritis | Completed | 250 | — | — | |
| NCT04515589 Central Aspects of Pain in Rheumatoid Arthritis | Rheumatoid Arthritis | Completed | 95 | — | — | |
| NCT05487586 Real-World Study of Ceftazidime Avibactam in China | Hospital Acquired Pneumonia, Ventilator Acquired Pneumonia | Terminated | 220 | — | ceftazidime avibactam group | |
| NCT03715361 AF Stroke Substudy SL-ECG Versus 12lead ECG | ECG, Atrial Fibrillation | Completed | 550 | — | — | |
| NCT00428051 Colombia Epidemiologic Surveillance Study | Pneumonia, Meningitis | Terminated | 32,867 | — | — | |
| NCT01620996 A Novel Approach to Cardiovascular Health by Optimizing Risk Management (ANCHOR) | Cardiovascular Risk Reduction of Having a Coronary Event | N/A | Completed | 1,708 | RCT, Open-label | — |
| NCT00646451 Pregabalin in the Treatment of Essential Tremor | Essential Tremor | Early P1 | Completed | 20 | RCT, Double-blind | pregabalin (Lyrica), placebo |
| NCT01151085 Voriconazole (Vfend) Drug Use Investigation (Regulatory Post Marketing Commitment Plan) | Systemic Mycosis | Completed | 1,002 | — | Voriconazole | |
| NCT00503308 HIV Testing Strategies in the Perinatal Setting | HIV Infections, Pregnancy Related | N/A | Completed | 281 | RCT, Single-blind | — |
| NCT00002089 An Open-Label Study of the Use of Azithromycin in Patients With Symptomatic Disseminated Mycobacterium Avium-Intracellulare Complex (MAC) Infection Failing Current Therapy | Mycobacterium Avium-Intracellulare Infection, HIV Infections | N/A | Completed | — | Open-label | Azithromycin |
| NCT01326468 Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer | Head and Neck Cancer | N/A | Withdrawn | — | Open-label | Temsirolimus, Cetuximab, Cisplatin |
| NCT04653259 Digital Nutrition Therapy for Patients With IBD | Crohn Disease, Ulcerative Colitis | N/A | Unknown | 44 | RCT, Open-label | — |
| NCT02921126 Real-World Evidence of Anticoagulation Treatment In Non-Valvular Atrial Fibrillation In Italy | Anticoagulation | Completed | 9,914 | — | — | |
| NCT01917214 A Retrospective Real World Analysis Of Sutent In Patients With Metastatic Renal Cell Carcinoma In Community And Academic Centers To Assess The Impact Of Dose Variation On Duration Of Response And Overall Survival | Metastatic Renal Cell Carcinoma | Completed | 212 | — | — | |
| NCT06113952 A Study to Compare the Experiences of Taking Daily Growth Hormone Injections to Weekly Ngenla in Children With Low Levels of Growth Hormone | Pediatric Growth Hormone Deficiency | Withdrawn | — | — | — | |
| NCT00248352 A Study Comparing Standard Care for Diabetes to Case-Managed Care for Diabetes in Patients With Coronary Artery Disease | Diabetes Mellitus, Type 2, Coronary Disease | N/A | Completed | 212 | RCT, Open-label | — |
| NCT00798889 Rollover Protocol for Prior SU011248 Protocols | Solid Tumors | N/A | Completed | 314 | Open-label | Sunitinib |
| NCT01936376 A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers | Head and Neck Cancer | Unknown | 150 | — | — | |
| NCT00958997 Positron Emission Tomography (PET) Imaging of Pancreatic Beta-Cell Mass in Healthy and Type 1 Diabetic Patients | Diabetes Mellitus, Type 1 | Completed | 16 | — | 18F-FP-DTBZ (18F-AV-133), Arginine-hydrochloride | |
| NCT04456582 Noninvasive Assessment of Myocardial Stiffness by 2D-SWE Ultrasound Technique (Bidimensional Shear Wave Elastography) in Patients With Transthyretin Amyloidosis | Amyloidosis | N/A | Unknown | 60 | Open-label | — |
| NCT01040585 Cost Effectiveness Of Linezolid In Central America | Ventilator Acquired Pneumonia | Withdrawn | — | — | Linezolid | |
| NCT01947894 A Prospective Non-Interventional Study Protocol With Primary Data Collection - Assessment Of The Long Term Treatment Outcomes Of Genotropin Treatment In Growth Hormone Deficiency (GHD) Patients | Growth Hormone Deficiency | Completed | 377 | — | — | |
| NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study | Venous Thromboses, Venous Thromboembolism | Completed | 266,890 | — | — | |
| NCT03127605 Inotuzumab Ozogamicin - PF-05208773 | APPROVED_FOR_MARKETING | — | — | Inotuzumab Ozogamicin | ||
| NCT00242229 Study Evaluating DVS-233 SR in Elderly Outpatients With Major Depressive Disorder | Major Depressive Disorder | N/A | Completed | 52 | RCT, Open-label | DVS-233 SR |
| NCT00827541 Post-Authorization Study Evaluating Safety Of Tigecycline | Intra-Abdominal Infections, Skin Disease, Infectious | Completed | 115 | — | Tigecycline | |
| NCT00827502 Trulimax (Azithromycin ) Non-Interventional Study In Acute Bacterial Upper Respiratory Tract Infections | Upper Respiratory Tract Infections | Completed | 421 | — | — | |
| NCT01648751 Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse | Pelvic Organ Prolapse | N/A | Terminated | 21 | RCT, Double-blind | Vaginal estrogen, Placebo |
| NCT00374829 Impact of an IT-Based and Healthcare Professional Support Program on Patients With High Blood Pressure | Hypertension | N/A | Unknown | 223 | RCT, Open-label | — |
| NCT05699135 A Study to Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer | Urinary Bladder Neoplasms, Bladder Cancer | Terminated | 150 | — | Avelumab first-line maintenance |